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Thesis summary 
 
Background: Diagnostic prediction rules are tools to assist clinical decision making and aim to 
either improve patients’ health or provide other benefits without adversely affecting patients. 
However their uptake in clinical practice has been limited. Possible explanations include 
uncertainty about their performance compared to and in combination with clinicians’ clinical 
judgment and complexity for use at the bedside.  
Objectives: My four aims in this thesis were to: 
1. compare the diagnostic performance of diagnostic prediction rules and clinical 
judgment versus a reference standard; 
2. determine the effect of care provided with and without diagnostic prediction rules on 
patient and process outcomes;  
3. derive and validate a prediction rule for the identification of children with serious 
bacterial infection in primary care, and to determine the accuracy, independent and 
added value of an inflammatory biomarker, C-reactive protein (CRP). An existing 
dataset was to be used for the derivation study and study of the added value of CRP;   
4. investigate how simplifying a prediction rule affected performance.  
Methods: To address aim 1, I completed a systematic review comparing the diagnostic 
performance of diagnostic prediction rules and clinical judgment against a reference standard. 
To address aim 2, I completed a systematic review comparing the effect of care provided with 
and without a diagnostic prediction rule on patient health and process outcomes. To address 
aim 3, I completed a systematic review of the diagnostic accuracy and independent value of 
CRP for detecting serious bacterial infection in non-hospitalised children. However, due to the 
volume of missing data in the dataset sourced to derive the prediction rule, a valid prediction 
rule could not be derived. To address aim 4, I conducted a study in which an existing prediction 
rule was simplified using several methods, and the effect on performance assessed.  
Results: Existing diagnostic prediction rules were not clearly superior to clinical judgment in 
terms of diagnostic performance.  In some situations prediction rules moved the threshold for 
diagnosing disease such that fewer patients with disease were missed, but this was at the cost 
of further investigations in a larger proportion of patients, or vice versa. The findings are 
limited by the small number and potential biases of the included studies. Diagnostic prediction 
rules improved symptoms and reduced antibiotic prescribing for sore throat, improved early 
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discharge and hospitalisations for possible cardiac chest pain and reduced time to therapeutic 
operations in suspected appendicitis, but did not improve process outcomes in studies of 
children with fever. Few studies evaluated patient health outcomes and details of study 
interventions and implementation were infrequently reported. CRP provides moderate 
diagnostic information for ruling in and ruling out serious bacterial infection in non-
hospitalised children and diagnostic information independent of other clinical features. 
Simplifying a diagnostic prediction rule did not affect overall accuracy, but reduced the 
proportion of patients classified as low risk and resulted in worse classification.  
Summary: In terms of diagnostic performance, existing diagnostic prediction rules do not 
clearly outperform the judgment of clinicians. However, they may improve patient health and 
process outcomes in some clinical conditions. C-reactive protein provides useful diagnostic 
information for children with suspected bacterial infection. Simplification reduced the 
performance of one diagnostic prediction rule with acceptability of this context dependent. 
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1.1 Introduction 
A clinicians’ ability to diagnose accurately is central in determining an individuals’ prognosis 
and providing timely and appropriate treatment.  However, making a diagnosis is often 
challenging and uncertainty an error a common feature of the diagnostic process.  Clinical 
prediction rules are tools developed to assist clinicians’ clinical reasoning and decision making. 
(1, 2) Clinical prediction rules designed for use in the diagnostic setting provide an estimate of 
the probability of an outcome being present and/or suggest a course of clinical action for an 
individual based on the underlying probability estimate using data on multiple individual level 
characteristics. There is a belief or expectation among proponents of these tools, that these 
tools will enhance diagnostic reasoning and decision making, and ultimately improve patient 
health or provide other benefits without causing harm.       
1.1.1 The terminology of clinical prediction rules 
The term ‘clinical prediction rule’ is generally used to refer to variably presented and labelled 
prediction tools that convert a combination of predictor values from an individual (such as age 
or gender, symptoms or findings from examination or laboratory or imaging investigations) to 
an estimate of the probability that a certain condition or disease is present (diagnosis) or will 
occur in the future (prognosis). When the clinical prediction rule provides an estimate of the 
probability that a certain condition or disease is present at the moment of prediction, and is 
developed for used in individuals suspected of having that condition, it is a diagnostic clinical 
prediction rule.  When the clinical prediction rule estimates the probability of a particular 
outcome or event occurring in a certain time period in the future, and is intended for use in 
individuals at risk of developing that outcome, it is a prognostic clinical prediction rule.  In 
earlier eras, clinical prediction rules were predominantly developed based on expert opinion, 
but the majority of contemporary clinical prediction rules are created by applying multivariable 
statistical techniques to data from patients in whom the outcome of interest is known.  
Clinical prediction rules are known by an array of synonymous terms including prediction tools 
or guides, decision rules, algorithms or risk scores. They may also be termed ‘decision aids’ or 
‘decision support systems’. However, while decision aids and decision support systems may 
incorporate a clinical prediction rule, they are complex interventions that are not synonymous 
with clinical prediction rules (3, 4) Though there is no agreement among developers and 
researchers in the area about the most appropriate term used to label clinical prediction tools, 
there is a desire to differentiate between and differentially label prediction tools that provide 
guidance to clinicians in the form of a probability estimate that reflects the continuum 
between absolute certainty (Pi=1) and certified impossibility (Pi=0) as prediction ‘models’ (see 
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Box 1-1), and those that, through the application of a decision threshold to the probability 
estimate, classify an individual into a risk group (i.e. high or low risk or positive or negative for 
disease) as prediction ‘rules’. (5, 6) There is also a desire to distinguish between prediction 
tools that provide a the user with a probability estimate only, and those that explicitly 
recommend clinical actions. The former, preferentially labelled ‘prediction’ rules, intend to 
assist clinicians without telling them what to do and assume that accurate predictions will 
improve clinical decisions. The later, known as ‘decision’ rules aim to effect clinical decisions 
directly. (5) The recommendations provided by diagnostic ‘decision’ rules may relate to further 
diagnostic testing or treatment or both. For instance, the Ottawa Ankle Rules, (7) when used in 
the assessment of acute ankle injury, identify a group of patients in whom fracture is very 
unlikely and x-ray unnecessary (Box ‎1-2). The Modified Centor Score, (8) when used in patients 
with a sore throat, provides three possible recommendations on further diagnostic testing and 
treatment (Box ‎1-3).   
1.1.2 The focus of and terminology used in this thesis 
Prediction tools developed for use in the diagnostic setting and derived from  multivariable 
statistical analyses are the focus of this thesis. Such tools provide an estimate of the 
probability of the presence of an outcome (and/or recommend a clinical course of action) for 
an individual at the moment of prediction and are developed for use in individuals suspected of 
having that condition. (1) The terminology to be used in this thesis is outlined below.  It is 
provided as a guide to facilitate reading of the thesis rather than as a definitive lexicon.    
Diagnostic prediction rule: This term is used throughout the introduction, Chapter 4 and 
discussion section of the thesis to refer to prediction tools developed for use in the diagnostic 
setting that provide either an estimate of the probability of the presence of the disease of 
interest (so called ‘prediction’ rules) and/or recommend a course of clinical action (so called 
‘decision’ rules).  The information presented in the introduction and discussion of the thesis 
relates, as far as possible, to diagnostic prediction rules specifically.  However, where the 
literature presented does not differentiate between diagnostic and prognostic prediction rules 
(as in the section on barriers to use of clinical prediction rules); the term ‘clinical prediction 
rule’ is used.   
Clinical prediction rule: In the introduction and discussion sections of this thesis, the term 
clinical prediction rule refers to prediction tools that may be used in the diagnostic or 
prognostic setting and that either provide a probability estimate and/or recommend a course 
of clinical action.  In Chapters 2, 3, and 6, which present published manuscripts, the term 
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clinical prediction rule or CPR is used for brevity as preferred by journal editors, though when 
used, the terms refer specifically to diagnostic clinical prediction rules.   
1.1.3 Applications of diagnostic prediction rules 
In the diagnostic setting, the probability estimate or risk classification  provided by a diagnostic 
prediction rule  may inform clinicians’ decisions as to whether a particular condition can be 
safely ruled out or ruled in, or be used for shared decision making with patients. When the 
diagnostic prediction rule provides a recommended course of action, this may be used to assist 
clinicians’ decisions on whether or not to order more invasive or costly diagnostic tests, or to 
identify patients who may benefit from referral. (1, 2, 9-11)  
Box ‎1-1. A clinical prediction rule for chronic obstructive pulmonary disease (COPD) 
 
Probability of COPD presence = 1/(1 + exp – [-5.6 + 0.2 x every 5 years above age of 50 + 0.6 x 
male sex + 1.0 x current smoking + 0.7 x >20 pack years + 0.6 x cardiovascular disease + 0.6 x 
complaints of wheezing + 0.7 x diminished breath sounds]) 
 
For a 62 year old male who complains of wheezing the predicted probability (pCOPD) is 
calculated as follows; 
 
1/(1 + exp – [-5.6 + 0.2 x 2 + 0.6 x 1 + 1.0 x 0 + 0.7 x 0 + 0.6 x 0 + 0.6 x 1 + 0.7 x 0]) 
pCOPD = 2 % 
Republished with permission of the Royal College of General Practitioners, from Does a decision aid help physicians 
to detect chronic obstructive pulmonary disease?, Broekhuizen et al., 61(591), 2011. (12); permission conveyed 
through Copyright Clearance Centre, Inc.  
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Box ‎1-2. A clinical prediction rule (Ottawa Ankle Rules) providing a testing recommendation 
 
Reprinted from the Annals of Emergency Medicine, 21(4) Stiell et al., A study to develop clinical decision rules for 
the use of radiography in acute ankle injuries, 384-90,  1992 (7), with permission from Elsevier.  
 
 
Box ‎1-3. A clinical prediction rule (The Modified Centor Score) providing a testing and treatment recommendation 
 
 
Reprinted from McIsaac et al., A clinical socre to reduce unnecessary antibiotic use in patients with sore throat, 
Figure 2, Canadian Medical Association Journal (1985, 158(1), 75-83. (8) © Canadian Medical Association (1985). 
This work is protected by copyright and the making of this copy was with the permission of the Canadian Medical 
Association Journal (www.cmaj.ca) and Access Copyright. Any alteration of its content or further copying in any 
form whatsoever is strictly prohibited unless otherwise permitted by law.   
  
Clinical prediction rules for assisting diagnosis 
 
6 
 
1.2 Diagnostic reasoning and error in healthcare 
The ability to transform medical data into an actionable diagnosis is the most critical of 
clinicians’ skills (13) and is central to providing timely and appropriate treatment.  It is of great 
importance to clinicians and patients alike. If a correct diagnosis is not made or is delayed, 
effective treatment may be withheld or patients may undergo inappropriate medical 
treatment, or they may receive inaccurate information about their prognosis. 
1.2.1 Clinical reasoning and diagnosis 
According to the prevailing model of clinical reasoning, clinicians’ decisions about diagnoses 
are characterised by both fast, unconscious (System 1), and slow, analytical conscious (System 
2) processes. (13) System 1 processing, also known as non-analytical processing, is 
characterised as an automatic and intuitive, largely heuristic process that allows clinicians to 
formulate diagnostic hypotheses efficiently and rapidly. System 2 processes are recognised as 
analytical, logical, deliberate processes of carefully and systematically gathering and weighting 
information. The systems are consistent with the recognised reasoning strategies of pattern 
recognition and hypothetic-deductive reasoning in their modus operandi and have been 
shown to be congruent with the reasoning processes of clinicians from several specialities. (14-
16) It is believed both systems are jointly involved in reasoning, with valance towards one 
system or another depending upon time constraints, the complexity of the situation, the 
nature of the problem (ambiguous, non-routine or ill-defined problems) and the context of 
uncertainty. (17) 
1.2.2 Diagnostic error 
Despite the importance of accurate diagnosis, diagnostic errors occur at an appreciable rate. 
(18) In a recent review of studies, diagnostic errors (defined as unintentionally delayed, wrong 
or missed diagnoses as judged from the eventual appreciation of more definitive information 
(19)) were found to occur at a rate of approximately 5% in perceptual specialties (for example 
radiology where diagnosis is made based on the perception of an image) and up to 15% in 
other settings requiring more data gathering and synthesis (for example primary care and 
emergency departments). (20) Although not all diagnostic errors translate into harm, a 
substantial number are associated with preventable morbidity and mortality (21) with 
diagnostic errors reported to result in death or disability twice as often as other types of 
medical error. (22) 
Causes of diagnostic error have been found to include one or more of the following: clinician 
cognitive factors (clinicians perceptual and thought processes) or faulty knowledge or skills; 
systems factors (organisational, technical and equipment problems); and patient factors 
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(communication practices and variability in clinical presentation). (19, 23) In a study to 
determine the contribution of system related and cognitive aspects to diagnostic error, 
diagnostic error was commonly multifactorial in origin with both system and cognitive factors 
the cause of error in 46% of cases. Cognitive factors were found to contribute to diagnostic 
error in 74% of cases (in 28% of cases it was the sole cause of error) and system related factors 
in 65%, while errors arising from faulty or inadequate knowledge were uncommon. (19)  
The cognitive failings that lead to diagnostic error have typically been attributed to cognitive 
biases associated with the non-analytical, intuitive (system 1) thinking, though they have also 
been found to be associated with analytical (system 2) reasoning. (24-26) A substantial number 
of cognitive biases that may affect decision making in the non-medical world have been 
identified and described and applied to the domain of medical practice.(27, 28) In one of the 
most extensive studies of the mechanisms of diagnostic errors, errors arising from flawed 
processing of the information gathered were more common than errors caused by knowledge 
gaps. (19) In this study, the most common information synthesis error was premature closure; 
the tendency to stop considering other possibilities after reaching a diagnosis. Other common 
causes of error were faulty context generation, faulty perception (for example incorrect 
reading of x-rays) and failed use of heuristics. (19) It is noted however, that the currently used 
research methods for examining the causes of diagnostic error are limited for examining the 
causal relationship between diagnostic reasoning and error. (29) As such, naturalistic and 
experimental research is being undertaken to determine the connection between diagnostic 
reasoning processes and diagnostic errors. (30, 31) 
Other inherent aspects of the diagnostic task, primarily the amount and mutual dependence of 
information collected during the diagnostic workup, also adds significant challenges to 
achieving accurate diagnosis and optimal decisions. Diagnostic reasoning often involves the 
collection of a substantial amount of information obtained from the patient history and 
physical examination and application of laboratory and imaging tests. In principle, the clinician 
implicitly integrates the information received into a judgment regarding the probability of the 
suspected or differential diagnosis. (32) However, this information is often received in an 
idiosyncratic manner and may simply be too much for clinicians to process (so-called bounded 
rationality). Further, the information obtained is to varying degrees overlapping or mutually 
dependent. Simply because diagnostic tests contribute either directly or indirectly to the cause 
or the result of the same underlying disease, they are likely to be correlated and provide to 
some extent the same information. For example, creatine kinase and troponin are blood tests 
that may be used in the assessment of chest pain. Both tests measure enzymes found in the 
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blood that are released when there is damage to the heart muscle cells. Because the enzymes 
measured by these tests occur through a related pathological mechanism there is a degree of 
dependency between the tests. Mutual dependency between test results means that the 
diagnostic potential of a test is conditional upon the information obtained from previous tests, 
(32) that is, the diagnostic value of troponin changes when creatine kinase is also used.   
Accounting for the mutual dependency between test results and reliably judging the relative 
contribution or true diagnostic value of the multiple symptoms, signs and test results for a 
diagnosis, presents a formidable obstacle for clinicians. Studies of novice and experienced 
clinicians have shown that both have difficulties in recognising the diagnostic value of 
information, leading them to use non-discriminatory findings - signs or symptoms that are not 
able to accurately validate a diagnosis, to support a diagnosis. (33, 34) A clinicians’ 
understanding of the diagnosticity of clinical information arises primarily from clinical 
experience. However, clinical experience is fallible: 
If our case numbers were truly vast (hundreds, if not thousands), if the spectrum of disease 
we had seen was sufficiently wide and representative, if we had used diagnostic criteria 
consistently over time, if we had searched for each clinical finding equally diligently in every 
patient, and if our memories were perfect, then perhaps our library of remembered cases 
would allow us to accurately estimate the frequencies of clinical manifestations of that 
disease and interpret them properly (35 p.A12) 
Consequently;  
…Short of exposure to truly representative samples, it may be difficult, if not impossible to 
determine relations among multiple pieces of diagnostic information and to distinguish 
what is useful from what is useless (36 p.1671)   
 
1.3 Clinical prediction rules as a strategy for improving diagnostic reasoning 
and reducing error 
As part of a greater patient safety focus in healthcare over the last decade, there has been 
heightened awareness of the extent and implication of diagnostic errors and increasing study 
aimed at determining the incidence and etiology of these errors. (37, 38) Though recent 
research in this area suggests that diagnostic errors have both cognitive and systems origins, 
(19) the prevailing belief has been that diagnostic errors are  principally the result of flaws in 
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the way clinicians think; that clinical judgment is suboptimal and flawed for making diagnosis 
and good clinical decisions.  
As such, strategies for minimising the cognitive shortcomings of clinicians have been pursued. 
(39) Diagnostic clinical prediction rules are one such strategy. Based on decades of research 
showing the superiority of statistical models over clinical judgment as alternate methods for 
integrating clinical data (36), there is a belief or expectation that prediction rules, through the 
provision of ‘accurate and objective’ estimates of probability, will lead to improved accuracy of 
diagnosis and subsequent clinical decisions. These sentiments are reflected in the following 
statements found in key multivariable prediction rule methodological and position papers: 
“Clinical prediction rules … are formulated to improve the efficiency and accuracy of 
physicians judgments” (40 p.797) 
“Clinical decision rules attempt to formally test, simplify and increase the accuracy of 
clinicians diagnostic and prognostic assessments” (41 p.79) 
“Clinical prediction rules provide powerful tools to improve clinical decision making…” (5 
p.207) 
“Prediction models are increasingly used to complement clinical reasoning and decision 
making in modern medicine” (42 p.683) 
“Prediction models are being developed… with the aim to assist doctors and individuals in 
estimating probabilities and potentially influence their decision making” (1 p.w1) 
Though rarely articulated in these documents, the underlying rational for the development  of 
diagnostic prediction rules is the expectation and unproven assumption that altered clinical 
decisions arising from their use will ultimately lead to improved patient outcomes or will 
confer other benefits (such as reduced resource use) without adversely affecting patients. Also 
implicit in these statements is the supposition that the two methods of judgment, clinical 
(clinical judgment) and statistical (clinical prediction rules) are used in combination, and that 
this approach is superior to either the statistical model (prediction rule) or clinical judgment 
alone. 
These expectations have led to a tremendous increase in the number of published articles 
relating to clinical prediction research over the last decade. ‘Prediction research’ comprises 
predictor finding studies (studies which aim to discover which predictors out of a number of 
candidate predictors independently contribute to the prediction of an outcome), clinical 
prediction rule studies (studies deriving or validating a multivariable clinical prediction rule) 
and impact studies (studies which quantify the effect of a clinical prediction rule). This increase 
is evident in Figure 1.1 which shows the number of prediction research studies (a total of 
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155,783 in 2014) published in PubMed (identified using a suggested search strategy for 
retrieving prediction research (43)) as a fraction of the total number of studies indexed in 
PubMed over the last decade. In relation to clinical prediction rules specifically, reviews have 
shown the increasing number of publications reporting their development over time (44, 45). 
In addition, clinical prediction rules are increasingly included in clinical practice guidelines and 
recommended for use by national bodies (46-48). For every article describing the development 
of a prediction model that is published, there may be half as many again, that remain 
unpublished (49). 
Figure ‎1.1 Studies of clinical prediction research (including predictor finding studies and clinical prediction rule 
studies) in PubMed published between 1994 and 2014 as a fraction of the total number of studies in PubMed  
 
1.3.1 How clinical prediction rules may alter clinical decision making and influence patient 
outcomes.     
The mechanisms by which clinical prediction rules may alter decisions and health outcomes 
are rarely articulated in studies describing their development. However, based on a framework 
of mechanisms through which a diagnostic test can cause changes to patient health, (50) the 
means by which a diagnostic prediction rule may conceivably influence clinical decisions and 
patient outcomes can be explored.   
The basic relationship between diagnostic tests such as diagnostic prediction rules and patient 
outcomes may be understood as a series of intermediate steps occurring between the two. 
This relationship is depicted in a simplified test-treat pathway (Figure ‎1.2). (50) Changes to any 
aspect of the pathway caused by the introduction of a diagnostic prediction rule could induce 
changes in patient outcomes.   
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Figure ‎1.2. Simplified test-treatment pathway showing the components of patient management that can 
influence patient health 
 
Reproduced from The BMJ, Ferrente di Ruffano et al., 344, e686, 2012 (50), with permission from  BMJ Publishing 
Group Ltd.  
1.3.1.1 Altering clinical decisions and actions 
The most widely recognised means for a diagnostic test such as a clinical prediction rule to 
affect downstream patient health is through its capacity to change decision making and 
management guided by the test result. (51) Depending upon the information provided by a 
diagnostic prediction rule (a probability estimate or a management recommendation), it may 
conceivably act to alter testing or treatment decisions directly or via a pathway of improved 
diagnostic accuracy. 
1.3.1.1.1 Altering clinical decisions and actions via changes to the diagnostic accuracy of 
clinical judgment 
Both the outcome of a prediction model or rule (i.e. the probability estimate or risk 
classification) and the actual process of using the rule may alter the clinicians’ ability to 
produce classifying information more accurately. Within the framework of probabilistic 
reasoning, in which a clinician continually revises their estimate of the probability of the 
disorder as clinical information is obtained, the estimated probability provided by a diagnostic 
prediction rule may either move a clinicians probability estimate above the test- treatment 
threshold in which case a diagnosis is made and treatment can be started, or below the test 
threshold where the probability of the disease being present is so low that either the individual 
can be reassured the disease is not present, an alternative diagnoses be pursued, or a watchful 
waiting practice adopted (Figure 1.3). (52, 53) 
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 Figure ‎1.3 The threshold approach to diagnosis  
  
 
 
 
Alternatively, or in addition, by specifying the data required to derive output from the model, a 
clinician’s attention is focused on factors from the history or examination that are known to be 
predictive of the disease of interest and possibly to discounting clinical variables that are less 
predictive. This ‘honing of their gestalt’, in itself, may have an effect on accuracy. (54)   
For a multivariable diagnostic prediction rule to enhance the diagnostic accuracy of a clinician, 
the prediction model or rule itself must provide more accurate probability estimates or have 
greater ability to distinguish between individuals with and without disease than clinical 
judgment alone. There are several reasons to believe that the outputs of prediction rules 
would be more accurate than clinical judgment. Firstly, when derived using multivariable 
regression modelling techniques applied to data from patients in whom the outcome is known, 
diagnostic prediction rules specify the combinations of predictors (information from the 
history, examination or test results) that, in view of other test results, have true predictive 
value for the outcome of interest. That is, they account for the mutual dependencies 
(correlation) between the different test results and ensure only those pieces of diagnostic 
information from the history, examination or test results that independently contribute to the 
estimation of the probability of disease presence are included and information that has no 
predictive power is ignored. Secondly, when multivariable logistic regression is used to derive a 
prediction model, the predictors are ‘weighted’ in accordance with their contribution to the 
estimation of the probability of disease presence. The estimated regression coefficients reflect 
the relative ‘weight’ of each predictor when mutually adjusted for the other predictors in the 
model, thus quantifying the independent contribution of each predictor to the outcome 
probability or risk estimation. (42) This is illustrated in Box ‎1-4 below.   
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Box ‎1-4. Multivariable logistic regression model for the diagnosis of pulmonary embolism showing the estimated 
regression coefficients which reflect the relative ‘weight’ of each predictor.  
Reproduced from Diagnostic and prognostic prediction models, Hendriksen et al., Journal of Thrombosis and 
Haemostasis, 11(Suppl 1). (10) Copyright © 2013 John Wiley and Sons.  
The comparative accuracy of clinical judgment and so called, ‘statistical methods‘ of 
prediction, in which predictions are based on empirically established relations between patient 
data and the condition to be predicted, has been extensively studied and debated. (36, 55-59)  
With few exceptions, studies and reviews published from the 1950s comparing the two 
methods of prediction from across a wide range of domains including finance, education, 
psychology and medicine, have concluded that statistical prediction methods are more 
accurate than clinical procedures. (36, 55, 58) This has been the case for comparisons where 
judgments are based on the same data (and are thus comparing the interpretive or data 
combination ability of the methods), in comparisons where judges have access to preferred 
sources of information (comparing the clinical judges collection and interpretation of 
information with the statistical method), when the statistical models are simple linear 
classification rules and when clinical judges have access to the statistical model. (36) However, 
this conclusion has been challenged by a more recent body of experimental work on heuristics, 
proposed as descriptive models of human judgment by ‘real minds under the constraints of 
limited knowledge and time’  which has found heuristics to be as accurate or, on occasions, 
more accurate than statistical models. (56)   
1.3.1.1.2 Altering clinicians decisions and actions directly 
Aside from altering clinical decision via a process of improved diagnostic accuracy, diagnostic 
prediction rules which provide specific testing and treatment recommendations may act 
directly to modify clinicians’ decisions. Conceivably, the recommendations of a prediction rule 
may alter a decision that is already made by the clinician, or guide the clinician to a decision 
different to one they would have arrived at without the input of the prediction rule. Whether 
Predictor Regression coefficient (SE) OR (95% CI P-value 
Intercept -3.75 (0.34) - - 
Clinical signs and symptoms DVT 1.93 (0.33) 6.9 (3.6-13.2) <0.01 
PE most likely diagnosis 1.32 (0.34) 3.8 (1.9-7.3) <0.01 
Heart rate > 100 beats min
-1
 0.90 (0.31) 2.4 (1.3-4.5) <0.01 
Recent immobilization or surgery 0.71 (0.32) 2.0 (1.1-3.8) 0.03 
Previous DVT or PE 0.91 (0.34) 2.5 (1.3-4.8) <0.01 
DVT, deep venous thrombosis; PE, pulmonary embolism; OR, odds ratio; CI, confidence interval; SE standard 
error.  The intercept reflects the baseline risk.  The regression coefficient reflects the relative weight per 
predictor.  The exponent of a regression coefficient yields the odds ratio (OR) of the predictor.  An OR of 2.0 
for the predictor ‘recent immobilization or surgery’ indicates that the odds of having PE in a patient suspected 
of PE is twice as high if the predictor is present, compared with a situation in which the predictor is absent, all 
other predictors kept constant. 
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either of these could occur would likely depend on the clinician’s confidence in the tool 
providing the recommendation.   
1.3.1.2  Altering the timing of diagnosis or clinical decisions 
Patient outcomes may improve if tests are undertaken earlier or produce results more quickly, 
triggering an earlier diagnosis or treatment. (50) Prediction rules comprised of few easily 
obtainable highly diagnostic indicators from the patients history or physical examination may 
provide results earlier than the alternative test or testing strategy. For example, a diagnostic 
strategy for the evaluation of chest pain patients comprised of a prediction model based on 
features from the history and physical examination and NT-proBNP test, may allow important 
information to be available more quickly than a departmental strategy based on exercise 
testing that is often not readily available and for which the patient may have to wait. (60)   
1.3.1.3  Altering the impact of the test process 
Diagnostic prediction models and rules may also influence health outcomes independently of 
subsequent diagnostic or treatment decisions by reducing harms arising from the testing 
procedure itself. For instance, among children with suspected serious infection, a diagnostic 
strategy comprised of a prediction rule (composed of elements from history and examination) 
and simple point of care test may confer direct physical benefits due to the avoidance of more 
invasive testing that may occur with the alternative method of investigation.     
1.3.1.4 Other mechanisms for altering clinical decisions or outcomes 
Diagnostic tests may also alter patient outcomes through their influence on the patients’ 
perception and experience of the testing process and response to their test result. (50, 61) For 
instance, patients may feel less confident in the skill of a clinician who utilises a clinical 
prediction rule or may feel that the investigation has been less thorough. Impressions of 
thoroughness may encourage improvements in perceptions of health status and lead to 
changes in patients’ behaviours including adherence to medical advice which will affect health 
outcomes. However, patients’ reactions to test results and diagnosis can be unexpected and 
difficult to predict and can have both beneficial and negative effects. For example, use of a 
prediction rule may influence the rate of referral or diagnosis. If serious disease is ruled out 
more promptly psychological benefits may ensue. On the other hand, confirming the presence 
of disease may increase anxiety and stress which affects aspects of mental health and social 
and physical wellbeing. (61)  
To summarise, diagnostic prediction rules may theoretically affect patient health outcomes in 
numerous complex ways. In addition to direct effects arising from the attributes of the 
prediction rule itself, diagnostic prediction rules may alter clinical decisions directly or through 
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a process of improved accuracy. In another pathway, prediction rules may affect the 
timeframes of diagnoses and or decisions and actions leading to changes in patient health.  
1.4 The derivation, validation and assessment of the impact of clinical 
prediction rules 
Conventionally, multivariable clinical prediction tools are developed in a multistep process 
involving 3 phases: derivation; validation; and analysis of impact (Figure ‎1.4). Each phase has a 
defined purpose and detailed methodological criteria that can be applied mutatis mutandis to 
both prognostic and diagnostic prediction rules have been published. (1, 2, 42, 62-64) The 
following description of each phase is deliberately brief, with detail provided only on 
methodological aspects relevant to the remainder of the thesis.   
Figure ‎1.4. Stages in the development of a clinical prediction rule 
 
1.4.1 Stage 1 –Derivation and internal validation of a clinical prediction rule 
Derivation of a multivariable diagnostic prediction model involves establishing the cross-
sectional relationship between predictor variables (symptoms, signs or diagnostic tests) and 
the presence or absence of the target condition of interest. This is typically achieved through 
the application of statistical techniques to data obtained from a study of individuals suspected 
of having the disease of interest in which the outcome of interest is reported. (65)  The 
resulting model is a mathematical function which relates the presence or absence of the 
outcome of interest to a set of predictors. To avoid the disease status of some individuals 
changing, and to maintain the cross sectional relationship of interest, there should be minimal 
delay between measurement of the predictors and the outcome, and no treatments should be 
started within this period. In situations where the prevalence of the outcome of interest is low, 
or the cost of measuring predictors is high, an alternative design may be used where the 
reference standard is performed first, with all the individuals with the target condition, and a 
random sample of individuals without the target condition included. (1) It has been observed 
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that many studies reporting the derivation of a CPR use data from studies originally designed 
and conducted for a purpose other than the derivation of a CPR. (1) However, the predictive 
accuracy and ability of such models may be affected due to poorer data quality and 
unmeasured predictors. (66, 67) 
The most common statistical techniques used for diagnostic outcomes (which are usually 
binary), are multivariable logistic regression and binary recursive partitioning. Classification 
and regression trees (CART) are a form of binary recursive partitioning in which the study 
population is progressively divided into subpopulations including only patients with that 
particular outcome. Both techniques have strengths and weaknesses and one or the other may 
be preferred in certain situations. (68, 69) In terms of comparative predictive ability, the 
results of research directly comparing the methods are conflicting. In some studies the 
predictive ability (as measured by the area under the ROC curve) of logistic regression is 
comparable to CART (70, 71) and in other comparisons it is superior. (68, 72) Recently, it has 
been suggested that both approaches can be used together, contributing different advantages. 
(69) Other, less commonly used statistical methods for deriving diagnostic prediction rules 
include discriminant analysis, genetic programming and neural networks. Regardless of the 
statistical technique used to derive the model, internal validation is advocated to estimate the 
potential for overfitting and optimism in model performance. (66) The preferred statistical 
method for internal validation is bootstrapping, which aims to mimic random sampling from 
the source population and yields an average estimate of the amount of overfitting or optimism 
and adjusts the model accordingly. (1)   
During clinical prediction rule derivation, the selection of predictor variables (variables that are 
chosen to be studied for their predictive performance) is split into two components; 1) the 
selection of predictors for inclusion in the multivariable analysis (predictor pre-selection), and 
2) selection during the multivariable modelling. The use of different predictor selection 
methods can yield different models and there is no consensus about the best approach. (42) 
Some form of predictor pre-selection is commonly required because there are usually more 
predictors available than the investigator can analyse or include in the final prediction model.  
A common approach for selecting variables for inclusion in the multivariable modelling is 
based on the association of the candidate predictors with the outcome. However, pre-
selection based on univariable significance testing carries a great risk of predictor selection 
bias, and this method is not recommended. (67) Alternatively, preselection may be achieved a 
priori by critical consideration of relevant literature or prior knowledge, by combining similar 
predictors into a single one, or by excluding predictors that are highly correlated with others. 
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(10) Excluding predictors that are difficult to measure or have high intraobserver variability 
because this will influence the predictive ability of the model when applied in other individuals 
is another option. Another consideration for predictor selection before statistical modelling is 
the context in which the prediction rule will be used. In some settings certain tests are not 
practical (e.g. high burden or cost) or are unavailable, and these candidate predictors can be 
excluded from further consideration.  In primary care practice, for example, predictor selection 
may be limited to only predictors that can be practically obtained in that setting such as items 
from the history or physical examination. In this case, a series of more complex models can 
sometimes be developed  with and without predictors that may or may not be available in that 
setting (e.g. point of care C-reactive protein).   
Just as the method of selecting predictors for inclusion in the multivariable modelling can 
contribute to optimistic and biased models, so can the method used to select predictors during 
multivariable modelling.  Two of the most commonly used methods are the ‘full model 
approach’ and the ‘predictor selection approach’.  In the full model approach, all a priori 
selected predictors are included in the multivariable analyses and no further predictor 
selection is used.  This avoids predictor selection bias but this approach requires substantive 
prior knowledge about the most promising candidate predictors, which is not always 
straightforward. (2) In the predictor selection approach, candidate predictors that do not 
contribute usefully in the multivariable model are removed.  Backward elimination starts with 
all candidate predictors in the multivariable model and runs a sequence of tests to remove or 
keep variables in the model based on a predefined nominal significance level for variable 
exclusion.  The forward selection approach starts with an empty model, and predictors are 
sequentially added until a pre-specified stopping rule is satisfied.  Backward elimination is 
generally preferred because all correlations between predictors are considered in the 
modelling procedure (1), however with either method, the criterion for predictors to be 
selected for inclusion in the model is critical.  Possible criteria for predictor inclusion include 
the use of a nominal p value, the Akaike or Bayesian Information Criterion, or using a change in 
the models c-index (see the following section). The choice of a relatively small significance 
level for predictor selection (e.g. p<0.05) generates models with fewer predictors, but 
increases the chance of missing potentially important predictors, while larger levels (e.g. 
p<0.20) increase the risk of selecting less important predictors.  In both cases, overfitting may 
arise, particularly in small datasets.(2, 42)  The use of the Akaike Information Criterion is the 
preferred alternative because it accounts for model fit while penalising for the number of 
parameters being estimated. (2) 
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The final step in model derivation is consideration of model presentation, and various 
graphical and simplified formats may be used to present different or the same prediction 
models and rules. The format selected by developers and implementers to present prediction 
models and rules may vary according to the desired user friendliness or simplicity of the tool, 
the information that is to be provided (a probability estimate or a risk classification), the 
intended audience (with some clinical areas routinely using and preferring certain graphical 
representations) and whether the model or rule is to be used as a paper based or 
computerised tool. When used as a computerised tool, the prediction model or rule may be a 
simple web or non-web based calculator, or may be part of a computerised decision support 
system integrated with the electronic patient record. Scoring systems are a common simplified 
presentation format of an underlying regression model aimed to facilitate use of the model in 
practice. When presented as scoring systems, predictors included in the model are assigned a 
point value with the points summed to give a total score that is related to absolute outcome 
probabilities. Assignment of an integer point value to each predictor may be achieved by 
rounding the regression coefficients, such that the predictors may have a different point value, 
or by assigning the same point value (the same ‘weight’) to each predictor. Such simplification 
is known to lead to some loss of predictive accuracy. (73) 
1.4.2 Stage 2 –External validation of clinical prediction rules 
The validation phase determines the performance of the prediction model or rule in 
individuals different to those from which the prediction model was derived. The process of 
external validation involves measuring predictor and outcome values in data from new 
individuals suspected of having the condition of interest, applying the prediction model to 
these data and quantifying the models predictive performance. (62)  
Three types of external validation are recognised, namely, temporal, geographical and domain 
validation, each providing a progressively more thorough and independent validation. In 
temporal validation studies, new individuals may be from the same institution in a different 
usually later, time period. Geographical validation examines the transportability or 
generalizability of the predictive performance of the prediction model to other institutes or 
countries and domain validation to very different individuals from those for whom it is 
developed (i.e. validating a prediction model derived in secondary care to individuals in a 
primary care setting). Recently methods for quantifying the degree of relatedness between 
derivation and validation samples have been developed, facilitating the interpretation of 
prediction model transportability to other settings. (74)   
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Key aspects of predictive performance to be determined in validation studies include 
discrimination and calibration. (63) Calibration reflects the agreement between predictions 
from the rule and observed outcomes. Generally, a rule is said to be well calibrated if, for 
every group of 100 individuals, each with a predicted risk of x%, close to x have the outcome of 
interest. Commonly used methods to assess calibration include calibration in the large, the 
calibration slope and the Hosmer-Lemeshow goodness of fit test.  Calibration in the large 
compares the mean of all predicted risks with the mean observed risks and indicates the 
extent that predictions are systematically too low or too high.  (63) The Hosmer-Lemeshow 
test examines how well the percentage of observed events matches the percentage of 
predicted events over deciles of predicted risk.  Limitations of this test have been well 
described and include its dependence on arbitrary groupings of individuals and poor power in 
small datasets. Furthermore, by only providing a p value, the test conveys no indication of the 
magnitude or direction of any miscalibration.  Consequently, a calibration plot is the preferred 
methods for assessing calibration.  (1, 75) Calibration plots categorise individuals into groups 
according to predicted risk. The observed risk (proportion of individuals with an event) is 
calculated for each group, and the predicted risk (the average risk score for individuals in each 
group) is plotted against the observed risk for each group. The plot displays the direction and 
magnitude of miscalibration across the probability range.   
Discrimination refers to the ability of a prediction rule to differentiate between those who do 
or do not experience the outcome event.  A model has perfect discrimination if the predicted 
risks for all individuals who have the outcome are higher than those for individuals who do not 
experience the outcome. Though many indices of discrimination exist, the discriminative ability 
of a prediction rule is commonly estimated by the concordance index (c-statistic) which is a 
measure of concordance between prediction rule based risk estimates and observed events. 
(76) The c-statistic is identical to the area under the receiver operating characteristic curve 
(AUROC) for logistic regression models. Simplistically, the AUROC represents how likely it is 
that the test will rank two individuals, one with the event and one without the event, in the 
correct order across all possible thresholds. (77) While the AUROC summarises the 
discrimination of a prediction rule in a single number, it lacks clinical interpretability because it 
does not effectively balance misclassification errors. By measuring performance over all 
thresholds it includes both those clinically logical and clinically illogical. In addition to measures 
of discrimination and calibration, measures of overall performance, including the Brier score or 
R2 (a measure of variation explained by the model), may be reported. (1) 
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For diagnostic rules, measures of classification performance such as sensitivity, specificity and 
predictive values are often presented. Though clinically useful measures, predictive values are 
highly dependent on the prevalence of the condition in the population. Sensitivity and 
specificity are generally believed to be unaffected by disease prevalence, though this has 
recently been shown not to be the case. (78) The use of these measures of performance relies 
on identification of a cut-off or test threshold to classify individuals as low or high risk. Defining 
the threshold is based on clinical judgment as to the consequences of false positive decisions 
(such as unnecessary testing or possible over diagnosis and treatment) and false negative 
decisions (possible under diagnosis and under treatment), with the optimal threshold defined 
by the balance between the harm of a false positive classification and the benefit of a true 
positive classification. If a false positive decision is of relatively low importance in comparison 
to a false negative decision, a low threshold should be used. For example, unnecessary testing 
for a patient with chest pain without acute coronary syndrome (false positive) should be 
avoided but has less clinical significance than withholding treatment in those with disease 
(false negative). The decision threshold of 2% reflects the relative weight of these errors. (79)  
However, it may be difficult to define an optimal threshold since empirical evidence for the 
relative weights of benefits and harms is often not available. (63) Recently, a novel approach 
(based on clinical vignettes) to determining clinically sensible thresholds for clinical prediction 
rules has been proposed. (80) 
Recently, several new measures aiming to capture the clinical consequences of a particular 
level of discrimination or degree of miscalibration have been proposed to evaluate the 
performance of prediction rules. Such approaches include decision curve analysis and relative 
utility. In decision curve analysis, a single probability threshold is used to weight false negative 
and false positive classifications. The performance of a model at a single threshold can then be 
summarised as a weighted sum of true minus false positive classifications (net benefit). (81)  
For comparison of different models or to quantify the clinical benefit of adding a new predictor 
to an existing model, methods based on the concept of reclassification of individuals across 
predefined risk categories have been developed. The net reclassification improvement (NRI) is 
a commonly used measure of reclassification, (82) but has been shown to be highly sensitive to 
the selection of thresholds used to define risk categories (83) and to have other limitations. 
(82) Consequently measures which appropriately weight false positive and negative decisions 
are preferred. (1) These include three mathematically interconverted measures, namely, the 
weighted net reclassification improvement, change in net benefit and change in relative utility. 
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These measures use a harm-benefit ratio to define the weights of true positive and false 
positive classifications to calculate a single summary measure of reclassification. (84)  
Studies validating a clinical prediction rule may be comparative, evaluating both the prediction 
rule of interest and alternate rules or diagnostic pathways in the same study population 
against a common reference standard. (1) In the most efficient design of so called ‘direct’ or 
‘head to head’ comparative studies, the alternate ‘tests’ and reference standard are applied to 
all study participants, (85) but randomised designs in which all patients undergo the reference 
standard and are then randomly assigned to only one of the alternate tests, may be utilised 
when the tests being compared interfere with each other. In direct comparative accuracy 
studies, the study design and analytical strategy depend upon the intended role of the 
prediction rule – that is, how the prediction rule will be positioned to alter the existing 
diagnostic pathway. (86) A CPR may assume the following roles in a diagnostic pathway: 
replacement of the existing strategy; add-on; or triage. (87) As an add-on test the prediction 
rule is used concomitantly with or after the existing testing strategy with the aim of correctly 
identifying patients with a false negative or positive test on the existing testing strategy. 
Alternatively, a prediction rule may assume a triage role where it is used before an existing test 
with the results of the prediction rule determining which patients will then undergo the 
existing test. As a triage test, the prediction rule may not be intended to improve the 
diagnostic accuracy of the existing testing strategy, but rather to reduce unnecessary further 
diagnostic testing. In early evaluations of prediction rules, the role may not be clear, but as the 
prediction rule progresses into validation studies and the performance of the prediction rule is 
better understood, the role of the prediction rule becomes apparent. The role may vary 
according to the context in which it is to be used (e.g. an add-on test in the primary care 
setting or a triage test in the emergency department), and it may change over time. 
Identification of the role of the prediction rule is essential for ensuring validation studies are 
efficiently designed and the most appropriate measure of accuracy and statistical method of 
analysis are used. (86)  
In addition to assessment of the accuracy of diagnostic prediction rules, quantification of their 
added or incremental value over and above clinical judgment alone may also be of interest. 
Studies of the incremental value of diagnostic tests aim to discern what the test adds to the 
diagnostic process over and above standardly available diagnostic information. (32) The 
incremental value will depend on how much information is already available from the 
diagnostic workup and it may be that the diagnostic information provided by a particular 
prediction rule is already conveyed by the previous test results. 
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Evaluation of the added value of a prediction rule over and above clinical judgment involves 
comparing multivariable models of clinical judgment with and without the clinical prediction 
rule as a covariate. An example of such a study is that of Broekhuizen et al., (12) who 
determined the added value of a prediction model for the diagnosis of chronic obstructive 
pulmonary disease (COPD) over clinical judgment. Using data from a diagnostic cohort study of 
patients with possible COPD, physicians’ estimates of the probability of COPD obtained after 
initial examination and history taking were entered into a multivariable logistic regression 
analysis with COPD as the diagnostic outcome (model 1). A second model was then 
constructed including the physicians estimate and the estimate of the probability from the 
prediction model. To quantify the added discriminative value of the prediction model over the 
clinician, the area under the ROC (AUROC) curve of the two modes was compared. Though the 
difference between the AUROC for the two models is the most familiar statistic for estimating 
incremental value, and there is broad agreement about its usefulness as a descriptive 
measure, (88) it has been criticised as being insensitive to detecting small improvements in 
model performance when a new test is added to a model that already includes important 
predictors. (77) Subsequently, the use of utility measures (decision curve analysis) and 
reclassification metrics, such as those discussed above, has been recommended for assessing 
added value. (1)   
1.4.3 Stage 3 – Assessment of the impact of clinical prediction rules 
In this stage of development, the extent to which a clinical prediction model or rule is used and 
affects decision making or health outcomes is quantified. (5, 64) To assess the impact of a 
clinical prediction model or rule a comparative study is necessary. Study outcomes are 
measured in a control group exposed to care or management without the use of information 
from a prediction model or rule and an experimental group exposed to care provided with a 
prediction model or rule. In these studies an assistive or directive approach may be taken. In 
the assistive approach, estimated probabilities of the target condition are provided without 
recommending a course of action. In the directive approach, an explicit management 
recommendation is provided (with or without the underlying probability estimate). While it is 
generally felt that assistive approaches are more respecting of clinicians’ autonomy, and 
therefore the information provided by the model more likely to be considered by clinicians, 
the directive approach is believed to have greater potential to influence clinicians’ behaviour 
(5, 89) and is often preferred by clinicians themselves. (90) However, head to head 
comparisons between these two approaches are lacking.   
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Empirical studies of the impact of diagnostic prediction rules may utilise randomised or non-
randomised designs, though randomised trials are preferred. (5)  The comparison between 
intervention groups is scientifically strongest when a cluster randomised controlled trial is 
used,  as randomising clusters of clinicians or centres avoids bias owing to learning effects that 
may result when individual clinicians or patients are randomised. (66) Given the significant 
challenges and practicalities of conducting cluster randomised trials, alternative randomised 
designs may be used, including the stepped-wedge cluster randomised trial which compares 
individuals outcomes between clusters which first apply care as usual and subsequently, at 
randomly allocated time points, management based on the clinical prediction rule. (10) Often, 
non-randomised study designs are used, including before-after studies which compare 
individuals’ outcomes in those treated conventionally in an earlier period and those treated in 
a later period, after introduction of the prediction rule. When the effect of a diagnostic 
prediction rule on clinicians’ behaviour or decision making is of key interest, cross sectional 
studies may suffice. In this approach, clinicians can be randomised either to exposure to or no 
exposure to a diagnostic prediction rule and their diagnostic or management decisions are 
compared. Qualitative studies may also be used, alone or as an adjunct to quantitative studies 
to describe the interplay between the prediction rule, the context in which it is used and the 
outcome.  
The impact of diagnostic prediction rules may also be estimated indirectly using decision 
analytic modelling. These models extrapolate the link between the predicted accuracy of the 
prediction model (and associated uncertainty) and clinical management and downstream 
patient outcomes using data about the effectiveness of treatments from randomised 
therapeutic trials or meta-analyses. (91) The use of models to evaluate the effect of diagnostic 
prediction rules offers several advantages over randomised trials, namely, they are relatively 
quick to perform and lower cost. It has been posited that models could be used as a 
preliminary step in the evaluation of diagnostic tests, with results guiding further randomised 
trial evaluation. (92, 93) The main limitation of this approach is that such models only provide 
indirect evidence of the effects that diagnostic prediction rules may have on patient health. 
Further, validity of the model is limited by the availability and quality of existing evidence with 
probability estimates from observational studies potentially subject to bias and confounding, 
and the need to extrapolate the results of several studies.      
1.5 Potential harms and unintended consequences of clinical prediction rules 
Potential harms and unintended consequences of clinical prediction rules are infrequently 
mentioned in the literature but may arise directly from their use as a strategy to facilitate 
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selective testing or improve accuracy, or via the unintended consequences of their use on 
clinicians’ reasoning processes or clinician patient relations. Diagnostic prediction rules are 
often developed as tools to decrease unneeded testing in situations where diagnostic tests are 
overused. While such prediction rules aim to reduce testing only in those who do not have the 
disease of interest, individuals who do have disease may be missed and potentially exposed to 
the harms of delayed or missed diagnosis. For example, in a study of the Wells pulmonary 
embolism score, application of the score increased the proportion of study participants 
classified as not having disease (and therefore not requiring further testing) compared to 
clinical judgment, however, this potential reduction in testing was offset by missing a greater 
proportion of cases of disease. (94) It has also been suggested that use of prediction rules may, 
over time, diminish skills in clinical diagnostic reasoning and promote ‘intellectual laziness’, 
particularly among trainee clinicians where CPRS may be used as teaching aids. (95) However, 
this anecdotal claim has not, to my knowledge, been the subject of study. Further, concerns 
about how diagnostic decision support will affect malpractice litigation have been raised. (96)  
Research to address this has found that use of a decision aid by a clinician did not affect 
judgments of malpractice in a mock jury trial, but use did affect ratings of punitiveness. (97) 
Clinicians’ use of clinical prediction rules may also affect the clinician-patient relationship. It 
has been shown that clinicians using a computerised decision support system are perceived as 
less capable than clinicians using unaided judgment. (98) How this may affect patient 
behaviour (e.g. treatment compliance) and health outcomes, however, is unclear.    
1.6 Standards of evidence for clinical prediction rules 
Though evidence of successful validation and, preferably, of clinical impact should exist before 
a diagnostic prediction rule is considered for adoption into practice, few derived clinical 
prediction rules ever undergo external validation, and fewer still impact assessment. The 
pattern of limited validation and even more limited impact analysis has been demonstrated in 
several analyses of prediction rule research within and across clinical settings. (45, 99, 100) In a 
series of reviews conducted over three time periods since 1981, the stages of development of 
prognostic models published in six leading general medical journals was examined. (5, 40, 45, 
101) In the latest review period (from 2006 to 2009), the vast majority of prediction rule 
studies identified, described the derivation of a prediction model. (61 of 84 studies) Only one 
quarter  (21 of 84 studies) reported an external validation of a prognostic model and only two 
of the eighty-four studies assessed the impact of use of a prognostic model. This situation does 
not appear to have changed over time, with the reviews using the same methods performed in 
earlier time periods reporting similar results. In a descriptive analysis of clinical prediction rules 
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(n=434) relevant to primary care identified for inclusion in a recently established register, just 
over half (55%) of the derived rules were evaluated in at least one validation study, but only 12 
rules (2.8%) were evaluated in an impact study. (44) This study also found differences in the 
stages of development of the prediction rules across clinical domains with some clinical areas 
being associated with more derivation than validation studies and vice versa, though 
assessment of prediction rule impact was generally rare or non-existent. (44) The reasons for 
this have not been explored, but most likely relate to the relative ease with which prediction 
models can be derived (102) and the progressively more difficult and resource consuming 
research effort required to assess validity and impact. Some have argued that many prediction 
rules are derived simply for the sake of publication, with developers having little regard for 
clinical need or intention to further evaluate or implement. (102, 103)  
1.7 Methodological standards of published clinical prediction rules 
Despite a substantial body of methodological literature and published guidance on how to 
perform and report prediction research, (1, 2, 5, 10, 42, 62, 64, 101) numerous reviews 
appraising the methodological conduct and quality of reporting of prediction rule studies have 
consistently found the methodology and reporting of such studies to be suboptimal. (104-107) 
In the most recent review of 78 published studies describing the external validation of clinical 
prediction rules, the quality of reporting was judged to be very poor with details needed to 
objectively judge the quality of the study either not reported, or inadequately reported. (105)  
Furthermore, the majority of studies were characterised by poor design, inappropriate 
handling and acknowledgement of missing data and absence of information on model 
calibration. (105) Another review assessed the reporting and conduct of prediction studies 
published in six high impact general medical journals in 2008. (104) The authors of this review 
concluded that the majority of prediction studies do not  follow current methodological 
recommendations for clinical prediction research, and that improvements in reporting and 
conduct are clearly needed. Other reviews of prediction models in specific clinical conditions 
similarly conclude that the methods and reporting of prediction research is ‘worryingly poor’ 
and likely to limit the reliability and applicability of such research. (106, 107) 
1.8 The use of clinical prediction rules 
Despite the abundance of clinical prediction rules in the published literature, it is often stated 
that few are widely implemented or used in clinical practice. (5, 99, 102, 108) While this may 
be appropriate for the majority of diagnostic prediction rules for which evidence of successful 
validation, let alone impact on patient health, is lacking, it may also be the case for tools for 
which validity and positive clinical benefit has been demonstrated. (109, 110) 
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1.8.1 Frequency of use 
Only a small number of published studies have assessed the extent to which diagnostic 
prediction rules are used by clinicians in practice. Using survey methods, these studies have 
reported: a) the frequency with which prediction rules are used as a diagnostic strategy in 
comparison to other strategies that may be employed at the same stage of diagnostic 
reasoning; or b) clinicians’ self-reported use of a specific diagnostic prediction rule with which 
they are familiar. From these studies the level of appropriate use, that is, use in instances 
where a prediction rule exists and it is appropriate to apply it, is unclear. In the first of these 
studies, investigators analysed data collected by six general practitioners after 300 
consultations and found that clinical prediction rules were the most infrequently used strategy 
employed by clinicians during the refinement stage of diagnosis. (111) However, it is not clear 
whether clinicians’ low preference for prediction rules is because there are no prediction rules 
available for the conditions encountered or, in some cases, that application of available 
prediction rules is inappropriate. In a series of surveys of emergency physicians regarding their 
use of the Ottawa Ankle Rules, the Canadian Cervical-spine Rule and the Canadian Computed 
Tomography Head Rule (CCHR), self-reported frequent use among physicians in Canada (where 
the prediction rules were developed) was high (ranging from 57% for the CCHR, to 90% for the 
OAR. (96, 109, 112-114) However use of these rules among clinicians from other countries was 
much lower. (90, 112) In a survey of 401 UK general practitioners, self-reported frequency of 
use of any prediction rules (either prognostic or diagnostic) varied widely by clinical domain 
and by particular prediction rules within a clinical domain. (46) For instance, most respondents 
reported using prediction rules for cardiovascular disease and depression but prediction rules 
for cancer were infrequently utilised. In a survey of emergency physicians, only half of all 
respondents reported using a prediction rule to estimate the pre-test probability of pulmonary 
embolism in more than half of applicable cases. (115) Low response rates in the survey studies 
and self-reported use of clinical prediction rules (which do not necessarily accurately reflect 
actual behaviour) make interpretation of the findings of these studies difficult.  
1.8.2 Barriers and facilitators to use of clinical prediction rules 
Numerous barriers to the use of clinical prediction rules have been identified. Barriers are 
reported either: 1) in survey studies of clinicians, some of which perform multivariate 
statistical analysis to identify barriers or facilitators that make the largest contribution to 
clinicians intention to implement prediction rules into practice, and 2) in opinion and editorial 
papers which often suggest barriers to use of clinical prediction rules based on research 
conducted with other evidence innovations such as clinical practice guidelines and shared 
decision making. Using a framework for considering barriers to evidence uptake, these barriers 
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may be classified into the domains of knowledge, attitude and behaviour. (116, 117) Table ‎1.1 
provides an overview of the literature informed potential barriers to the adoption of clinical 
prediction rules using this schema. Recognition of the facilitators and barriers to 
implementation of clinical prediction rules in practice is necessary to improve understanding 
on how to effectively translate clinical prediction rules into clinical practice. 
Opposing knowledge acquisition are clinicians’ lack of awareness, multiple rules for the same 
or similar outcome, and unfamiliarity with a prediction rule. (46, 118)  Lack of awareness may 
be due, paradoxically, to the overwhelming volume of prediction research available and to 
suboptimal efforts to disseminate prediction rule research.  With few exceptions, (90) the 
majority of clinical prediction rule studies are disseminated through passive methods such as 
journal publication or presentation at scientific meetings which are generally reported to be 
minimally effective strategy for altering clinical behaviour. (119, 120) Systematic reviews of 
studies developing prediction rules have identified numerous models for predicting the same 
outcome or target population, (121-123) making it difficult to decide which one to use. (103, 
124, 125) In multivariate analysis, younger age, full time employment and employment in a 
teaching hospital have been found to be significant predictors of awareness of prediction rules 
for cervical spine and head injury. (96, 112, 126) 
Barriers that prevent change in attitude identified in survey studies include lack of confidence 
in the prediction rule (115, 118) and conviction that a clinician’s own judgment is superior to a 
prediction rule. (46, 115, 118, 127) The perception that prediction rules oversimplify the 
assessment process has been reported to be a barrier to use in some studies (128) but not 
others. (114) Attitudes that may impede the use of prediction rules has been found to vary 
across countries, with clinicians in the United States, for instance, indicating that the use of 
prediction rules protects against malpractice lawsuits far less often than clinicians from other 
countries. (114) In the only available survey of non-medical clinicians, inhibitive attitudes 
towards prediction rules for a particular condition included views that available prediction 
rules were not sufficiently developed, were rarely generalizable, oversimplified the reasoning 
process or were not needed by experienced clinicians. (95)   
Behaviour change may be impeded by external pressures that favour the inertia of the status-
quo, including environmental, patient and institutional factors, and features of the prediction 
rule itself. In survey studies, clinicians’ report agreement with use of a prediction rule when a 
prediction rule helps to save time and is easy to use and remember. (95, 109, 126) Ratings that 
a rule is an efficient use of time and not too much trouble to apply were also significant 
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predictors of use of a prediction rule for cervical spine injury in a study of emergency 
physicians. (96) Perceived reduction in patient satisfaction has also been reported by clinicians 
as a barrier to use. (118, 129) While environmental and institutional factors (e.g. lack of time 
or institutional support) have been shown to be barriers to the use of clinical practice 
guidelines, (116) and have been suggested as barriers to use of clinical prediction rules 
specifically, they have been rarely studied or reported. (129) 
The features of the clinical prediction rule itself that may facilitate or impede adoption or use 
in practice are unclear.  Methodological papers, editorials and survey studies have suggested 
that rule presentation, face validity and complexity of the clinical prediction rule may influence 
use, but empirical studies linking these features to use (or non-use) are uncommon. (1, 45, 
130, 131) For a clinical prediction rule to have face validity it should include predictors that are 
anticipated by clinicians (often termed content validity) and are biologically plausible. There 
should be no obvious omissions, and the way the predictor variables are organised should 
seem appropriate for the purpose of the rule. (130, 131) While absence of predictors that 
clinicians feel are important may contribute to non-use of a specific clinical prediction rules 
(118, 128), inclusion of predictors that don’t have a logical relationship with the dependent 
variable also presents as a threat to acceptance and implementation. (95)   
While ‘ease of use’ is frequently mentioned as necessary for clinical prediction rule adoption 
into practice (45, 109, 118, 130, 131), what makes a clinical prediction rule ‘easy to use’ is not 
clear and is predominantly a subjective judgment by the user. The format used to present the 
prediction model to users may be a factor in perceptions of useability, particularly for clinical 
prediction rules that are not computerised. (131) Inextricably linked to the presentation 
format of clinical prediction rules is their complexity, which may include factors such as the 
number of predictors included in the clinical prediction rule, the ease with which information 
on the predictors can be obtained and the calculations required to obtain an output from the 
clinical prediction rule.  Scoring systems are a frequently used presentation format of 
diagnostic prediction rules that, when not available electronically, require users to sum 
variably scored predictors, or more simply to count the number of predictors. Uncomplicated 
calculations or simple graphical aids are likely to facilitate use in practice (95, 132), and may 
prevent calculation errors when deriving the output of the clinical prediction rule. The number 
of predictors included in a clinical prediction rule is another modifiable feature that may 
enhance the perceived usefulness of a clinical prediction rule.  In a survey of physiotherapists, 
clinical prediction rules with a ‘large’ number of predictors were viewed negatively as were the 
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inclusion of predictor variables that are difficult to obtain in a timely fashion without 
sophisticated equipment.  (132) 
1.8.3 How diagnostic prediction rules may be used during clinical encounters 
Little is known about how clinicians actually use diagnostic prediction rules in practice. Limited 
research among physiotherapists and emergency physicians suggests that a prediction rule 
may be used as a ‘second opinion’ or ‘safety net’ to validate clinicians’ decision-making. (95, 
133, 134) Among clinicians intent upon using a particular prediction rule, research suggests 
that the prediction rule may be variably implemented. (109) For example, a prediction rule 
may be used in part, meaning that only some predictors included in the prediction rule are 
considered and data collected. This may be intentional (e.g. if predictor data is not available or 
difficult to obtain) or accidental (e.g. if the clinician is applying the clinical prediction rule by 
memory but is unable to recall all the included predictors). (109, 115) Further, a clinician may 
not use the prediction rule as the primary determinant of decisions, incorporating other 
clinical features known to be unrelated to the outcome (e.g. cracking sound for ankle fracture) 
or correlated with the outcome but of no added value over and above the variables in the rule 
(e.g. age for ankle fracture) and subjectively adjusting the rule for these factors. (109, 135) A 
clinical prediction rule may be applied inconsistently, being applied only in some clinical 
situations for which it would be appropriate and not others. Or it may be applied incorrectly. 
For instance, a diagnostic prediction rule may be proposed as  a ‘1-way rule’ designed to rule 
out a particular condition. If the rule is negative, no x-ray should be performed. If the 
prediction rule is positive, however, it means only that the condition cannot be confidently 
ruled out, not that an x-ray should be performed. Further, the prediction rule output may be 
derived incorrectly, for instance by incorrectly adding a scoring system. Where clinicians in 
practice deviate from the application of a prediction rule as specified by rule developers, it is 
likely to alter the predictive value and performance of the rule in accuracy studies.   
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Table ‎1.1. Literature informed potential barriers to the adoption of clinical prediction rules in practice 
Theme Subtheme Barrier 
Knowledge Awareness Clinician unaware of the existence of CPRs for certain conditions 
  Clinician unable to select CPR when multiple CPRs for a condition are 
available 
 Familiarity Clinician not familiar enough with a CPR to implement it 
Attitudes Agreement with CPRs in 
general or a specific CPR 
Clinician perception that CPRs threaten autonomy 
  Clinician perception that CPRs oversimplify the clinical assessment 
process 
  Clinician conviction that clinical judgment is superior to CPRs 
  Clinician belief that clinical judgment is not error prone and therefore 
does not need to be ‘fixed’ 
  Clinician belief that use of CPRs leads to intellectual laziness 
  Clinician belief that CPRs not sufficiently developed 
  Clinician belief that patient will find them less capable if using a CPR 
  Clinician belief that CPRs are only relevant for inexperienced clinicians 
   Clinician belief that probability estimates are not helpful for decision 
making 
  Clinician dislike of the term ‘rule’ 
 Outcome expectancy Belief that use of CPRs will not lead to improved patient or process 
outcomes 
  Fear of unintended consequences of use 
  Belief that the information from the CPR is not sufficient to change 
clinical decisions 
  Uncertainty about the effects of use in patients with atypical 
presentation 
 Self –efficacy Clinician belief that CPR is too difficult to use 
  Clinician uncertainty as to how to interpret or use CPR output 
 Motivation Lack of motivation to use CPR 
Behaviour Patient factors Patients expectations are not consistent with the CPR 
 Features of the CPR Perception that CPR to complicated or complex 
  Perception that CPR not an efficient use of time 
  Perception that CPR does not have face validity – predictors clinicians 
consider important are missing 
  Perception that CPR is too much trouble to apply 
  CPR requires input of difficult to obtain predictor data 
  Perception that use of CPR does not fit in with normal work flow 
  Perception that CPR not generalizable to their patient 
  Perception that CPR is static and does not take into account the 
dynamic nature of clinical practice 
 Environmental factors Lack of time 
  Lack of organisational support 
  Lack of peer support for use 
  Perceived increased risk of litigation with use 
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1.9 Gaps in the evidence base and research justification 
Diagnostic prediction rules are tools developed to support clinical judgment during the 
diagnostic workup. They are purported to have the potential to improve clinical decision 
making and ultimately patient outcomes or to provide other benefits (such as reduced 
resource use) without compromising patient wellbeing. Studies describing the derivation of 
clinical prediction rules are abundant in the medical literature, and health care providers and 
policy makers are increasingly recommending their use within clinical practice guidelines. 
However, the value of diagnostic clinical prediction rules is unclear.   
A key step in the evaluation of a diagnostic prediction rule is investigation of its diagnostic 
performance relative to a reference standard. Ideally these studies also compare the 
diagnostic performance of the diagnostic prediction rule to the performance of the existing 
test or testing pathways. (85, 87) In the diagnostic setting this is most likely to be the judgment 
of the clinician. Comparing diagnostic performance and other features of the diagnostic 
prediction rule when it is applied independently of clinical judgment, and clinical judgment 
alone, in the early phase of development can assist in defining how the prediction rule may be 
used (as a replacement, add-on or triage test) and in guiding further evaluation. Though at the 
commencement of this thesis, the comparative accuracy of probability estimates or diagnosis 
provided by clinical judgment and those provided by statistical models had been extensively 
studied across diverse fields, the findings of this large body of research were difficult to apply 
to clinical practice. Primarily, the metrics used in these comparative studies to judge the 
superiority of the alternate methods precluded consideration of the clinical importance of any 
differences detected, for example, the occurrence and relative importance of false positive 
and false negative findings. Given the limitations of the existing research, a systematic review 
of the comparative performance of diagnostic prediction rules and clinical judgment, and the 
added value of diagnostic prediction rules was considered warranted.     
Ideally, diagnostic prediction rules should only be introduced into practice if evidence indicates 
that they are more likely than the existing diagnostic process to improve patient health or to 
maintain patient health while offering other benefits. (62) The focus of prediction rule 
research to date, however, has been to establish the accuracy of prediction rules compared to 
the prevailing reference standard. Often this information is used as the basis for judgments on 
the clinical value of a prediction rule and/or to inform recommendations for its use in practice. 
Given the numerous mechanisms by which prediction rules may act to alter patient health 
beyond those arising from superior accuracy, reliance on evidence of accuracy (which 
correlates poorly with patient outcomes) to inform of the clinical value of diagnostic prediction 
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rules is problematic. Quantification of whether, and the extent to which, the use of a 
diagnostic prediction rule, either as an add-on test, a replacement for an existing testing 
strategy, or as a triage test to determine who undergoes the existing test, alters health 
outcomes is necessary and, to this end, a systematic review of studies comparing care 
provided with and without a diagnostic prediction rule was considered justified.    
Diagnostic prediction rules have been proposed as a strategy for assisting clinicians in one 
clinical area where diagnosis is especially challenging, namely differentiating a child with a 
serious bacterial infection from one with a self-limiting illness. This is particularly difficult in the 
primary care setting where the incidence rates of serious infection are low and children usually 
present in the early stage of illness where signs and symptoms of serious and non-serious 
infections appear similar. Though, in the early stages of this thesis, several clinical prediction 
rules for the identification of children with serious infection had been developed, these tools 
were of questionable applicability to the primary care setting (for example, they included tests 
not generally available) and/or had key methodological limitations. Subsequently clinicians 
across a range of developed countries had identified the management of children with fever 
and possible serious infection as the clinical problem they would most like to approach with a 
well-designed prediction tool. (136) To address this need, the derivation of a prediction model 
based on features from history and physical examination, with external validation was 
planned. At the same time, C-reactive protein, an inflammatory marker was being promoted as 
a useful test for the detection of serious bacterial infection in children. Point of care versions 
of the test were available and being used or promoted in many parts of the world. However, 
the diagnostic accuracy of the marker had not been determined. It was my view, therefore, 
that a review of the accuracy of C-reactive protein was justified, with a subsequent study to 
determine the added value of C-reactive protein over clinical characteristics readily available in 
the primary care setting of key interest.    
Few clinical prediction rules are used in clinical practice. While many barriers to the 
implementation of prediction rules relating to the clinician or the environment in which they 
operate have been identified, features of the prediction rule itself are likely to be important in 
facilitating or impeding uptake. Intuitively, prediction rules that are easier to use are more 
likely to be adopted into practice. Given the potential for simplification to facilitate the uptake 
of prediction rules, an examination of the effect of several methods of simplification of a 
diagnostic prediction rule on accuracy and risk classification was believed to be warranted.  
Clinical prediction rules for assisting diagnosis 
 
33 
 
1.10 Research aims and thesis overview 
1.10.1 Research aims 
This thesis addresses a common challenge facing clinicians, namely, how to efficiently and 
accurately arrive at a diagnosis or clinical decision. The primary goals of this thesis were to 
determine the clinical value of diagnostic prediction rules developed to assist clinicians in a 
range of clinical scenarios and to assist primary care clinicians in their diagnostic management 
of children with possible serious bacterial infection. Within these goals, my aims were; 
Aim 1: To determine the comparative diagnostic performance of diagnostic prediction rules 
(when applied to patient data independently of clinicians’ judgment) and clinical judgment 
versus a reference standard and the added value of diagnostic prediction rules beyond clinical 
assessment.    
Aim 2: To determine the effect of care provided when a clinician has access to a diagnostic 
prediction rule compared to care provided without a diagnostic prediction rule on patient and 
process outcomes. 
Aim 3: To assist primary care clinicians in the differentiation of children with serious bacterial 
infections from children without serious infection. This is to be achieved through the 
derivation and validation of a clinical prediction rule for the identification of serious bacterial 
infections generally and pneumonia specifically, in children presenting to primary care, and 
through the determination of the diagnostic accuracy, independent and added value of the 
inflammatory biomarker C-reactive protein. An existing dataset of children presenting to a 
paediatric assessment unit in the United Kingdom will be used for the derivation study and 
study of the added value of C-reactive protein.  
Aim 4: To assess the effect of prediction rule simplification on performance.   
1.10.2 Thesis outline 
The proposed research aims are addressed in the following five chapters. Three chapters have 
been published in peer reviewed journals (Chapters 2, 5 and 6) and one has been submitted 
and is under external review (Chapter 3). In order to make the published chapters easier to 
read they have been formatted in a style consistent with the body of the thesis. 
Chapter 2 is a systematic review comparing the diagnostic performance of diagnostic 
prediction rules and clinical judgment with a reference standard.  
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Chapter 3 presents a systematic review comparing the effects of care provided by clinicians 
with access to a diagnostic prediction rule, versus care provided without a diagnostic model or 
rule, on patient and process outcomes.     
From this point the thesis focuses on aspects of clinical prediction rule development and 
application in a clinical area where diagnosis is known to be especially challenging, namely, the 
identification of serious bacterial infection in children with fever. The nature of this difficult 
diagnostic problem is introduced in Chapter 4.   
Four projects were proposed to address the thesis goal to assist primary care clinicians in their 
diagnostic management of children with possible serious bacterial infection. The first of these 
was the derivation and validation of a diagnostic prediction rule for the identification of 
serious infection in children presenting to primary care using an existing dataset. The second 
and third were projects to determine the accuracy, independent and added value of the 
inflammatory marker C-reactive protein in the primary care setting using systematic review 
methodology and by performance of a modelling study using the derived prediction model as 
the base model for the analysis. The fourth and final project was to test the effects of methods 
of simplification of the derived model on accuracy and reclassification of individuals across 
predefined risk categories.  
However, the first project to derive and validate a clinical prediction rule to assist primary care 
clinicians in the diagnostic management of children with possible serious infection could not 
be completed. During preliminary work to develop the prediction rule, I judged that due to the 
volume and likely nature of missing data and limitations of methods of dealing with missing 
data at the time, development of a credible prediction rule was not achievable. Consequently, 
the study to determine the added value of C-reactive protein beyond information obtained 
from the history and physical examination could also not be undertaken. In Chapter 4, the 
rationale for the proposed but unexecuted studies is briefly discussed, as are the reasons for 
this eventuality. The systematic review to determine the accuracy and independent value of C-
reactive protein was completed and the project to test the effects of simplification was 
performed with data obtained from an alternate source. The remainder of the thesis is 
therefore comprised of the following chapters. 
Chapter 5 presents the results of the systematic review of the accuracy and independent value 
of C-reactive protein for the identification of serious bacterial and bacterial infection in non 
hospitalised children.   
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Chapter 6 of this thesis presents the study undertaken to ascertain the effects of various 
methods of simplification of a diagnostic prediction rule on performance. As the prediction 
rule for serious infection in children could not be derived and used for this study, and efforts to 
obtain data in the clinical area of interest were unsuccessful, the effect of simplification was 
evaluated in an existing dataset from which a prediction rule had been developed for the risk 
stratification of individuals with chest pain and suspected cardiovascular event.  
The concluding chapter of this thesis, Chapter 7 summarises the main findings and discusses 
limitations and implications of the research conducted.      
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Chapter 2 The comparative performance of 
diagnostic prediction rules and 
clinical judgment 
 
 
This chapter presents an article published in PLOS One on 3rd June 2015. 
Sanders S, Doust, J, Glasziou P. A systematic review of studies comparing diagnostic clinical 
prediction rules with clinical judgment.  PLOS One.  2015;10(6):e0128233. 
Doi:10.1371/journal.pone.0128233. 
© 2015 Sanders et al. This is an open access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original author and source are credited.  
Minor modifications to the methods section of the published manuscript have been made in 
response to comments received during the thesis examination process. Details of the 
modifications and their location in the manuscript are tabulated in Section 2.6.4 at the end of 
this chapter. 
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2.1 Preface to Chapter 2 
Quantifying the diagnostic performance of a diagnostic prediction rule is a key step in its 
evaluation.  Comparing the diagnostic performance and other features of the prediction rule 
with the existing diagnostic test or pathway can assist in defining how the prediction rule may 
be used and in guiding its further evaluation. The following chapter describes a systematic 
review which aimed to determine the comparative performance of clinical judgment and 
diagnostic prediction rules (when the diagnostic prediction rule is applied to the study data 
independently of clinical judgment). Diagnostic performance is compared in terms of a) the 
ability of the two methods to classify individuals as not having disease and thereby avoiding 
further testing, referral or treatment and b) the proportion of those individuals classified as not 
having the condition of interest that actually do. The comparative discriminative ability of both 
judgment methods in terms of the traditional paired summary statistics sensitivity and 
specificity is also presented.  
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2.2 Abstract 
Background: Diagnostic clinical prediction rules (CPRs) are developed to improve diagnosis or 
decrease diagnostic testing. Whether, and in what situations diagnostic CPRs improve upon 
clinical judgment is unclear. 
Methods and findings: We searched MEDLINE, Embase and CINAHL, with supplementary 
citation and reference checking for studies comparing CPRs and clinical judgment against a 
current objective reference standard. We report 1) the proportion of study participants 
classified as not having disease and hence may avoid further testing and or treatment and, 2) 
the proportion, among  those classified as not having disease, who do (missed diagnoses) by 
both approaches.  
31 studies of 13 medical conditions were included, with 46 comparisons between CPRs and 
clinical judgment. In 2 comparisons (4%), CPRs reduced the proportion of missed diagnoses, 
but this was offset by classifying a larger proportion of study participants as having disease 
(more false positives). In 36 comparisons (78%) the proportion of diagnoses missed by CPRs 
and clinical judgment was similar, and in 9 of these, the CPRs classified a larger proportion of 
participants as not having disease (fewer false positives). In 8 comparisons (17%), the 
proportion of diagnoses missed by the CPRs was greater. This was offset by classifying a 
smaller proportion of participants as having the disease (fewer false positives) in 2 
comparisons. There were no comparisons where the CPR missed a smaller proportion of 
diagnoses than clinical judgment and classified more participants as not having the disease.  
The design of the included studies allows evaluation of CPRs when their results are applied 
independently of clinical judgment. The performance of CPRs, when implemented by clinicians 
as a support to their judgment may be different.    
Conclusions: In the limited studies to date, CPRs are rarely superior to clinical judgment and 
there is generally a trade-off between the proportion classified as not having disease and the 
proportion of missed diagnoses. Differences between the two methods of judgment are likely 
the result of different diagnostic thresholds for positivity. Which is the preferred judgment 
method for a particular clinical condition depends on the relative benefits and harms of true 
positive and false positive diagnoses. 
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2.3 Introduction 
Diagnostic clinical prediction rules (CPRs) are tools designed to improve clinical decision 
making. (2) Theoretically, CPRs, by providing objective estimates of the probability of the 
presence or absence of disease derived from the statistical analysis of cases with known 
outcomes and or by suggesting a clinical course of action, can improve the accuracy of 
diagnosis and or decision making.   
Understanding whether and in what situations CPRs improve upon clinical judgment is an 
important step in the evaluation of CPRs and for the acceptance of CPRs by clinicians. (131) 
Existing research, which has focused on the comparative performance of CPRs and clinical 
judgment when both judgment methods are viewed as competing alternatives, is difficult to 
interpret. One body of research on the relative merits of clinical and statistical prediction has 
consistently reported the superior accuracy of statistical models over a clinicians ability to 
integrate the same data and to collect and integrate their preferred data, (36, 55, 58) while 
another, more recent body of research has found that heuristics – proposed as models of 
human judgment, are on occasions more accurate than statistical models. (56) It is also 
difficult to know how to apply the general findings of this research to clinical practice. Many of 
the reviews of comparative accuracy have summarised findings from diverse professional 
fields including finance, medicine, psychology and education. Further, judging the clinical 
utility of clinical judgment and CPRs requires consideration of not just overall accuracy but the 
consequences of missed diagnoses (false negative) and false positive results. Results of the 
existing comparative research are generally not reported in a way that allows such evaluation.  
We conducted a systematic review of studies that compared the performance of diagnostic 
CPRs with clinical judgment or the performance of the combination of CPR and clinical 
judgment versus either alone in the same study participants against a current and objective 
reference standard.    
2.4 Methods 
This review was performed following methods detailed in the systematic review protocol and 
is reported in line with the PRISMA Statement (Appendix A).  
2.4.1 Data sources and searches 
We searched MEDLINE, Embase and CINAHL from inception to January 2012, with an updated 
MEDLINE search to March 2013 (Appendix A). No limits were applied to the database searches.  
We also searched for systematic reviews of diagnostic CPRs using PubMed Clinical Queries.   
The reference lists of systematic reviews and the included studies were checked. We 
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conducted forward searches of included studies using Science Citation Index Expanded in Web 
of Science and checked related citations using PubMed's Related Citations link. 
2.4.2 Study selection 
We included studies that compared the CPRs with clinical judgment in the same participants 
using a current and objective reference standard. We also included studies that compared a 
CPR or clinical judgment alone with the combination of CPR and clinical judgment and 
modelling studies to determine the added value of CPRs above clinical judgment. The CPR had 
to have been developed using a method of statistical analysis and tested against clinical 
judgment in a population different (by time, location or domain) to that from which it was 
derived. Studies where the CPR and clinical judgment were applied to different individuals (for 
example, in randomised trials) or were not applied at approximately the same point in the 
diagnostic pathway were excluded (for example, if the result of a CPR was determined using 
data collected at first presentation and this was compared to clinical judgment made after 
further consultation, testing and observation). We excluded studies of CPRs for the diagnosis 
of disorders across multiple body systems, that are not applied to actual patients, that are 
used for the interpretation of tests such as ECGs or that are performed in selected samples of 
patients not consistent with populations for whom use of the CPR is intended.  
Titles and abstracts identified by the searches were screened by one reviewer and obviously 
irrelevant articles excluded. A second reviewer independently screened 15% of the titles and 
abstracts to ensure that no further studies met the inclusion criteria.  After screening, 
potentially relevant studies were obtained in full text and independently assessed by two 
reviewers against the review inclusion criteria. Discrepancies were discussed and resolved with 
a third reviewer. 
2.4.3 Data extraction and risk of bias assessment 
Two reviewers independently extracted data on the characteristics of the study, the risk of bias 
and the results using a piloted data collection form. QUADAS-2 (137) was used to assess the 
risk of bias and concerns regarding applicability in each of the included studies. We added an 
additional signalling question to identify if clinical judgment and the CPR were determined 
independently. Discrepancies between reviewers were discussed and resolved by discussion 
with a third reviewer. 
2.4.4 Data synthesis and analysis 
We grouped studies where a probability estimate, clinical diagnosis or decision was made by:  
a) Clinical judgment alone;  
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 b) Clinical judgment with a method of structured data collection.  Clinicians may have 
collected data on variables contained in the CPR as per the study protocol but calculation of 
the results of a CPR by the clinician was not anticipated or expected, or occurred after the 
clinician had provided their probability estimate or diagnosis; or 
c) A combination of clinical judgment and clinical prediction rule, where the clinician had 
access to the results of the CPR but could also use their own judgment or override the CPR.   
We also recorded whether the result of the CPR was calculated by the examining clinician or a 
researcher, the method used to elicit clinical judgment and whether clinical judgment was a 
clinicians’ probability or risk assessment (e.g. low or high risk), a diagnosis or a clinical decision.   
Because many clinical prediction rules are developed to either improve the proportion of 
individuals with a suspected disease classified as not having the disease (thereby decreasing 
the number of participants undergoing further testing, referral or treatment), or to reduce the 
number of cases of disease missed by the current diagnostic protocol, the main outcome 
measures of the review were 1) the percent of study participants classified as not having the 
disease by the CPR or clinical judgment (False negative (FN)+ True negative (TN))/total number 
of participants in the study (total N). The higher this proportion, the fewer individuals that may 
undergo further testing, referral and or treatment, and  2) the percent of study participants 
among those classified by the CPR or clinical judgment as not having the disease who actually 
have the disease (FN/(FN+TN) or 1-negative predictive value). It is desirable that this be as 
close to 0% as possible (Box 2.1). We also report measures of diagnostic accuracy including the 
sensitivity (True positive (TP)/(TP+ FN)) and specificity (True negative (TN)/(FP+TN)) of CPRs 
and clinical judgment, and present graphically the proportion of all study participants who are 
classified by CPRs and clinical judgment as having disease who do (True Positives/total N) and 
do not (False Positives/total N) and the proportion of all participants who are classified as not 
having disease who do (False Negatives/total N) and do not (True Negatives/total N). When 
the output of the CPR or clinical judgment was not a binary decision or action (e.g. the CPR 
classified individuals as low, moderate or high risk, or clinical judgment was a clinicians’ 
decision to not test or treat, to test, or to test and treat), we dichotomised the output by 
combining probability estimates that were not ‘low’ (e.g. moderate and high or possible or 
probable), and decision or actions that involved tests or treatment (e.g. for a score throat 
score, the directive output ‘culture’ and ‘culture and treat’ were combined and compared to 
‘no culture or treatment’).   
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We did not perform a meta-analysis due to clinical and statistical heterogeneity. Instead, we 
synthesised the results of the included studies overall, and by clinical condition (where there 
were 2 or more studies available) by determining the number of comparisons in which the 
proportion of participants classified as not having disease and the proportion of missed cases 
of disease (missed diagnoses) in participants classified as not having disease for CPRs and 
clinical judgement was similar, greater or lesser. To determine whether there was a difference 
in the proportion classified as not having disease between CPRs and clinical judgment we 
conducted a statistical test of the difference between two proportions from dependent 
samples. To obtain the statistical significance of the relative difference in the proportion 
classified by CPRs and clinical judgment as not having disease that do, we conducted a test of 
the strength of association between two proportions (false negative rates) from dependent 
samples. If studies reported different thresholds for clinical judgment or the CPR, and if the 
proportions (i.e. the proportion classified as not having disease and the proportion of missed 
diagnoses) at the different thresholds were both in favour of, or opposed to the CPR or clinical 
judgment (this only occurred in 1 study included in this review) we reported only the 
comparison for the threshold with the highest Youden’s index ((sensitivity + specificity)-1). 
 
 
 
 
 
 
 
 
2.5 Results 
2.5.1 Literature search 
Of 10,155 titles and abstracts screened against review eligibility criteria, 330 were obtained in 
full text and assessed for eligibility by two reviewers. 31 studies (94, 138-167) were included in 
the review (Figure ‎2.1).   
     Disease  
Positive Negative 
Test 
Positive TP FP TP + FP 
Negative FN TN FN + TN 
 TP + FN FP + TN Total N 
 
TP – true positive; FP – false positive; FN – false negative; TN – true negative 
The percent of study participants classified as not having the disease by the test (CPR or clinical 
judgment) = (FN + TN)/ Total N 
The percent of study participants among those classified by the test (CPR or clinical judgment) as 
not having the disease who actually have the disease = FN/ (FN + TN) 
Sensitivity = TP/ (TP + FN)                Specificity = TN/ (FP + TN) 
Box ‎2-1 Outcomes of the review 
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2.5.2 Study characteristics 
The studies addressed a variety of conditions: 9 for pulmonary embolism (PE), (94, 143, 145, 
153-155, 160, 162, 163) 6 for deep vein thrombosis (DVT), (140, 141, 146, 151, 158, 167) 3 for 
streptococcal throat infection, (139, 144, 161) 3 for ankle and/or foot fracture, (138, 152, 164) 
2 for acute appendicitis (150, 157) and one each for acute coronary syndrome, (159) 
pneumonia, (149) head injury in children, (147) cervical spine injury, (166) active pulmonary 
tuberculosis, (148) malaria, (142) bacteraemia (156) and influenza. (165) (Table 2.1) Twenty 
five different CPRs were evaluated. The majority (n=16) were derived from logistic regression 
analysis and the remainder from recursive partitioning analysis (n=3), discriminant analysis 
(n=2), neural networking (n=1), simple Bayesian analysis (n=2) and an unspecified multivariable 
analysis (n=1). In just over half of the included studies (n=17), clinical judgment was a 
clinician’s estimate of the probability of the presence of disease or categorisation of a study 
participant into a risk group (e.g. low, intermediate or high risk). In the remaining studies, 
clinical judgment was a clinician’s diagnosis (n=8), intended management (n=3) or the clinical 
action taken (n=3). In half of the included studies (n=15) the experience of clinician’s 
estimating the probability of the target disorder or making a diagnosis or management 
decision was not reported. Ten studies included clinicians with varying levels of experience 
(e.g. ‘post graduates’ and ‘confirmed emergency physicians’), 3 included specialists only and 3 
junior staff only.  
Clinical prediction rules for assisting diagnosis 
 
45 
 
Figure ‎2.1. PRISMA flow diagram of the article selection process 
 
 
2.5.3 Risk of bias 
87% (27/31) of studies were judged to be at high or unclear risk of bias on two or more 
domains of the QUADAS-2 tool ( 
Figure ‎2.2). The most common risk of bias was due to interpretation of the reference standard 
occurring with knowledge of the index test result. For most studies in which the CPR was 
applied retrospectively to the data, it was not possible to determine whether researchers were 
blind to the result of the reference standard test. This is likely to bias results in favour of the 
CPR.  55% (17/31) of studies were judged to be at high risk of bias on the flow and timing 
domain. Studies commonly failed to include all enrolled cases in the data analysis or 
incorporated one of the index tests in the reference standard.  Risks of bias assessments for 
individual studies are shown in Table ‎2.2. 
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Table ‎2.1. Clinical conditions and study comparisons 
Clinical condition Number of 
studies (number 
of comparisons) 
Methods of estimating a probability, making a diagnosis or 
management decision being compared (number of comparisons) 
Pulmonary embolism (94, 
143, 145, 153-155, 160, 
162, 163) 
9* (16) 
 
CPR versus clinical judgment  alone (1) 
CPR versus clinical judgment + structured data collection (13) 
CPR versus combination of clinical judgment and CPR (2) 
Deep vein thrombosis (140, 
141, 146, 151, 158, 167) 
6  (7) CPR versus clinical judgment  alone (1) 
CPR versus clinical judgment + structured data collection (5) 
CPR versus combination of clinical judgment and CPR (1) 
Streptococcal throat 
infection (139, 144, 161) 
3 (5) CPR versus clinical judgment + structured data collection (5) 
 
Ankle or foot fracture (138, 
152, 164) 
3 (4) CPR versus clinical judgment  alone (1) 
CPR versus clinical judgment + structured data collection (3) 
Acute appendicitis (150, 
157) 
2 (2) CPR versus clinical judgment  alone (1) 
CPR versus combination of clinical judgment and CPR (1) 
Acute coronary syndrome 
(159) 
1 (1) CPR versus clinical judgment + structured data collection (1) 
 
Pneumonia (149) 1 (4) CPR versus clinical judgment + structured data collection (4) 
Abnormalities on 
computed tomography 
scan in child with head 
injury (147) 
1 (1) CPR versus clinical judgment  alone (1) 
 
Cervical spine injuries (166) 1 (1) CPR versus combination of clinical judgment and CPR (1) 
Active pulmonary 
tuberculosis (148) 
1 (1) CPR versus clinical judgment + structured data collection (1) 
Malaria (142) 1 (2) CPR versus clinical judgment  alone (2) 
Bacteremia (156) 1 (1) CPR versus clinical judgment + structured data collection (1) 
Influenza (165) 1 (1) CPR versus clinical judgment  alone (1) 
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Figure ‎2.2. Summary QUADAS-2 risk of bias and applicability judgments 
 
Table ‎2.2. Risk of bias and applicability concerns for individual studies included in the review 
Study                                            Risk of Bias        Concerns regarding Applicability 
Patient 
selection 
Index test 
(CPR)* 
Index test 
(clinical 
judgment) 
Reference 
standard† 
Flow and 
timing ‡ 
Patient 
selection 
Index 
test 
(CPR) 
Index test 
(clinical 
judgment) 
Reference 
standard 
Pulmonary embolism 
 
Runyon et al., 
2005 (162) 
Unclear Unclear Low Low High Low Low Low Low 
Kabrhel et al., 
2009 (153) 
Low Unclear Low Unclear High Unclear Low Low Low 
Kline et al., 
2008 (155) 
Low Unclear Low Unclear Unclear Unclear Low Low Low 
Kabrhel et al., 
2005 (154) 
Unclear Unclear Low Unclear High Unclear Low Low Low 
Carrier et al., 
2006 (143) 
Low Unclear Low Unclear High Low Low Low Low 
Chagnon et al., 
2002 (145) 
Low Unclear Low Unclear High Unclear Low Low Low 
Penaloza et al., 
2012 (160) 
Low Unclear Low Unclear High Low Low Low Low 
Sanson et al.,  
2000 (163) 
Low Unclear Low Unclear High Low Low Low Low 
Penaloza et al., 
2013 (94) 
Low Unclear Low Unclear High Low Low Low Low 
Deep vein thrombosis 
 
Geersing et al., 
2010 (151) 
Low Low Low Unclear High Low Low Low Low 
Bigaroni  et 
al.,2000 (140) 
Low Low Low Unclear Unclear Low Low Low Low 
Miron et al., 
2000 (158) 
Low Low Low High High Low Low Low Low 
Blattler et al., 
2004 (141) 
Low High Low Unclear Low Low Low Low Low 
Cornuz  et al., 
2002 (146) 
Low Low Low Low High Low Low Low Low 
Wang et al., 
2013 (167) 
Unclear Unclear Low Unclear Unclear Low Low Low Low 
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Table 2.2 Continued 
 
Study                                            Risk of Bias        Concerns regarding Applicability 
Patient 
selection 
Index test 
(CPR)* 
Index test 
(clinical 
judgment) 
Reference 
standard† 
Flow and 
timing ‡ 
Patient 
selection 
Index test 
(CPR) 
Index test 
(clinical 
judgment) 
Reference 
standard 
Streptococcal throat infection 
 
Cebul and 
Poses, 1986 
(144) 
Unclear Unclear Low Low High Low Low Low Low 
Rosenberg et 
al., 2002 (161) 
High Unclear Low Low High Low Low Low Low 
Attia et al., 
2001 (139) 
Unclear Unclear Low Low High Unclear Low Low Low 
Ankle or foot fracture 
 
Glas et al., 
2002 (152) 
Low Unclear Low Low Low Low Low Low Low 
Singh-Ranger 
and Marathias, 
1999  (164) 
Low Low Low Unclear Low Low Low Low Low 
Al Omar and 
Baldwin, 2002 
(138) 
Unclear Low Low Unclear Low Low Low Low Low 
Conditions with ≥ 2 studies 
 
Fenyo, 1987 
(150) 
Low Low Low Unclear High Low Low Low Low 
Meltzer et al., 
2013 (157) 
Unclear Unclear Low Unclear High Low Low Low Low 
Mitchell et al., 
2006 (159) 
Low Unclear Low Unclear Unclear Low Low Low Low 
Emerman et 
al., 1991 (149) 
Unclear Unclear Low Low Low Low Low Low Low 
Crowe et al., 
2010 (147) 
High Unclear Low Unclear Unclear Low Unclear Low Low 
Vaillancourt et 
al., 2009 (166) 
High Unclear Low Low High Low Low Low Low 
El-Solh et al., 
1999 (148) 
Low Unclear Low Low Low Low Low Low Unclear 
Bojang et al., 
2000 (142) 
Unclear Low Low Low Low Low Low Low Low 
Leibovici et al., 
1991 (156) 
Low Unclear Unclear Low Low Low Low Low Low 
Stein et al., 
2005 (165) 
Unclear Unclear Low Low Unclear Low Low Low Low 
*In studies where the CPR is applied retrospectively to data by the researcher using predictor data collected by the clinician, if 
there was no statement that researchers were blind to the reference standard the risk of bias was considered to be unclear. If 
predictor data was collected by the researcher and there was no statement that researchers were blind to the reference standard, 
the risk of bias was considered to be high; †When the reference standard comprised subjective tests, if there was no statement 
that those interpreting the reference standard test were blind to the results of either the CPR or clinician, the risk of bias was 
considered to be unclear; ‡If the method of determining disease status involved a combination of different test in which some test 
were applied to some patients and one test applied to all patients (differential verification) then the risk of bias was considered to 
be unclear. If performance of any of the reference standard test was dependent upon the results of the index test, the risk of bias 
was considered to be high.  If it was not possible to determine whether all eligible patients had been included in the analysis the 
risk of bias was considered to be unclear. If it was clear that not all patients had been included in the analysis (due to missing 
outcome data or because data from the clinicians estimate or data necessary to derive the results of the CPR were not available 
(and these studies reported results for the comparison sin different numbers of cases or only presented the results for cases on 
which data for both the comparisons was available, the risk of bias was considered to be high.  Risk of bias was recorded as high if 
either of the issues relating to the reference standard test or analysis were high.   
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2.5.4 Study results 
Results of the included studies are tabulated in Table 2.3 and Table 2.4, and presented 
graphically in Figure 2.3 and Figure 2.4.   
There were 41 comparisons between CPRs and clinical judgment. (94, 138-144, 146-149, 152-
165, 167). In 2 (5%) comparisons, (155, 156) CPRs reduced the proportion of missed diagnoses 
in those classified as not having the disease, but this was offset by classifying a larger 
proportion of study participants as having disease (more false positives). In 33 (80%) 
comparisons, (139, 142-144, 146, 148, 149, 152-154, 157, 161, 162, 165) the proportion of 
diagnoses missed by the CPR and clinical judgment was similar and in 7 of these comparisons 
(140, 142, 149, 158, 163, 164) CPRs classified a larger proportion of participants as not having 
disease (fewer false positives) and a similar proportion in 16. (139, 142-144, 146, 148, 149, 
152-154, 157, 161, 162, 165) In 6 (15%) comparisons (94, 139, 141, 162, 167) the proportion of 
diagnoses missed by the CPR was greater. This was offset by classifying a smaller proportion of 
participants as having the disease (fewer false positives) in 2 (139, 162) comparisons. In 3 of 
the 6 comparisons (94, 141, 167) the CPRs classified a similar proportion of participants as 
having the disease. There was 1 comparison (94) where the CPR both missed more diagnoses 
and classified a larger proportion of participants as having the disease (more false positives), 
but no comparisons where the CPR missed fewer diagnoses and classified a larger proportion 
of participants as not having disease.   
There were 5 comparisons between CPRs and the combination of CPR and clinical judgment. 
(145, 150, 151, 166) (Table 2.3, Table 2.4, Figure 2.3 and Figure 2.4) In 3 (60%) comparisons the 
proportion of diagnoses missed was similar (145, 151, 166) and in 2 (151, 166) of these 
comparisons, CPRs classified a larger proportion of study participants as not having disease 
(fewer false positives) than the combination of CPR and clinical judgment. In 2 (40%) 
comparisons, (145, 150) the proportion of diagnoses missed by the CPRs was greater while the 
proportion classified as not having disease by the CPRs and the combination of CPR and clinical 
judgment was similar. There were no comparisons between the combination of CPR and 
clinical judgment and clinical judgment alone.   
There were 5 studies (139, 142, 143, 151, 154) of 10 comparisons, that used different 
thresholds for the CPR or clinical judgment (for example, Kabrhel et al., 2005 (154) compared 
clinical judgment to the Wells PE score at threshold <2 and ≤4). We report on the results of 9 
of these comparisons, excluding the results of 1 comparison (151) where the proportions of 
interest (that is, the proportion classified as having disease or the proportion of missed 
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diagnoses) were similar at the different thresholds. This means that for a small number of 
comparisons (n=4) clinical judgment is counted twice. (139, 142, 143, 154) 
Pulmonary embolism 
From 9 studies in pulmonary embolism, there were 9 comparisons between the Wells PE score 
(original 3 level or 2 level score) and clinical judgment. (94, 143, 145, 153, 154, 162, 163) In 8 
(89%) comparisons, (143, 145, 153, 154, 162, 163) the proportion of diagnoses missed by the 
score and clinical judgment was similar. In 1 of these, (163) the score classified a larger 
proportion of all participants as not having the disease (fewer false positives), a similar 
proportion in 5 comparisons (143, 145, 153, 154, 162) and a larger proportion of participants 
as having the disease (more false positives) in 2. (143, 154)  In 1 (11%) comparison, (94) the 
proportion of diagnoses missed by the Wells PE score was greater, while the proportion of 
participants classified as not having the disease was similar. In 2 comparisons between the 
PERC Rule and clinical judgment, (155, 160) the rule reduced the proportion of missed 
diagnosis in 1, (155) but this was offset by classifying a larger proportion of participants as 
having the disease (more false positives). In the other comparison, (160) the proportion of 
diagnoses missed by the PERC rule and clinical judgment was similar. In 1 comparison (94) the 
Revised Geneva Score both missed more diagnoses and classified a larger proportion of 
participants as having the disease than clinical judgment. In 1 comparison (145) between the 
Geneva score and the combination of clinical judgment and score, the proportion of diagnoses 
missed by the CPR was greater.   
Deep vein thrombosis  
From 6 studies of DVT, there were 6 comparisons between the Wells DVT score and clinical 
judgment. (140, 141, 146, 158, 167) There were no comparisons in which the score reduced 
the proportion of missed diagnoses. In 4 (67%) comparisons the proportion of diagnoses 
missed by the score and clinical judgment was similar. (140, 146, 158) In 3 of these (141, 158) 
the score classified a larger proportion of all participants as not having disease (fewer false 
positives) and in 1 (146) the proportion was similar. In 2 comparisons (141, 167) the proportion 
of diagnoses missed by the CPR was greater, with a similar proportion classified as not having 
the disease. In 1 comparison (151) between the Oudega Rule and the combination of clinical 
judgment and Oudega Rule, the proportion of diagnoses missed was similar, with the rule 
classifying a larger proportion of participants as not having the disease (fewer false positives).  
Streptococcal throat infection  
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There were 3 studies of streptococcal throat infection.  
In 2 comparisons (144, 161) between the Centor Score (Modified and Original score combined 
with Tomkins Management Rule) and 1 comparison between the Walsh score and clinical 
judgment (144)  the proportion of diagnoses  missed and the proportion of all participants 
classified as not having disease was similar. In these studies clinicians would likely have been 
aware that all study participants would have pharyngeal swabs taken for testing as per study 
protocol. This may lead to an overestimate of the proportion of participants classified as not 
having disease by clinical judgment.   
Foot and or ankle fracture  
From 3 studies of foot and or ankle fracture, there were 3 (100%) comparisons between the 
Ottawa ankle and foot rules (OAR) and clinical judgment. (138, 152, 164) In all 3 comparisons 
the proportion of diagnoses missed by the CPR and clinical judgment was similar. In 1 of these 
(164) the rule classified a larger proportion of study participants as not having disease (fewer 
false positives) and in 2 comparisons (138, 152) the CPR classified a larger proportion of 
participants as having disease (more false positives). In the 2 comparisons from 2 studies (138, 
152) in which the OAR classified a larger proportion of participants as having disease than 
clinical judgment, the clinicians when making a decision or diagnosis, would likely have been 
aware that all participants would be x-rayed as per study protocol (152) or would have known 
that an x-ray could be ordered at their discretion. (138) This may lead to an overestimate of 
the proportion of study participants classified as not having disease by clinical judgment.   
Acute appendicitis  
There were 2 studies of acute appendicitis. In 1 comparison (150) between the Fenyo Score 
and the combination of score and clinical judgment, the proportion of diagnoses missed by the 
score was greater while the proportion classified as not having disease was similar. In 1 
comparison (157) between the Modified Alvarado Score and clinical judgment, the proportion 
of diagnoses missed and the proportion of all study participants classified as not having disease 
was similar. 
Acute coronary syndrome, pneumonia, head injury in children, cervical spine injury, active 
pulmonary tuberculosis, malaria, bacteraemia and influenza. 
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Of 8 studies (11 comparisons) addressing a variety of conditions, the CPRs showed either an 
improvement in the proportion of missed diagnosis or the proportion classified as not having 
disease, but this was often offset by a worsening of the other measure.   
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Figure ‎2.3. Results of the included studies for conditions with >2 studies 
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Figure ‎2.4. Results of the included studies for conditions with ≤2 studies 
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2.6 Discussion 
In this review, CPRs were rarely superior to clinical judgment and there was generally a trade-
off between the proportion of study participants classified as not having disease and among 
those classified as not having disease, the proportion of missed diagnoses of disease. CPRs for 
the diagnosis of DVT generally classified a larger proportion of all participants as not having 
disease than clinical judgment, but this was often at the expense of missed diagnoses. In other 
disease areas, CPRs showed either an improvement in the proportion classified as not having 
disease or the proportion of missed diagnoses, but often with the trade-off of worsening the 
other measure. These findings, however, are limited by the small number of studies for many 
of the conditions, the design features and generally unclear or high risk of bias in many of the 
included studies.   
Trade-offs in the proportion classified as not having disease and the proportion of missed 
diagnosis by CPRs and clinical judgment seen in this review probably represent differences in 
the diagnostic threshold for positivity of the two judgment methods. For example, CPRs might 
be developed to avoid missing people with disease and as such the threshold for positivity is 
set very low. The CPR would therefore likely be safer than clinical judgment where the 
threshold for positivity is implicitly set and variable between and within clinicians, but this is 
often at the expense of classifying fewer participants as not having disease (and thereby 
avoiding further testing or treatment). Whether clinical judgment or a CPR is the preferred 
judgment methods for a particular clinical condition will therefore depend on the relative 
benefits and harms arising from true positive and false positive diagnosis.  
Variability in the proportion classified as not having disease and proportion of missed 
diagnoses of CPRs compared with clinical judgment, even amongst studies of the same CPR, 
may be explained in part by features of the clinical setting of the studies. Differences in study 
design and methodology, including the type of CPR tested (logistic regression model or other 
statistical technique), the rigour with which it was developed, the case-mix of the study 
population,  ‘modifications’ to clinical judgment (with or without structured data collection), 
by whom (novice or experienced clinicians) or the way in which the result of the CPR is derived 
(calculation by clinician or researcher) may also explain the variation in performance seen in 
the studies included in this review. In many studies, clinicians collected diagnostic data on a 
structured data collection form. This systematic collection of diagnostic information may 
improve the observed diagnostic accuracy of the clinicians. (168) Clinician experience has also 
been shown to improve the accuracy of diagnosis. (169)  
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Variability in the outcomes of clinical judgment and CPRs within conditions may also be 
explained by the method used to elicit clinical judgment, as the method used will likely be 
associated with the implicit threshold for positivity. In studies of appendicitis for example, 
clinical judgment was a clinician’s diagnosis of appendicitis or the clinician’s actual action to 
perform surgery or not. In studies of ankle fracture, clinical judgment was either a clinicians 
diagnosis of fracture or their intention to x-ray a patient, and for studies of sore throat, clinical 
judgment may have been a clinicians actual action to prescribe antibiotics or not, or a clinicians 
statement of their intention to treat with antibiotics. The clinicians threshold for positivity will 
likely be higher for instance, if asked to provide a diagnosis (diagnostic threshold) than when 
asked of their intention to do further definitive testing (testing threshold). Where clinical 
judgment was elicited by obtaining a clinicians probability estimate on a continuous scale, 
there was also variation in the thresholds applied by study researchers. For studies of 
pulmonary embolism for example, thresholds were applied at probabilities of 15 or 20%.   
The design of the studies included in this review allows comparison of the performance of 
CPRs and clinical judgment when applied independently. In practice, however CPRs are likely 
to be used as tools to support or complement clinical judgment. When used in this manner, 
the performance of the diagnostic CPRs may vary from that shown in this review. The effect of 
a CPR when used in conjunction with clinical judgment can only be fully tested in a study 
design in which participants are assigned (ideally randomly) to apply or receive clinical 
judgment alone or clinical judgment with access to a CPR. However, studies of diagnostic 
accuracy or incremental value (12, 32) provide a useful and less costly interim step in the 
evaluation of CPRs prior to a randomised controlled trial and can guide future research.     
Our study shows that, in the context of medical diagnosis, CPRs do not consistently classify 
more individuals as not having disease or miss fewer diagnoses among those classified as not 
having disease than clinical judgment. This is in contrast to several reviews comparing clinical 
and statistical methods of prediction, often combining studies from fields as diverse as 
education, criminology and healthcare, which have generally found statistical methods to be 
superior. (36, 55, 58) A more recent body of research however has found that when formally 
tested, heuristics, proposed as models of human judgment are, in some situations as accurate 
as, or more accurate than statistical models. (56) A review comparing the diagnostic accuracy 
of doctors and statistical tools for acute appendicitis (170) found that statistical tools had 
greater specificity than clinicians.  However, most of the studies included in this review were 
excluded from the present review because a) the statistical tools and clinical judgment were 
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not applied at the same time point or b) the statistical tools and clinical judgment were not 
applied to the same participants.    
Due to variation in the design and purpose of the included studies, we did not attempt meta-
analysis across or within study conditions. Instead, we compared CPRs and clinical judgment 
using two measures 1) the proportion of all study participants classified as not having disease 
(a measure or efficiency) and 2) the proportion of participants among those classified as not 
having disease, who actually have the disease (false negative rate, a measure of safety). 
Because many CPRs seek to either improve diagnosis or identify a group of patients who do 
not require additional testing, we believe these are the most clinically relevant measures. 
Though these measures are dependent on the prevalence of the disease in the study 
population, the studies were judged to have been undertaken in relevant clinical settings.  
Traditional measures of diagnostic accuracy, such as sensitivity, specificity and area under a 
receiver operator characteristic curve are often favoured accuracy metrics because they are 
commonly believed to be unaffected by disease prevalence, though this has recently been 
shown not to be the case. (78) The proportion of participants classified as having disease and 
the proportion with false positive results can also be obtained from Figure 2.3 and Figure 2.4 
and the traditional measures of diagnostic accuracy from Table 2.3 and Table 2.4.    
The majority of included studies were judged to be at high or unclear risk of bias on 2 or more 
of the 4 risk of bias domains assessed. Differential verification (the results of clinical judgment 
or the CPR influence the performance of reference tests) and incorporation bias (the results of 
the CPR are used to make the final diagnosis) affected many studies, particularly studies of 
DVT and PE. Further, studies commonly did not include all eligible cases in the analysis and 
often it was not clear whether researchers applying a CPR retrospectively to a dataset were 
blind to the results of the reference standard. The design of studies of ankle fracture and 
streptococcal throat infection may also have led to inaccurate estimates of the diagnostic 
accuracy of clinical judgment. In these studies, the clinicians’ diagnosis or decision that x-ray or 
antibiotics are necessary may have been influenced by knowledge that all or most study 
participants would undergo confirmatory testing with an x-ray or throat swab. In this review, in 
two of the three studies of ankle and or foot fracture, the Ottawa Ankle Rules were 
considerably less efficient than clinical judgment that a fracture was present or that an x-ray 
was necessary. This finding conflicts with that a multicentre randomised controlled trial in 
which application of the rules lead to x-rays for 79% of study participants compared to 99.6% 
of participants when the decision was made by emergency department physicians. (171)   
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The database searches to identify studies for the review were conducted up to March 2013 
and eligible studies may have been published since this time. Because of the size of the search, 
not all titles and abstracts identified in electronic searches were screened by 2 reviewers.  
However, a second reviewer screened a subset of titles and did not find any additional studies.  
The search terms used may not have located all eligible studies, but manual searches of 
systematic reviews of CPRs and comprehensive reference and citation checking minimise this 
possibility. An assessment of the risk of bias in the studies deriving the CPRs or the ‘useability’ 
features of the CPRs evaluated in this review was not conducted, but updates to this review 
should seek to do this.  Such information may assist in the interpretation of the results of the 
review.   
While CPRs show promise as a way of improving clinical decision making, to date there have 
been limited studies comparing, in the same participants, the accuracy of CPRs and clinical 
judgment, and those studies often had design issues that raised the potential for bias and 
made interpretation of their results difficult. Though detailed guidance on the validation and 
evaluation of prediction models and rules is available, (42, 105) guidance on issues specific to 
studies comparing the diagnostic performance of CPRs and clinical judgment may improve this 
situation. To inform of the potential of diagnostic CPRs to improve diagnosis and patient 
outcomes when the CPR is used in combination with clinical judgment, particularly in 
situations where the clinician has a high degree of uncertainty, an analysis of studies 
comparing care provided when clinicians have access to a diagnostic CPR with usual care 
would be useful.   
2.6.1 Conclusion 
The limited studies included in this review show that none of the CPRs evaluated to date are 
clearly superior to clinical judgment across a range of medical conditions. They also show 
variation in the comparative performance of clinical judgment and CPRs between studies for 
the same condition and between the same CPRs. There is generally a trade off in the 
proportion classified as not having disease and missed diagnosis that is most likely due to 
different thresholds for positivity associated with clinical judgment and CPRs. The current 
review highlights some of the methodological issues relating to the conduct of studies 
comparing CPRs and clinical judgment, with design features of many of the included studies 
increasing the potential for bias. 
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2.6.4 Modifications to the published journal article that appear in this chapter 
Location Alteration/Addition 
2.4.4 Data synthesis 
and analysis, page 
42 of the thesis 
Addition: 
When the output of the CPR or clinical judgment was not a binary 
decision or action (e.g. the CPR classified individuals as low, moderate 
or high risk, or clinical judgment was a clinicians’ decision to not test or 
treat, to test, or to test and treat), we dichotomised the output by 
combining probability estimates that were not ‘low’ (e.g. moderate and 
high or possible or probable), and decision or actions that involved 
tests or treatment (e.g. for a score throat score, the directive output 
‘culture’ and ‘culture and treat’ were combined and compared to ‘no 
culture or treatment’).   
2.4.4 Data synthesis 
and analysis, page 
43 of the thesis 
Addition: 
Box 2.1 
2.4.4 Data synthesis 
and analysis, page 
43 of the thesis 
Alteration: 
If studies reported different thresholds for clinical judgment or the CPR, 
and if the proportions (i.e. those classified as not having disease and 
the proportion of missed diagnoses) at the different thresholds were 
similar both in favour of, or opposed to the CPR or clinical judgment at 
the different thresholds  (this only occurred in 1 study included in this 
review) we reported only the comparison for the threshold with the 
highest Youden’s index ((sensitivity + specificity)-1). 
 
 
 
 
 
 
 
Chapter 3  The effects of care provided with 
and without diagnostic prediction 
rules on patient and process 
outcomes 
 
 
Sanders S, Rathbone J, Bell K, Glasziou P, Doust J. A systematic review of the effects of 
diagnostic clinical prediction rules. Submitted to BMJ Open May 2016.   
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3.1 Preface to Chapter 3 
Decisions on whether to implement a diagnostic prediction tool in practice should be informed 
by rigorous evidence that they do patients more good than harm.  This chapter presents the 
second study addressing the thesis aim to determine the value of diagnostic prediction rules as 
tools to assist clinical judgment. It does so by providing a systematic review of randomised 
trials comparing the effect of care provided with and without a diagnostic prediction rule on 
patient and process outcomes. The review also evaluates the reporting of the study 
interventions and implementation methods.  
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3.2 Abstract 
Background: Diagnostic clinical prediction rules (CPRs) are developed to improve clinical 
decision making with the expectation that this will lead to either improved patient outcomes 
or other healthcare benefits such as reduced resource use, without adversely affecting 
patients. We conducted a systematic review to assess the effects of diagnostic CPRs on process 
of care and patient outcomes.   
Methods and findings:  We searched MEDLINE and CENTRAL with citation and reference 
checks in Web of Science, for randomised trials comparing a diagnostic strategy incorporating 
a diagnostic CPR, with a diagnostic strategy without a CPR.   
Twenty five studies evaluating diagnostic CPRs for 14 different conditions were included with 
most evaluating a management decision as the primary study outcome. The majority of the 
studies were judged to be at high or uncertain risk of bias on three or more of the six domains 
of bias, one of which was performance bias.   
Exposure to a diagnostic CPR for Group A Streptococcus throat infection reduced symptoms (1 
study) and antibiotic prescriptions (5 studies, RR 0.86 95%CI 0.75 to 0.99). For cardiac chest 
pain, a diagnostic strategy incorporating a CPR improved early discharge rates (1 study) and 
decreased hospitalisations (1 study). The Ottawa Ankle Rules reduced radiography requests 
when used in conjunction with clinical examination (1 study) but had no effect on length of 
stay as a triage test prior to clinical examination (1 study). CPRs for acute appendicitis reduced 
time to therapeutic operation (1 study) and nontherapeutic operations but the effect was not 
statistically significant (5 studies, pooled RR 0.68 95%CI 0.43 to 1.08). CPRs in 3 studies of 
children with fever and possible serious bacterial infection did not improve process outcomes 
(prescribing, length of stay, appropriate test use). Details of study interventions and 
implementation were infrequently reported. 
Conclusion:  Diagnostic CPRs had a positive effect on process outcomes in some clinical 
conditions but few studies evaluated their effects on patient outcomes. These results may be 
context specific however and future studies should seek to provide detail on how the CPR 
might alter the diagnostic pathway, measure relevant patient and process outcomes, and to 
improve reporting of the study interventions and the way in which the CPR is implemented in 
practice.  
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3.3 Introduction 
Diagnostic clinical prediction rules (CPRs)are tools intended to supplement clinicians’ 
diagnostic reasoning and judgment (42) by providing an estimate of the probability of the 
presence of a particular disease in an individual, and/or by suggesting a course of clinical 
action based on the underlying probability estimate. 
The decision to introduce a diagnostic CPR into practice should ideally be based on evidence 
that actual use leads to either 1) improved patient outcomes or 2) other benefits such as 
reduced resource use, relative to the current alternative pathway, without adversely affecting 
patients. The vast majority of studies of diagnostic CPRs in the literature however, have 
focused on establishing the accuracy of the CPR relative to a reference standard test in 
derivation and validation studies, with no comparison to the existing diagnostic pathway.  
Often this information is used to decide on the clinical usefulness of the CPR. However, 
diagnostic accuracy does not necessarily translate into patient benefits, (172) nor is it a 
necessary prerequisite for improved patient health as a CPR may alter patient health through 
other non-decisional routes including by changing the timing of decisions and actions relative 
to the existing pathway, or through direct effects of the CPR itself. (50) Therefore impact 
studies are necessary.  These studies compare testing strategies with and without a diagnostic 
CPR reporting relevant patient and/or process outcomes. (5)  
Whether implementation of current, validated diagnostic clinical prediction rules leads to 
more benefit than harm is unclear. The effects of CPRs as part of a broader group of clinical 
decision support tools (computerised and non-computerised tools for improving clinical 
decision making including, among other things, prediction rules, guideline based 
recommendations, alerts or reminders, condition specific order sets and contextually relevant 
reference information) have been extensively reviewed. (173-177) However, the effect of 
prediction rules specifically is difficult to discern, as these reviews have not analysed effects 
according to type of clinical decision support system implemented. To our knowledge, there 
has been no review of the effect of diagnostic prediction rules developed for a range of 
conditions commonly encountered in clinical medicine. Such a review may inform the selection 
and implementation of diagnostic CPRs in practice and future CPR research. 
To determine the effect of exposure to diagnostic CPRs on patient and process outcomes, we 
reviewed studies randomly allocating clinicians or patients to care provided with a diagnostic 
CPR, or to care without a diagnostic CPR.      
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3.4 Methods 
This review was performed following methods detailed in the systematic review protocol and 
is reported in line with the PRISMA statement for reporting in systematic reviews and meta-
analyses (Appendix B).   
3.4.1 Data sources and searches 
We searched electronic databases including MEDLINE and The Cochrane Central Register of 
Controlled Trials (CENTRAL) to June 2015 using MeSH and text word terms for the intervention 
and a study design filter (Appendix B). We checked systematic reviews of diagnostic clinical 
prediction rules and clinical decision support systems identified using PubMed Clinical Queries. 
Reference lists of studies obtained in full text were checked and studies included in the review 
were forward searched using the Science Citation Index Expanded in Web of Science. The 
International Clinical Trials Registry Platform (ICTRP) was searched (June 2015) to identify trials 
planned, in progress or recently completed.    
3.4.2 Study selection 
We included randomised controlled studies allocating clusters of individuals, or individual 
clinicians or patients, to a group ‘exposed’ to a diagnostic strategy comprised of or 
incorporating a previously derived diagnostic clinical prediction rule (experimental), or to care 
provided without a CPR (control).  
Eligible experimental interventions comprised the provision of a diagnostic CPR or the output 
of it, or a diagnostic strategy incorporating a diagnostic CPR (for example a strategy including a 
CPR and another laboratory or imaging test) to a clinician. A diagnostic clinical prediction rule 
was defined as a combination of variables obtained from history, examination or diagnostic 
testing, developed using a statistical method and which provide a probability of the presence 
of disease for an individual and/or suggested a diagnostic or therapeutic course of action. The 
course of action may relate to further testing or management or both. Studies evaluating tools 
incorporating a CPR designed for use by the patient or as part of joint decision making by the 
clinician and patient were not eligible for inclusion. The control intervention was an alternative 
diagnostic test or testing pathway that did not incorporate a diagnostic CPR. Studies that 
reported diagnostic accuracy as a primary outcome were included if a current and adequate 
reference standard was used.   
Titles and abstracts identified in the searches were screened by one reviewer and obviously 
irrelevant articles excluded. A second reviewer independently screened 15% of the titles and 
abstracts. The second reviewer did not identify any titles or abstracts as potential inclusions 
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that were ultimately included in the review, but considered not relevant by the first reviewer.  
Potentially relevant studies were obtained in full text and independently assessed by two 
reviewers against the review inclusion criteria. Discrepancies were discussed and resolved by 
inclusion of a third reviewer. 
3.4.3 Data extraction, assessment of risk of bias and data synthesis 
Two reviewers independently extracted data and assessed risk of bias.  
Data extraction 
We extracted information on the experimental arm including: 
a) The prediction rule or diagnostic strategy tested and its role in the existing diagnostic 
pathway (replacement, triage or add-on). (87) 
b)  Whether the strategy was assistive (e.g. provided a probability estimate or risk 
classification, or directive (e.g. suggested or recommended a course of action), 
c) Whether the use of the prediction tool was discretionary (e.g. the study methods 
stated the clinician could choose to use or not use the prediction tool) or expected 
(e.g. the study methods implied or stated that the prediction tools be used by 
clinicians) and,    
d) Whether application of the output of the CPR (when the CPR output was a suggested 
course of action) was discretionary (e.g. the study report stated a clinician could 
decide whether to follow the rule recommendation or override it) or mandatory (e.g. 
the recommendation of the CPR was followed in all patients). 
For the control arm of the studies, we extracted the description of care as reported by the 
study authors. For studies describing the control arm only as ‘usual practice’ or similar, we 
noted whether the study design may have led to some modification of ‘usual practice’ (for 
example, where clinicians in the control group may have received training or information on 
the CPRs under evaluation).  
We also assessed whether elements of the study interventions necessary for interpretation of 
study findings and replication in clinical practice were reported. We determined the minimum 
items required for reporting of the interventions through discussion and consideration of 
internationally accepted standards for reporting of clinical trials. (178, 179) This included a 
description of the diagnostic strategies tested (beyond stating the name of the test), 
description of the criteria used for establishing a diagnosis or treatment decision and, for 
studies reporting primary outcomes affected by administration of selected treatments (e.g. 
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patient symptoms), a description of the administered treatment. For the experimental arm, 
reporting of aspects of implementation (e.g. training in or exposure to the diagnostic strategy) 
was also assessed. The items were judged as ‘reported’ if any relevant information was 
described. 
Risk of bias assessment 
Risk of bias was assessed using the criteria in the Cochrane Handbook for Systematic Reviews 
of Interventions. (180) This domain based evaluation involved independent assessment of risk 
of bias due to selection, performance, detection, attrition, reporting and other. We considered 
the following features to judge the risk of bias for each domain; random sequence generation, 
allocation concealment (selection bias), blinding of participants (performance bias), binding of 
outcome assessors (detection bias) incomplete outcome data (attrition bias) and selective 
reporting (reporting bias). Assessments of risk of bias arising from allocation concealment 
were based on the methods used to assign clusters of individuals (hospitals or practices), 
individual clinicians or individual patients to experimental or control groups. Judgements on 
the likelihood of detection bias were based on details about how outcomes were determined, 
ascertained or verified and the subjectivity of the primary outcome of the study. For trials that 
randomised centres, and trials that randomised individual clinicians who then recruited 
patients to the study, we also assessed risk of bias arising from the recruitment of patients to 
the study by clinicians aware of their allocation (recruitment bias). For these studies we also 
assessed whether the analysis had been adjusted for clustering and whether there was 
baseline comparability of clusters or statistical adjustment where there was imbalance. The 
potential for contamination was also recorded. Contamination may occur, for instance, when 
patients are randomised to either the intervention or control group with the clinician switching 
between use and no use of the prediction rule, or when clinicians within the same centre 
randomised to different study groups discuss their experiences. We assessed the methods as 
low risk, high risk or unclear risk for each domain. We resolved any disagreement through 
discussion or inclusion of a third reviewer.  
 
 
Data synthesis 
Given differences in the objectives of the included trials and clinical prediction rules applicable 
to each condition, we expected heterogeneity in the outcomes reported between and within 
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clinical conditions.  To facilitate interpretation, the included studies were grouped by the 
clinical condition for which use of the CPR was proposed, and the results described in terms of 
patient outcomes (outcomes which are a direct measure of a patient’s health e.g.  mortality, 
clinical events, health related quality of life, patient symptoms and adverse events), process 
outcomes that are a measure of the healthcare service provided (e.g. length of stay, time to 
operation), clinicians’ decisions (test ordering, treatment or referral decisions) or the 
appropriateness of their decisions, accuracy (agreement with a reference standard test), and 
use and implementation (use of the tool or compliance with the output of the directive CPR) of 
the CPR or diagnostic strategy.  
We extracted and tabulated results data for all outcomes reported in the trials. For 
dichotomous outcomes, we presented the adjusted estimates of effect reported in the paper 
and calculated risk ratios and 95% confidence intervals when this was not presented. For 
instances where the intervention is intended to prevent an undesirable outcome (e.g. 
symptoms or antibiotic prescribing), an OR, HR or RR of <1 indicates the intervention is better 
than the control. Where the intervention is intended to promote a positive event (e.g. safe 
discharge) an OR, RR or HR >1 confirms treatment efficacy. Continuous outcome measures are 
presented as reported in the paper. For each study we identified the primary outcome. The 
primary outcome was considered to be either the outcome stated by the study as being the 
primary outcome, or the outcome for which a power calculation was conducted. In the 
absence of these, the primary outcome was considered to be the outcome mentioned in the 
study objective or reported first in the results section. Statistical analysis was carried out using 
the Cochrane Collaborations’ Review Manager (Version 5.3) software. When five or more 
studies for a clinical condition assessed the same outcome, in the same manner, regardless of 
the specific prediction tool or diagnostic strategy, we obtained a pooled estimate of effect 
using the general inverse variance method.  We chose the risk ratio, a relative measure of 
effect as the summary statistic for its ease of interpretation. (181) We considered clinical 
heterogeneity sufficient to expect that the underlying treatment effects differed between 
trials.  Consequently, we used random effects meta-analysis to produce an overall summary of 
the average treatment effect across the included studies. For studies including two 
experimental arms (e.g. CPR and CPR plus RADT), (182, 183) we included data only from the 
CPR alone arm. For the one study including two control arms (e.g. clinical judgment with no 
diagnostic aid or with a standardised data collection form), (184) we included data only from 
the clinical judgment with no diagnostic aid arm. To pool individual and cluster randomised 
trials in the same model, adjustment for clustering was conducted. Adjustment involved 
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reducing the size of the cluster trials to the effective sample size by dividing the sample size by 
the design effect, where the design effect is equal to 1 + (m-1) x intracluster correlation 
coefficient (ICC)  and m is the average cluster size. (180) To calculate the design effect for 
studies of sore throat we used the intracluster correlation coefficient reported in a duplicate 
publication of one of the other sore throat studies. (8) For appendicitis studies, we used the 
median ICC reported for implementation research studies reporting process variables (ICC 
0.063), and undertook sensitivity analysis using the extremes of the interquartile range. (185) 
3.5 Results 
3.5.1 Study selection 
Of 10,351 titles and abstracts screened, 166 were obtained in full text and 25 studies were 
included in the review (Figure ‎3.1). (60, 171, 182-184, 186-205) The 141 excluded studies are 
presented in Appendix B with reasons for their exclusion. One study (194) evaluated two 
different prediction rules for different clinical conditions. Two studies (182, 183) compared 
two different diagnostic strategies incorporating the same CPR (e.g. Centor score alone and 
Centor score with rapid antigen detection testing), and one study compared the experimental 
arm to a control arm with no diagnostic aids and to clinicians using a standardised data 
collection form, (184) so there are 29 comparisons between a group exposed to a diagnostic 
CPR alone or as part of a diagnostic strategy, and a control group with no exposure to a 
diagnostic CPR.   
3.5.2 Trial characteristics 
Characteristics of the 25 included trials grouped by the clinical condition for which the CPR was 
developed, are presented in Table 3.1.  
The prospective role of the CPR or diagnostic strategy incorporating a CPR was usually not 
specified in the study report, but was determined based on aspects of study design or 
descriptions provided in the study introduction or objectives. Nine of the 25 included studies 
were considered to have evaluated a diagnostic CPR or strategy designed to replace the 
existing approach, (60, 182, 186, 190, 195, 196, 201, 202, 205) while 12 assessed the impact of 
adding a CPR to the usual diagnostic pathway in order to evaluate the benefit of extra 
information to diagnostic decision making. (171, 183, 187, 189, 192-194, 198-200, 203, 204) 
One study with 3 intervention arms evaluated a CPR as both a replacement and add-on test. 
(184) Three of the 25 studies evaluated CPRs as a triage test. In these studies, the CPR was 
used before the existing test to determine which patients undergo the existing test. (188, 191, 
197) 
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In 18 of 25 studies, the CPR was introduced as a stand-alone tool (171, 184, 186, 188-196, 198-
200, 202, 204, 205) and in 5 studies, (60, 187, 197, 201, 203) the CPR was part of a diagnostic 
pathway with other tests (e.g. a pathway including a CPR, electrocardiogram and cardiac 
troponin tests). Two studies evaluated both the introduction of a CPR alone and a CPR in 
combination with another diagnostic test. (182, 183) The diagnostic CPRs and strategies tested 
were directive in 23 of the 25 studies, making a recommendation regarding treatment or 
disposition in 8 studies, (60, 183, 186, 189, 192, 193, 201, 205) further diagnostic testing in 8 
studies, (171, 188, 191, 197-200, 204) and both further testing and treatment in 7 studies. 
(182, 187, 190, 194-196, 202) 
In most studies (16/25), the control group intervention was variably described as ‘clinicians’ 
assessment’ or ‘usual care’. (171, 183, 187-194, 198-200, 202-204) This ranged from control 
groups in which clinicians were explicitly asked not to change their usual practice, and control 
groups where clinicians received information on the CPRs being tested in the intervention arm, 
to control groups where clinicians’ actions were expected to be based on local care guidelines.   
In 2 studies, clinicians in the control group were required to use a standard data collection 
form (195, 196) and in 4 studies, care provided by the control group was a specific 
management pathway (e.g. a chest pain clinic protocol or delayed antibiotic treatment 
strategy). (60, 182, 201, 205) In 2 studies, the control group intervention was a single imaging 
test, (186, 197) and in 1 study with 3 intervention arms, the control interventions were 
clinicians’ usual care and clinicians using a structured data collection form. (184)   
Patient outcomes were considered the primary outcome in 3 (182, 190, 197) of the 25 studies, 
and process of care outcomes (e.g. length of stay) were the primary outcome in 4. (187-189, 
198)  A clinicians’ decision was the primary outcome in 11 studies, (60, 171, 183, 191, 194, 195, 
199, 200, 202, 204, 205) and the appropriateness of the decision the primary outcome in 3. 
(196, 201, 203)  Accuracy of a diagnosis or decision was the primary outcome in 4 studies. 
(184, 186, 192, 193)   The types of primary and secondary outcomes reported in the included 
studies are shown in Appendix B. 
Figure ‎3.1. Study flow diagram 
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3.5.3 Risk of bias 
The majority of studies included in the review (19/25 (76%)) were judged to be at unclear or 
high risk of bias on 3 or more domains (including performance bias). Concealment of 
allocation, one of the key domains in the assessment of bias, was reported in insufficient detail 
to enable accurate judgment in over half of the included trials (16/25 (64%)).Due to the nature 
of the intervention, in most studies included in this review, clinicians would have been aware 
of group allocation. We judged the impact of this on risk of performance bias to be high in the 
majority (22/25 (87%)) of the included trials and unclear in 1 study. In this study the 
interventions were very similar and the study stated that clinicians were not aware of the 
alternate interventions. The risk of performance bias was considered to be low in 3 studies 
where the CPR was used as a triage test. In 2 of these studies, triage nurses used the CPR and 
care was provided by clinicians unaware of whether the patient had entered through the 
control protocol or was negative according to the experimental protocol. (188, 191) In the 
other study, the clinicians using the CPR and providing care were different, and sham 
procedures were also applied. (197) The likelihood of detection bias was judged to be high or 
unclear in 19 of 25 (74%) studies, and low in 6.  The potential for selective reporting bias could 
not be determined in the majority of studies (18/25 (72%)). Contamination was judged to be 
possible in 3 of the 25 studies and an unclear risk in 3. The majority (8/10) of studies 
randomising centres, or individual clinicians’ who recruited patients, adjusted for clustering 
using appropriate methods.  Details of the risk of bias assessment for each trial are shown in 
Table 3.2. 
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3.5.4 Effects of diagnostic strategies incorporating diagnostic clinical prediction rules 
The estimated effects of exposure to a diagnostic strategy incorporating a diagnostic CPR are 
presented in Tables 3.3 to 3.8 and Figures 3.2 and 3.3.  
Studies of Group A streptococcus throat infection (Table 3.3 and Figure 3.2) 
5 studies evaluated 3 different CPRs (Walsh, Centor and FeverPAIN score) and a modified 
version of one (Modified Centor Score). (182, 183, 194-196) All CPRs evaluated were directive 
(i.e. provided management recommendations) and in all 5 studies, application of the output of 
the CPR or diagnostic strategy was discretionary (i.e. the clinician could follow, or not follow 
the recommendations of the CPR). Four of the five studies were judged to be at high or unclear 
risk of bias on 3 or more of the 6 key domains.  
Clinical outcomes 
In one trial reporting patient reported symptoms (primary study outcome) and adverse effects 
(182), there were greater improvements in symptom severity among patients randomised to 
the FeverPAIN score compared to the control arm with a strategy of delayed antibiotics (Mean 
difference adjusted for baseline symptom severity and fever -0.33 on a score of 0-6, 95% CI -
0.64 to -0.02 p=0.04). The combination of FeverPAIN score and rapid antigen detection test 
(RADT) had similar effects on symptoms as the score alone (approximately 1 person in 3 rated 
score throat and difficulty swallowing as slight rather than moderately bad), however the 
effect of the combination of score and rapid antigen detection test (RADT) was not clinically or 
statistically significantly different to the control arm (0.30 95% CI -0.61 to 0.004 p=0.05). 
Symptom resolution was faster among patients randomised to the FeverPAIN score (HR 
adjusted for baseline symptom severity and fever 1.30 95% CI 1.03 to 1.63; Median duration 5 
days (IQR 3-7) in the control arm and 4 days (IQR 2-6) in the score only arm).  There were no 
differences between the study groups in the proportion returning to the clinic with sore throat 
within a 1 month period or the occurrence of suppurative complications (none occurred during 
the trial).   
Clinicians’ decisions 
All 5 trials reported clinicians’ decisions to prescribe antibiotics (this was the primary outcome 
in 3 trials). (182, 183, 194-196) In pooled analysis, clinical prediction rules reduced antibiotic 
prescriptions compared to care provided without a CPR (pooled RR 0.86 95% CI 0.75 to 0.99) 
(Figure 2). Two of these 5 trials contained 2 experimental arms; 1 arm evaluated the CPR alone 
and the second arm a strategy of CPR and rapid antigen diagnostic testing (RADT). In one of 
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these studies, the combination of CPR and RADT decreased antibiotic prescriptions compared 
to usual clinical judgment but use of the  CPR alone did not (% of visits where antibiotics 
prescribed; 58.2% usual practice, 55.3% CPR alone p=0.58, 38.2% CPR plus RADT p=<0.00). 
(183) In the other study, both strategies reduced antibiotic prescribing compared to a strategy 
of delayed antibiotic prescribing (adjusted RR CPR alone 0.71 95%CI 0.50 to 0.95, CPR plus 
RADT 0.73 95%CI 0.52 to 0.98). (182)  
Two trials reported the appropriateness of antibiotic prescribing. The first (196) reported no 
difference between the study arms in unnecessary antibiotic prescriptions defined as a 
prescription for an antibiotic in a patient with a throat culture (which was performed in all 
patients) negative for Group A streptococcus (OR adjusted 0.76 95%CI 0.42 to 1.40). In the 
second study (195)  appropriateness of prescribing was determined by assessing whether the 
prescribing decisions of the experimental group were more like the management 
recommendations of the CPR than the control group, and by comparing the proportions of 
patients prescribed antibiotics at different levels of probability of GAS infection.  In the 
experimental group, antibiotic prescribing and throat culture use corresponded more closely 
to suggested management recommendations, and a greater reduction in prescribing was 
observed for patients with low probability of GAS infection.  
In one trial evaluating the effect of the Walsh rule, clinicians in the experimental group were 
significantly less likely to order rapid streptococcal tests (RR adjusted 0.75 95%CI 0.58 to 0.97), 
but not pharyngitis throat cultures (RR adjusted 0.54 95% CI 0.18 to 1.64). (194)        
Use and application outcomes 
In the one trial where use of the CPR was discretionary, (194) clinicians opened the 
computerised CPR tool for 74.3% (278/374) of eligible patients and opened the risk score 
calculator embedded within the tool for 66.6% (249/374) of eligible patients.   
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Table ‎3.3. Results of studies of Group A Streptococcus throat infection by outcome 
Outcomes Number of trials/ N of trial 
or comparison 
Result 
Patient outcomes 
Symptom severity  (6 point scale) 
 
 
Resolution of symptoms rated moderately bad 
or worse 
 
Return within 1 month with sore throat 
 
 
Suppurative complications 
1 (Little et al., (182))*/336 
1 (Little et al., (182))*/334 
CPR only        MD† -0.33 (95% CI  -0.64 to -0.02) 
CPR + RADT   MD† -0.30 (95% CI -0.61 to 0.00) 
 
CPR only        HR† 1.30 (95% CI 1.03 to 1.63) 
CPR + RADT   HR† 1.11 (95% CI 0.88 to 1.40) 
 
CPR only         RR‡ 0.91 (95% CI 0.47 to 1.72) 
CPR + RADT    RR‡ 0.74 (95% CI 0.36 to 1.47) 
 
no suppurative complications during the trial 
Clinicians’ decisions/appropriateness of clinicians’ decisions 
Antibiotic prescriptions 
 
 
 
 
 
 
Unnecessary antibiotic prescriptions§ 
 
Antibiotic prescription by CPR 
recommendation 
  No swab, no script 
  Swab, no script 
  Script if early or swab 
 
Throat swab by CPR recommendation 
  No swab, no script 
  Swab, no script 
  Script if early or swab 
 
Rapid streptococcal test orders 
 
Pharyngitis throat culture orders 
5 (Little et al., (182), McIsaac et 
al., (196), Worrall et al., (183)*, 
McIsaac & Goel (195)*, McGinn 
et al., (194)*) 
 
1 (Little et al., (182))/334 
1 (Worrall et al.,(183))/243 
 
1 (McIsaac et al.,(196)*)/621 
 
1 (McIsaac & Goel (195))/396 
 
 
 
 
1 (McIsaac & Goel(195))/396 
 
 
 
 
1 (McGinn et al.,(194))/598 
 
1 (McGinn et al.,(194))/598 
 CPR only pooled RR 0.86 (95%CI 0.75 to 0.99)   
 
 
 
 
CPR + RADT RR† 0.73 (95%CI 0.52 to 0.98) 
CPR + RADT RR 0.66 (95%CI 0.5 0 to 0.87) 
 
OR 0.76ǁ (95%CI 0.42 to 1.40) 
 
 
OR 0.30 (95%CI 0.05 to 1.18) 
OR 0.55 (95%CI 0.26 to 1.15) 
OR 0.71 (95%CI 0.01 to 59.77) 
 
 
OR 0.80 (95%CI 0.44 to 1.44) 
OR 2.44 (95%CI 0.84 to 7.67) 
OR 1.73 (95%CI 0.289 to 12.70) 
 
RR¶ 0.75 (95%CI 0.58 to 0.97) 
 
RR¶ 0.54 (95%CI 0.18 to 1.64) 
Use and application outcomes
**
 
Decision support tool opened 
 
CPR calculator opened 
1 (McGinn et al.,(194))/598 
 
74.3% 
 
66.6% 
CPR – clinical prediction rule; MD – mean difference; RADT – rapid antigen detection test; HR – hazard ratio; OR – odds ratio; RR – 
risk ratio      
*primary outcome of the trial; †adjusted for baseline severity and fever; ‡Adjusted for baseline severity, fever and previous 
antibiotic use; §prescription of an antibiotic when throat culture negative; ǁ Adjusted for patient and physician characteristics; 
¶Adjusted for age; **only relevant to the intervention arm of studies where use of the CPR was discretionary         
 
Figure ‎3.2. Meta-analysis of Group A Streptococcus throat infection studies for the outcome antibiotic 
prescriptions 
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Studies of acute appendicitis (Table 3. 4 and Figure 3.3) 
Five studies evaluated 3 different CPRs (Alvarado score, Lintula score and the Leeds Decision 
Support System). (184, 187, 189, 192, 193) The Leeds decision support system was assistive, 
providing only an estimate of the probability of appendicitis without recommending a course 
of action, and application of the management recommendations of the Alvarado and Lintula 
scores was discretionary. All 5 studies were judged to be at high or unclear risk of bias arising 
from lack of blinding of care providers and outcome assessors.       
Clinical outcomes 
Perforated appendix rates did not significantly differ between the experimental group and a 
control group providing care without a diagnostic aid (RR 0.47 95% CI 0.19 to 1.15) and a 
control group where clinicians used a standard data collection form (RR 0.81 95% CI 0.31 to 
2.16). (170, 184)  
Process of care outcomes  
The results of two studies providing data on the effect of CPRs on duration of hospitalisation 
among patients with suspected appendicitis are conflicting. One small study  of the Alvarado 
score reported significantly shorter duration of hospitalisation in the intervention group 
(Median 37.00 hrs vs 60.40 hrs p=0.03), (189) while the other study reported no difference in 
mean duration of hospital stay between a diagnostic protocol incorporating the Alvarado score 
and graded compression ultrasound, and the control group (Mean 53.4 hrs vs 54.5 hrs p=0.84). 
(187)  
The effect of CPRs on admission rates was conflicting. Admission rates were reduced in one 
study compared to clinical judgment without a diagnostic aid (RR 0.90 95% CI 0.82 to 0.99). 
(184) CPRs did not reduce admission rates in 2 studies compared to a control group where 
clinicians used a standard data collection form (RR 1.0 95%CI 0.91 to 1.12)(184)  and usual 
clinical assessment(RR 0.72 95%CI 0.49 to 1.05). (189) There was an increase in delayed 
treatment in association with perforation in the experimental arm of two trials, but the 
difference was not statistically significant (RR 3.0 95% CI 0.13 to 69.7, (189) and RR 2.22 95%CI 
0.44 to 11.26). (187) 
In 1 small trial (n=42) reporting time to surgery (from randomisation to skin preparation), time 
to surgery was significantly shorter in the experimental group (Median 2.05 hrs vs 8.35 hrs 
p=0.03). (189)   
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One trial evaluated time to therapeutic operation (an operation was considered therapeutic if 
the disease found seemed to be the cause for the patients pain, and surgery was considered 
the appropriate treatment for the disease), and found that patients in the experimental group 
(diagnostic protocol incorporating Alvarado score and grade compression ultrasound) who 
underwent therapeutic operation had significantly shorter time to operation than patients in 
the control group (mean 7.0 hrs vs 10.2 hrs p=0.016). (187) 
Clinicians’ decisions/appropriateness of clinicians’ decisions 
In pooled analysis of five  trials, diagnostic strategies incorporating CPRs reduced unnecessary 
surgeries compared to usual clinical assessment, but this was not statistically significant 
(pooled RR 0.68 95% CI 0.43 to 1.08). (184, 187, 189, 192, 193) The direction of effect was 
consistently in favour of the experimental arms of the trials, though the risk ratios varied 
widely (Figure 3). An ICC obtained from an analysis of implementation research studies 
reporting process outcomes (ICC 0.063) was used to adjust for clustering in the one cluster 
randomised trial included in this analysis. In sensitivity analysis, using the lower extreme of the 
ICC interquartile range, in which more weight is given to the study in the meta-analysis similar 
to that applied when unadjusted data are used, the confidence intervals were narrower and 
the effect significant (pooled RR 0.64 95% CI 0.41 to 0.98). The results of the studies in the 
main and sensitivity analysis are homogenous. 
Accuracy 
3 trials report indices of accuracy. (184, 192, 193) The reference standard was a diagnosis 
obtained at surgery or at discharge in 1 trial (184) or at 1 month follow-up in 2 trials. (192, 193) 
In these two trials, accuracy of the presumptive diagnosis was compared at initial and final (> 3 
hours after initial) examination.   
In one trial in children, there was no difference in sensitivity and specificity of the initial 
examination between the experimental and control groups (sensitivity 83% vs 85 p value not 
significant and specificity 69% vs 52 % p value not significant respectively) (192). In one trial in 
adults there was no difference in sensitivity (87% vs 89% p value not significant) but specificity 
of initial clinical assessment was higher (59% vs 80% p=0.03). (193) In the third trial, sensitivity 
and specificity in the experimental arm was higher than clinical judgment with no diagnostic 
aids (sensitivity 48% vs 28% p=0. 01 and specificity 98% vs 96% p=0.04) and clinical judgment 
with standardised data collection (sensitivity 48% vs 42% p=0.48 and specificity 98% vs 96% 
p=0.01). (184)   
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Table ‎3.4. Results of studies of acute appendicitis by outcome 
Outcomes Number of trials/N of trial 
or comparison 
Result 
Intervention Control 
Patient outcomes 
Perforated appendix rate 1 (Wellwood et al., (170, 
184)*)/4194 
CPR vs judgment with no diagnostic aid  RR 0.47 (95%CI 0.19 to 1.15)  
CPR vs judgment with SDC form RR 0.81 (95%CI 0.31 to 2.16)  
Process outcomes 
Time to therapeutic 
operation (mean hrs) 
1 (Douglas et al., (187)†)/302 7.0 (95% CI 5.9 to 8.1) 10.2 (95%CI 7.9 to 13) p=0.01 
Time to surgery  
   (median hrs) 
1 (Farahnak et al., (189)†)/42 2.05 8.35  p=0.03† 
Duration of hospitalisation  
  (mean hrs) 
Duration of hospitalisation  
  (median hrs) 
1 (Douglas et al., (187))/302 
 
1 (Farahnak et al., (189))/42 
53.4 (95% CI 47 to 60) 
 
37.00 
54.5 (95%CI 46 to 63)  p=0.84‡ 
 
60.40 p=0.03‡ 
Clinicians’ decisions/appropriateness of clinicians’ decisions 
 
Nontherapeutic 
operations 
 
5 (184, 187, 189, 192, 193)/931 
 
Pooled RR 0.68 (95%CI 0.43 to 1.08) 
Admissions 2 (Farahnak et al., (189))/42 
(Wellwood et al., (184))/2596 
(Wellwood et al., (184))/2584 
RR 0.72 (95%CI 0.49 to 1.05)      
CPR vs judgment with no diagnostic aid RR  0.90 (95%CI 0.82 to 0.99) 
CPR vs judgment with SDC form RR 1.0 (95%CI 0.91 to 1.12) 
Delayed treatment in     
association with 
perforation§ 
2 (Farahnak et al., (189))/42 
(Douglas et al., (187))/302 
RR 3.0 (95%CI 0.13 to 69.7) 
RR 2.22 (95%CI 0.44 to 11.26) 
Accuracy 
Sensitivity of initial   
examination 
3 (Lintula et al.,(192)†)/126 
(Lintula et al.,(193)†)/177 
(Wellwood et al.,(184)†)/2596 
(Wellwood et al.,(184))/2584 
83% 
87% 
48% 
85% p=NS‡ 
89% p=NS‡ 
28% judgment with no diagnostic aid p=0.01‡ 
42% judgment with SDC form p=0.48‡ 
Specificity of initial 
examination  
3 (Lintula et al., (192))/126 
(Lintula et al., (193))/177 
(Wellwood et al., (184))/2596 
(Wellwood et al., (184))/2584 
69% 
59% 
98% 
52% p=NS‡ 
80% p=0.03‡ 
96% judgment with no diagnostic aid p=0.04‡ 
96% judgment with SDC form P=0.01† 
Sensitivity of final 
examination ǁ 
2 (Lintula et al., (192))/126 
(Lintula et al., (193))/177 
100% 
87% 
96% p=NS‡ 
100% p=0.02‡ 
Specificity of final 
examination ǁ 
2 (Lintula et al., (192))/126 
(Lintula et al., (193))/177 
88% 
98% 
67% p=0.03‡ 
84% p=0.03‡ 
CPR – clinical prediction rule; NS – not significant; SDC – structured data collection    
*Data from this outcome are from the original study report and systematic review by the same author; †primary outcome;‡p value for 
difference between intervention and control groups; §patients with perforation where surgery not started within 10 hours of 
randomisation; ǁ>3 hours after initial examination 
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Figure ‎3.3. Meta-analysis of acute appendicitis studies for the outcome unnecessary appendectomies 
 
 
Studies of serious bacterial infection in children with fever (Table 3.5) 
Three studies evaluated 3 different directive CPRs. (198, 204, 205) There was a non-statistically 
significant increased length of stay in the emergency department with diagnostic strategies 
incorporating a CPR in the 2 studies reporting this outcome (138 v 123 median minutes p=0.16, 
and 117 vs 114 median minutes p=0.05 in experimental and control groups of both studies 
respectively). (198, 204) A CPR comprised of 3 laboratory tests (procalcitonin, C-reactive 
protein and urinary dipstick) did not reduce antibiotic prescribing compared to the judgment 
of clinicians with access to the results and associated treatment recommendation of the white 
blood cell count, band count and C-reactive protein tests (prescriptions for 41% and 42% of 
experimental and control groups respectively p=0.88). (205) A CPR also had no effect on the 
use of diagnostic tests when serious bacterial infection was and was not present as judged by a 
reference standard (60% vs 57% of children without pneumonia in the experimental and 
control groups respectively received chest x-ray p>0.05, and 67% vs 53% of children without 
urinary tract infection had urine culture performed p>0.05). (204) This CPR resulted in a 
significant increase in the number of urine dipstick tests, a significant reduction in the number 
of full blood count tests, and a non-significant decrease in the number of diagnostic tests 
overall compared to the control group. 
Studies of ankle or mid-foot fracture (Table 3.6) 
Two studies evaluated the impact of the Ottawa Ankle Rules (OARs). (171, 188)  In 1 trial, the 
OARs were used as a triage test. (188) In this trial, standard departmental care was compared 
to a pathway in which the OARs were applied at presentation: if positive, the patient was x-
rayed, and if negative, the patient underwent usual clinical assessment.  In the second trial, 
(171) clinicians in hospitals randomised to the intervention were encouraged to use the OARs 
as part of their clinical assessment. 
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Table ‎3.5. Results of studies of serious bacterial infection in children with fever 
Outcomes Number of trials/N of trial or 
comparison 
Result 
Intervention Control 
Process outcomes 
Length of stay in the ED 
(median minutes (25th to 
75th percentile)) 
2 (Roukema et al., 2008 (198))*/164 
   (de Vos-Kerkhof et al., 2015 (204))/439 
138 (104 to 181) 
117 (84 to 158) 
123 (83 to 179)(p=0.16)† 
114 (81 to 162)(p>0.05)† 
Clinician decisions/appropriateness of decisions 
Antibiotic prescriptions 1 (Lacroix et al., 2014 (205))*/271 Clinician + CPR 41% 
CPR alone 31% 
42% (p=0.88) 
42% (p=0.009) in entire 
study cohort 
Laboratory tests ordered 
when recommended by 
CPR (%) 
1 (Roukema et al., 2008 (198))/164 82%‡ 44% (p<0.002)† 
Chest x-ray performed 
when no pneumonia (false 
positive) 
1 (de Vos-Kerkhof et al., 2015 
(204))*/439 
60% 57% (p>0.05) 
No chest x-ray performed 
when pneumonia (false 
negative) 
1 (de Vos-Kerkhof et al., 2015 
(204))*/439 
1% 1% (p>0.05) 
Urine culture performed 
when no UTI (false 
positive) 
1 (de Vos-Kerkhof et al., 2015 
(204))*/439 
67% 53% (p>0.05) 
No urine culture 
performed when UTI (false 
negative) 
1 (de Vos-Kerkhof et al., 2015 
(204))*/439 
0% 0.5% (p>0.05) 
Urine dipstick performed 1 (de Vos-Kerkhof et al., 2015 (204))/439 71% 61% (p>0.05) 
Overall diagnostics (minus 
urine dipstick analysis) 
1 (de Vos-Kerkhof et al., 2015 (204))/439 57% 63% (p>0.05) 
Antibiotics prescribed at 
discharge  
1 (de Vos-Kerkhof et al., 2015 (204))/439 32% 36% (p>0.05) 
% with SBI prescribed 
antibiotics 
1 (de Vos-Kerkhof et al., 2015 (204))/439 93% 93% (p>0.05) 
% with no SBI prescribed 
antibiotics 
1 (de Vos-Kerkhof et al., 2015 (204))/439 23% 27% (p>0.05) 
Hospitalisation 2 (de Vos-Kerkhof et al., 2015 (204))/439 
    (Lacroix et al., 2014 (205))/271 
12% 
34% 
11% (p>0.05) 
36% (p=0.81) 
Accuracy 
Area under the curve for 
any SBI 
1 (Lacroix et al., 2014 (205))/271 0.91 (95%CI 0.87 to 0.95) 
Area under the curve for 
pneumonia 
1 (de Vos-Kerkhof et al., 2015 (204))/439 0.83 (95%CI 0.75 to 0.90) 
Area under the curve for 
other SBI 
1 (de Vos-Kerkhof et al., 2015 (204))/439 0.81 (95%CI 0.72 to 0.90) 
CPR – clinical prediction rule; SBI – serious bacterial infection; UTI – urinary tract infection 
*primary outcome; †p value for difference between intervention and control groups; ‡adjusted for age        
 
When used as a triage test, the OARs did not decrease total length of stay in the emergency 
department (mean difference -6.7 minutes 95%CI -20.9 to 7.4), and there was no difference in 
patient satisfaction ratings and radiography requests between the study groups. (188) The 
OARs, when used and applied at the discretion of the clinician as an add-on test, significantly 
decreased radiography requests (76% vs 99% p=0.03). Three fractures were later diagnosed 
among participants who had not received an x-ray -  all were randomised to the experimental 
arm. However, there was no active follow-up in this trial and participants were only advised to 
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consult again if there was persistent pain or inability to walk so it is possible other fractures 
may have been missed.  In this trial, 96% and 98% of patients in the experimental and control 
groups respectively were satisfied with the care received. (171)   
Table ‎3.6. Results of studies of ankle or mid-foot fracture by outcome 
Outcomes Number of trials/N of trial or 
comparison 
Result 
Intervention Control 
Patient outcomes 
Patients satisfied with care (%) 1 (Auleley et al., 1997 (171))/1911 96% 98% 
Patient satisfaction rating  
  (median score on 5 point scale) 
1 (Fan et al., 2006 (188))/124 4 4   p=0.34† 
Process outcomes 
Total length of stay in ED (minutes) 1 (Fan et al., 2006 (188)*)/124 MD -6.7 (95%CI -20.9 to 7.4) 
Time from triage to registration  
  (mean minutes) 
8.0 8.0 p=0.80† 
Time from registration to room  
assignment (mean minutes) 
20.0 13.0 p=0.05† 
Time from room assignment to clinician 
assessment (mean minutes) 
25.0 19.0 p=0.16† 
Time from clinician assessment to 
disposition (mean minutes) 
21.0 27.0 p=0.62 
Clinician decisions/appropriateness of decisions 
Radiography requests (%) 2 (Auleley et al., 1997   (171)*)/1911 
 
   (Fan et al., 2006 (188))/124 
76% 
 
94% 
99%   p=0.03† 
 
89%   p=0.36† 
Number of fractures in those not x-rayed 1 (Auleley et al., 1997 (171))/1911 3 0‡ 
Use and implementation/application outcomes
§
 
Use of the data collection for containing 
the CPR 
1 (Auleley et al.,1997 (171))/1911 75%  
Requested x-ray when CPR 
recommended x-ray 
99% 
 
Requested x-ray when CPR 
recommended no x-ray 
21% 
CPR – clinical prediction rule; MD – mean difference; ED – emergency department  
*primary outcome; †p value for difference between intervention and control groups; ‡There was no active follow-up of 
participants in this trial and individuals with persistent pain or difficulty walking may have presented for care elsewhere; §only 
relevant to the intervention arm of studies where use of the CPR was discretionary  
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Studies of acute coronary syndromes (Table 3.7) 
Two studies judged to be at low risk of bias evaluated different diagnostic strategies 
incorporating different CPRs and tests for individuals presenting with possible cardiac chest 
pain. (60, 201) In the first of these studies, a strategy incorporating a diagnostic CPR (TIMI 
score), ECG and cardiac troponin testing significantly increased the number of patients 
successfully discharged within 6 hours (discharge was considered successful if it occurred 
within 6 hours of emergency department arrival and patient did not experience a major 
cardiac adverse event within 30 days) (OR 1.92 95% CI 1.18 to 3.13), (201) compared with a 
conventional chest pain protocol. In the second study, a diagnostic strategy comprising a CPR 
and NT-proBNP test decreased the number of patients hospitalised (OR 0.6 95% CI 0.4 to 0.9) 
with no differences in death or myocardial infarction between study groups after 1 year 
follow-up. (60) 
Table ‎3.7. Results of studies of acute coronary syndrome by outcome 
Outcomes Number of trials/N of trial or 
comparison  
Result 
Intervention Control 
Patient  outcomes 
Death or myocardial infarction at 1 year follow-up 1 (Sanchis et al., 2009 (60))/320 HR 1.9 (95%CI 0.7 to 5.2) 
Major adverse cardiac event at 30 day follow-up 1 (Than et al., 2014(201))/542 1 0 
Process outcomes 
Revascularisations at index visit (%) 
Urgent post discharge revascularisations (%) 
Planned post discharge revascularisations (%) 
1 (Sanchis et al., 2009 (60))/320 8.1% 
1.3% 
5% 
18.1% p=0.01† 
2.5% p=0.07† 
0.6% p=0.04† 
Clinicians’ decisions/appropriateness of clinicians’ decisions 
Discharge within 6 hours without major adverse 
cardiac event within 30 days 
1 (Than et al., 2014 (201)*)/542 OR 1.92 (95%CI 1.2 to 3.1) 
Hospitalisation at index episode 1 (Sanchis et al.,2009 (60)*)/320 OR 0.6 (95%CI 0.4 to 0.9) 
Use and implementation/application outcomes
‡
 
Number (%) classified as low risk by the diagnostic 
pathway incorporating CPR but admitted to 
hospital  
1 (Than et al., 2014 (201))/542 35 (12.9%)§  
HR – hazard ratio; OR – odds ratio; CPR – clinical prediction rule 
*primary outcome; †p value for difference between intervention and control groups; ‡only relevant to the intervention 
arm of studies where use of the CPR was discretionary; §none received a diagnosis of acute coronary syndrome     
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Studies of single conditions (Table 3.8) 
Clinical outcomes 
Two studies reported clinical outcomes as the primary outcome of the study. In the first, a 
score directed treatment algorithm for patients with upper abdominal complaints significantly 
decreased symptom severity (MD on a scale of 0-10 2.5 95% CI 1.49 to 3.51). (190) The other 
study was an equivalence trial of a triage strategy of ‘bedside tests’  incorporating a diagnostic 
CPR for directing ventilation perfusion scanning verses a strategy of scanning all patients. In 
this study there was no significant difference in venous thrombotic events among patients not 
taking anticoagulation agents during follow-up (% difference in venous thromboembolic event 
rate -0.6 95% CI -4.1 to 2.9), but the triage strategy excluded pulmonary embolism in 34% of 
patients (who therefore avoided ventilation perfusion scanning) and reduced other diagnostic 
imaging test performed. (197)  
Clinicians’ decisions/appropriateness of clinicians’ decisions 
Prescriptions for antibiotics were significantly reduced with use of a CPR in patients with non-
severe community acquired pneumonia of unknown aetiology, and in patients with suspected 
pneumonia, (194) with no difference in unfavourable outcomes between interventions. (202) 
Radiography requests increased, but time in the emergency department significantly 
decreased, in a study of a CPR used as a triage test in children with extremity trauma. (191) 
There was no difference in appropriate referrals in adults with pigmented skin lesions with use 
of a diagnostic protocol incorporating a CPR and the MoleMate scanning technique. (203) A 
CPR for head injured patients did not lead to a reduction in ED use of CT imaging, (200) but a 
CPR for patients with blunt head and neck trauma and possible cervical spine fracture 
significantly decreased imaging without missing injuries. (199)   
Accuracy 
A CPR had similar sensitivity and higher specificity for complete bowel obstruction in patients 
with acute small bowel obstruction compared to contrast radiography. (186) 
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Table ‎3.8. Results of single studies of different clinical conditions 
Trial/N of 
trial 
Outcomes Result 
Intervention Control 
Children with pneumonia of bacterial aetiology 
Torres et al., 
2014 (202)/120 
Antibiotic prescriptions* 
Unfavourable clinical outcome 
OR 0.13 (95%CI 0.05 to 0.35) 
OR 1.0 (95%CI 0.2 to 3.6) 
Pneumonia 
McGinn et al., 
2013 (194)/395 
Antibiotic prescriptions* 
Chest radiographs ordered 
Decision support tool opened 
CPR calculator opened 
RR 0.79 (95%CI 0.64 to 0.98)† 
RR 0.98 (95%CI 0.60 to 1.62)† 
42.5% 
41.5% 
 
Children with joint or bone injury of the extremities 
Klassen et al., 
1993 
(191)/991‡ 
Radiography requests* 
   CPR only 
   CPR as triage test 
Missed fractures (%) 
   CPR only  
   CPR as triage test 
Time spent in ED (mean hrs) 
 
RR 0.94 (95%CI 0.89 to 0.99) 
RR 1.12 (95%CI 1.08 to 1.16) 
 
3.2% 
0% 
3.3 (SD 1.7) 
 
0% 
0% 
3.6 (SD 1.5) ( p<0.001)§ 
Suspicious pigmented lesions 
Walter et al., 
2012  
(203)/1580ǁ 
Appropriate referral rate¶ 
Benign lesions appropriately managed in PC 
(%)  
Sensitivity 
Specificity 
Lesions referred (%) 
% difference -8.1 (95%CI -18.0 to 1.8) 
% difference 0.5 (95%CI -0.6 to 2.0) 
98.5% 
84.4% 
29.8% 
95.7% (=0.26)§ 
90.6%  (p<0.001)§ 
22.4% (p=0.001)§ 
Pulmonary embolism 
Rodger et al., 
2006 (197)/398 
Venous thromboembolic event rate during 3 
month f-up* 
Total bleeding episodes during 3 months 
follow-up 
Diagnostic imaging tests performed (mean 
no./patient) 
% difference -0.6 (95%CI -4.1 to 2.9) 
 
5 
 
1.36 
2 (p=0.45)§ 
 
1.9 (p<0.001)§ 
Gastro-oesophageal reflux disease 
Horowitz et al., 
2007 (190)/132 
Relief of symptoms* 
Improvement in daily activities 
Management costs (US$) 
Number of GP visits 
Number of specialist referrals 
Cost of medications (US$) 
Number of imaging diagnostic tests 
MD 2.5 (95%CI 1.49 to 3.51) 
MD 0.6 (95%CI 0.18 to 1.02) 
MD -138.00 (95%CI -230.70 to -45.30) 
MD -0.3 (95%CI -0.59 to -0.00) 
MD -0.36 (95%CI -0.65 to -0.09) 
MD -68.00 (95%CI -269.40 to 133.38) 
MD -0.10 (95%CI -0.23 to 0.03) 
Complete acute bowel obstruction 
Bogusevicius et 
al., 2002 
(186)/80 
Sensitivity* 
Specificity* 
Time to make diagnosis (hrs) 
Mortality 
100% (95%CI 86.2 to 1) 
87.5% (95%CI 6.39 to 96.5) 
1 
5.0% 
100% (95%CI 87.5 to 1) 
76.9% (95%CI 49.7 to 91.8) 
16 (p<0.001)§ 
0.0% 
Clinically important brain injury 
Stiell et al., 
2010 
(200)/4531 
% change in CT scan rates from before to 
after*  
Missed brain injuries during the ED visit 
% of clinicians using rule 
% of clinicians accurately completing rule 
13.3% (95%CI 9.7 to 17.0) 
 
0 
78% 
82.5% 
6.7% (95%CI 2.6 to 10.8) (p=0.16)** 
 
0 
Cervical spine fracture 
Stiell et al., 
2009 
(199)/11,824 
% change in cervical spine imaging before to 
after*  
Missed cervical spine fractures during the 
ED visit 
% of clinicians using rule 
% of clinicians accurately completing rule  
-12.8 (95%CI -9.2 to -16.3) 
 
0 
 
85.7% 
82.9% 
12.5 (95%CI 7.2 to 18.2)(p=0.00)** 
 
0 
 
CPR – clinical prediction rule; SD – standard deviation; MD – mean difference; OR – odds ratio; RR – risk ratio 
*primary outcome; †adjusted for age; ‡ 991 injury sites in 974 participants; §p value for difference between intervention and 
control group; ǁ 1580 lesions in 1297 participants; ¶no. of referred lesions secondary care experts decided to biopsy or 
monitor/number referred; **p value for relative change in mean imaging rates from the before period to the after period 
between intervention and control hospitals.   
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Effect on patient outcomes across clinical conditions 
Three studies reported patient outcomes as the primary outcome of the study. (182, 190, 197)  
Two of these studies reported decreased patient symptoms of sore throat or upper 
gastrointestinal discomfort with application of a diagnostic strategy incorporating a CPR 
compared to a strategy of delayed antibiotic prescribing or usual clinical management 
respectively. (182, 190) The third study compared a triage strategy incorporating a diagnostic 
CPR with other bedside tests and selective VQ scan, with a strategy of ventilation perfusion 
scanning in all patients with suspected pulmonary embolism. (197) This equivalence study 
reported similar rates of venous thromboembolic events (primary outcome) in both study 
groups but reduced use of diagnostic tests.   
3.5.5 Assessment of the reporting of interventions 
Assessment of the reporting of interventions in these studies found details of the components 
necessary to replicate the intervention were often missing (Table 3.9). When present, they 
were usually only partly described (for example, a diagnostic strategy comprising a CPR and 
laboratory test described the technique used to perform the laboratory test but did not 
describe the CPR), or were described with very low level of detail. Only 1 of 25 included studies 
was judged to have described the diagnostic strategy and criteria for arriving at a diagnosis or 
decision in both the experimental and control groups, (60) and 6 studies to have reported both 
whether training or exposure to the CPR was provided and the means by which the CPR was 
implemented into the workflow. (171, 188, 194, 198, 203, 204) Control interventions that were 
variably described as ‘usual’ care were less frequently described than control interventions 
comprising more technological procedures (e.g. contrast radiography). Most studies did not 
report providing clinicians with briefing or training in use of the CPR, or details on the manner 
in which it was integrated into workflow. In 6 studies, the CPR was a computer based tool. In 
one of these it was integrated into the electronic health record platform, (184, 186, 194, 198, 
203, 204) and in 2 studies it was a paper based tool. (195, 196) In the remainder, the means by 
which the CPR was made available could not be determined.   
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3.6 Discussion 
Diagnostic CPRs evaluated in this review were found to have beneficial effects on process 
outcomes in some clinical conditions, and in some cases had a positive effect on patient 
health. Though improvement in patient outcome, or increased efficiency of the diagnostic 
process without worsening patient outcomes, is the ultimate measure of effectiveness for 
diagnostic CPRs, few included studies primarily aimed to determine the effect of diagnostic 
CPRs, or diagnostic strategies incorporating CPRs, on patient outcomes. The majority of studies 
included in this review investigated the consequences of use of the CPR on clinicians’ decisions 
to test or treat. Study methods, intervention and implementation details necessary for 
interpretation and safe application of the intervention were generally poorly reported. This 
non-transparency also hinders attempts to replicate studies or their findings, and erodes the 
value of the research in this area. (206, 207)  
The conclusions drawn in this review are based on a small number of studies and, as a 
substantial number of these studies were categorised as high or unclear risk of bias on 3 or 
more domains of bias (one of which was performance bias), caution is advised in 
interpretation of their results. Potential bias varied across studies for different clinical 
conditions and it was often difficult to judge whether any bias would result in an over or under 
estimation of treatment effect. The assessment of risk of bias relied upon the reporting of 
trials and there was insufficient detail to confidently assess risk in many cases. Due to the 
nature of the experimental intervention, which requires interaction with and interpretation by 
clinicians, blinding of clinicians was not possible. As such, clinicians’ prior expectations of 
effectiveness of the intervention were judged to have the potential to lead to bias either 
through disparity in other care that is administered to patients or by affecting clinicians’ 
decisions which are an outcome in many studies. The risk arising from non-blinding of 
individuals assessing outcomes was judged unclear for most studies. This was due either to 
inadequate reporting, or absence of blinding of independent data collectors or adjudicators.   
The comparative performance of the interventions evaluated in this review, and the means by 
which performance is judged, are likely to be dependent on the context in which the diagnostic 
strategy is implemented. For example, in a study of the effect of a CPR for predicting 
streptococcal infection conducted in general practice in the UK, discretionary application of 
the CPR decreased the severity of sore throat symptoms compared to a strategy of delayed 
antibiotic prescribing. (182) It is not clear how the prediction rule could affect resolution of 
sore throat, but it is possible that it helped to identify patients who would respond to 
antibiotics more accurately or quickly. In a setting where antibiotics are prescribed for sore 
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throat more frequently and possibly earlier, the relative effect of the prediction rule on 
symptoms may be different. As another example, a diagnostic strategy incorporating a CPR 
and BNP testing may lead to less hospital admissions in a country where admissions for 
possible cardiac chest pain are common, (60) but may have less effect in a situation where 
admissions are infrequent.   
Conclusions of many of the studies included in this review are likely to be limited by 
inadequate sample size. Test-treatment trials reporting patient outcomes may need to be 
considerably larger than standard treatment trials in order to account for the fact that the 
effects of administered treatments are only experienced in the small proportion of patients 
who receive different care as a result of their diagnosis. (208) However, this need for inflation 
of the sample size may depend on the mechanism by which the CPR operates. If the effects on 
health outcomes are the result of changes to the timing of tests and treatments these are 
likely to be experienced by all randomised participants rather than only the small proportion of 
patients managed differently. Another reason why a larger sample size may be required is the 
high rate of contamination of aspects of the CPR intervention in the control group when 
randomisation is at the patient level. Trial designs that attempt to mitigate this by randomising 
groups of people rather than individuals will also need inflation of required sample sizes to 
retain equivalent power to an individually randomised trial after allowance is made for 
correlation of observations within the patient clusters. (209) Of the included studies utilising 
this design, only half took into account the clustered design in sample size calculations. 
Within and across clinical conditions, there was heterogeneity in the degree to which CPRs and 
diagnostic strategies incorporating CPRs were used and their output applied. The protocols of 
the included studies took one of two approaches to the use of the CPRs or diagnostic 
strategies: a pragmatic approach in which clinicians could decide whether or not to use the 
tool, or an approach in which clinicians in the study were expected to use the CPR or were 
provided with the output from it. Further, there were varying degrees to which the clinician 
was required to follow the recommendation provided by the directive rules or strategies. In 
some studies, the subsequent treatment provided was dictated entirely by the CPR. In others, 
the clinician was ‘encouraged’ to follow the recommendations, and in others, clinicians could 
adopt or ignore the recommendations at their discretion. These variations may lead to 
differences in intervention effect but also have implications for transferring the research 
findings to clinical practice. Results from studies mandating use of a CPR and carefully 
monitoring its correct application may be different to results seen when the CPR is introduced 
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in a situation where clinicians are given license to override its recommendations.  It has been 
suggested that impact studies should assess both actual impact – impact when clinicians can 
use their discretion in following the CPRs recommendations, and potential impact – measured 
by analysing the CPRs recommended decision regardless of implementation. (5) This was done 
by 2 studies included in the review. In one of these studies, (191) application of the CPR alone 
reduced x-rays but missed more fractures than standard care. When the CPR was used as a 
triage test and those negative on the CPR were assessed by clinicians, far more x-rays were 
performed, but no fractures were missed. In the other study, (205) strictly following the CPR 
recommendations would have resulted in a treatment rate (antibiotic prescribing) of 31% as 
opposed to an actual treatment rate of 42% when clinicians could override the CPR 
recommendations (control group treatment rate 42.1% and 41.7% in the entire study cohort).  
Such information is likely to assist in the interpretation of impact study findings by informing of 
the interactions taking place between the clinician and the CPR and the reasons for any 
disagreements.   
The design of another trial invites discussion on whether CPRs may affect clinicians’ judgment 
in a particular clinical situation through refinement of the process of data collection alone or 
through the combination of refined data collection and probability information. In this 3-arm 
study, the effects of clinicians’ use of an assistive CPR were compared to the effects of a) 
clinicians’ assessment with a standardised data collection form and, b) clinicians’ usual care 
with no diagnostic aid. (184)  For the outcomes studied, clinicians with structured data 
collection forms and clinicians with structured data collection and a probability estimate, 
generally performed as well as each other and better than clinicians with no diagnostic aids.  
The issue of whether, and in what circumstances improved performance occurs through the 
process of refining clinicians’ judgment or the combination of refinement and information in 
the form of probability estimates and or recommendations, deserves further research.   
Though clear reporting of interventions is necessary for interpretation of study findings and 
safe replication of the intervention in practice, (210) documentation of the interventions 
tested in the majority of included studies was poor. This is similar to research on other 
complex interventions and non-pharmaceutical treatments. (211, 212) Furthermore, studies 
rarely stated how a diagnostic CPR is expected to alter outcomes relative to the alternate 
diagnostic strategy, making it difficult to judge the adequacy of the outcomes reported. For 
many of the included trials where the control intervention could broadly be described as 
‘usual’ care, no, or minimal description of the test method or the criteria by which 
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management decisions were made was provided. ‘Usual’ care had various permutations 
ranging from what is termed ‘wild type’ or ‘care as it is now’, to a more regimented guideline 
driven care. (213, 214) It is acknowledged that such strategies are internalised, likely complex, 
probably highly variable and nuanced and difficult to translate into a prescriptive format.  
However, lack of even mention of the tests performed makes it very difficult to interpret 
differences in trial outcomes and to judge generalisability. Furthermore, basic details about 
the process of implementation were infrequently reported making it difficult to know whether 
failure to demonstrate an effect is more likely due to inadequate implementation of the 
experimental strategy, than lack of effect of the experimental intervention itself. Nor did the 
majority of trials provide information on which to judge the risk of behaviour change among 
clinicians in the control groups arising from knowledge of study conditions. (214)  
The information provided by a diagnostic prediction rule should either: 1) lead ultimately to 
improved outcomes for patients (e.g. resolution of symptoms), or 2) maintain (not worsen) 
patient outcomes whilst providing other benefits (e.g. reduced unnecessary tests or 
treatments). Despite this, few studies included in this review report any patient outcomes, and 
fewer still report patient outcomes as the primary study outcome. Clinicians’ decisions to test 
or treat are the primary outcomes, and sometimes the only study outcome, in the majority of 
included studies. There may be several explanations for this: randomised studies reporting 
patient outcomes are difficult, costly and time consuming to conduct; researchers may believe 
that patient management is a valid surrogate for health outcomes; or researchers may select 
outcomes that reflect the primary intention of many diagnostic CPRs to reduce testing or 
treatment. However, recent research suggests that it is not possible to infer the effects of a 
diagnostic test on patient outcomes based on how a test influences management decisions. In 
an analysis of a large sample of diagnostic randomised controlled trials, the effects of the index 
test on further diagnostic and therapeutic interventions did not correlate with the effects on 
patient outcomes. (172) This study also found that estimates of accuracy do not inform well 
about the clinical utility of diagnostic tests. Given the multitude of ways CPRS may affect 
patient outcomes, (50) improved accuracy or management decisions afforded by a CPR are 
neither a necessary requisite nor a guarantee for improving patient health. Though 
measurement of the effects of CPRs on patient management may be of some use for planning 
further evaluations of a CPR, and as part of a suite of outcome measures to assist in 
understanding the means by which a CPR may exert its effects, we argue that impact studies 
reporting only management decisions, or reporting management decisions without 
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considering effects on patient outcomes, are insufficient to judge the clinical utility of 
diagnostic CPRs.   
To our knowledge, this is the first review of diagnostic CPRs across a range of clinical 
conditions. We are aware of one systematic review evaluating the impact of diagnostic 
prediction rules for acute appendicitis. (170) This review included only 1 trial, (184) which we 
also included in our review (along with 4 other trials subsequently published). Based on the 
findings of this trial which found similar and statistically significantly decreased admission rates 
among clinicians randomised to a) an assistive CPR and b) standardised data collection forms, 
compared to clinicians with no diagnostic aid, the review concluded that standardised data 
collection is a promising strategy for assisting diagnosis, while criticising the reporting and 
conduct of existing studies. The findings of our review, that CPRs reduce prescribing and test 
ordering for some conditions, are broadly consistent with existing research evaluating clinical 
decision support tools which has found that some systems can improve test ordering and 
antibiotic prescribing behaviour. (173-175)  
Our review has limitations. Because of the large number of titles and abstracts retrieved in the 
searches, only 1 reviewer performed screening of titles and abstracts, with a second reviewer 
screening only a proportion. Therefore, some studies may have been overlooked. However, 
screening of systematic reviews of clinical decision support systems, reference checks and 
forward searches minimised the possibility that eligible studies were missed. The presence of 
study publication bias in this review is possible. For instance, many of the CPRs were tested by 
the researchers who developed the CPR and thus may be more likely to submit studies with 
positive results for publication. In reporting whether a study described components of the 
interventions, we determined only whether a description was present, rather than providing a 
judgment about the adequacy of the description. Consequently the review is likely to 
overestimate the reporting quality of the included studies, as components were judged to 
have been described even if only partially so, or with little detail. Furthermore, the criteria 
assessed were considered by the authors to be the minimum essential to the reporting of 
intervention content. To properly appraise reporting quality of impact studies, more criteria 
should be considered.  
3.7 Conclusion 
This review provides insight into the current status of research evaluating the impact of 
diagnostic clinical prediction rules and provides information that may assist clinicians and 
policy makers’ decisions regarding the application of these tools. This review found that 
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diagnostic CPRs improve process of care measures for some clinical conditions, and in some 
cases improved or maintained patient health while providing other benefits. However, this 
conclusion is based on a small number of studies, many of which are judged to be at high or 
unclear risk of bias and is likely to be context dependent. It is apparent from this review that 
future impact studies need to be more carefully designed and conducted and more thoroughly 
reported. Consideration of the many mechanisms by which a CPR may alter outcomes during 
the trial design stage, should guide the nature and number of outcomes measured and 
facilitate understanding of why particular effects are observed. Use of a framework such as 
that developed by Ferrante de Ruffano and colleagues (50) may assist firstly in identifying the 
means by which a CPR may alter the existing diagnostic pathway, and secondly to 
consideration of the full range of direct and downstream outcomes that should be measured. 
Furthermore, reporting of such studies should be improved to assist interpretation and 
replication in practice. Establishing benefit to patient health or showing that patient health can 
be maintained while providing other benefits, should be the priority of impact evaluations of 
diagnostic prediction rules.   
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Chapter 4 The identification of serious bacterial 
infection in children with fever 
presenting to primary care  
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4.1 Preface to Chapter 4 
The following chapters of this thesis focus on diagnostic prediction rules in a specific clinical 
area where diagnosis is known to be challenging, the identification of serious bacterial 
infection in children. The goal of this part of the thesis is to assist primary care clinicians’ 
diagnostic management of children with possible serious infection through the derivation and 
validation of a diagnostic prediction rule, and simplified versions of the rule, and elucidation of 
the accuracy, independent and added value of the inflammatory biomarker C-reactive protein.  
The clinical problem, the rationale for, and design of proposed studies to achieve this goal are 
outlined in this chapter. Reasons for inability to complete two of the proposed projects, and 
subsequent modifications to one of the proposed studies are also discussed.   
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4.2 The clinical problem 
The investigation of fever in young children has been identified by physicians in several 
countries as one of the most difficult clinical problems. (136) Fever is also one of the most 
common reasons for a child to be seen by primary care practitioners (215) and to present to 
emergency departments for care. (216-218) However, differentiating a child with serious 
infection from the large number of children who have minor illnesses that are often self-
limiting is difficult for several reasons. Firstly, serious infections are rare in most settings.  
Incidences of <1% have been reported in primary care (219) and 7% in a large cohort of febrile 
children presenting to an Australian emergency department. (220) Secondly, infection is a 
dynamic process and children may present in the early stages of disease when severity is not 
apparent and may then deteriorate rapidly. Thirdly, the initial presentations of serious and 
non-serious infections can be similar. (221) Fourthly, in some settings, potentially useful 
diagnostic procedures may not be available. Lastly, assessment of children can be difficult and 
is often undertaken by staff with limited paediatric experience or under high pressure because 
of large patient volumes. (222) 
Clinical assessment, including history taking for symptoms and physical examination for signs, 
forms the basis for diagnostic decision making in children with possible serious infection. 
However, the consideration of signs and symptoms alone often results in residual diagnostic 
uncertainty. (223) While some clinical features increase or decrease the probability that a child 
has serious infection, none is sufficient on its own to substantially raise or lower the risk of 
serious infection. (223) Though some features are recognised as red flags or highly specific 
warning signs for serious infection, (223) these features are seen infrequently in the primary 
care setting (224) and are uncommon even in children with serious infection. (222)  
Due to the small but real chance that the child with acute infection will not recover as 
expected and will suffer complications with severe and occasionally fatal consequences, (225)  
many children who ultimately have self-limiting diseases are referred to secondary care as a 
precaution. (226) This use of secondary care resources results in significant cost to the 
healthcare system and subjects the child to risks inherent in further diagnostic testing and or 
treatment. Prescribing antibiotics in the hope of preventing a negative outcome is another way 
primary care clinicians may deal with this uncertainty. (227, 228) This low threshold for 
prescribing exposes many children to unnecessary adverse effects and costs and contributes to 
antibiotic resistance at an individual and societal level. (229, 230) On the other hand, children 
who do have a serious bacterial infection may not be sent to hospital promptly when the first 
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signs of severe infection are present, or are prescribed antibiotic treatment when they would 
likely benefit from them. (220, 221)  
4.3 Strategies to improve the diagnostic management of children with 
possible serious bacterial infection presenting to primary care 
In an effort to bridge the diagnostic gap between the predictive value achievable by the 
consideration of clinical features and the implicit threshold for referral or treatment, clinicians 
may rely on their instinct that something is wrong, utilise diagnostic safety netting procedures, 
(226) or conduct more invasive and involved testing. Clinical prediction models that combine 
signs and symptoms and laboratory or imaging tests have also been developed as a means to 
assist clinicians to identify children with serious bacterial infections. Two of these strategies, 
diagnostic prediction rules and additional diagnostic testing will be considered further in this 
chapter.   
4.3.1 Clinical prediction rules as a strategy to improve the diagnostic management of 
children with possible serious bacterial infection 
Many clinical prediction rules have been proposed to differentiate children with a serious 
bacterial infection from those with a benign self-limiting non-bacterial infection or to identify 
specific serious infections such as pneumonia, meningitis or septicaemia. (222) The 
expectation, though rarely stated in studies deriving these rules, is that clinicians’ use of the 
prediction rule and/or knowledge of the estimated probability of serious bacterial infection, 
will improve the accuracy of the clinicians’ diagnosis leading to improved management 
decisions. Ideally, the prediction rule will improve the sensitivity of the clinicians’ diagnosis, 
thus avoiding missed cases of serious bacterial infection, as well as the specificity of diagnosis, 
thus minimising the number of children without serious bacterial infection subject to further 
testing or treatment. Though the primary mechanism by which diagnostic prediction rules may 
be expected to drive changes to decisions and downstream patient health is through improved 
accuracy, prediction rules may also alter the temporality of clinicians’ decisions and actions.  
Use of the prediction rule, which focuses the clinician on a small number of highly diagnostic 
indicators for serious bacterial infection, may lead to earlier diagnosis and subsequently earlier 
management decisions.   
4.3.2 Additional testing  
In some clinical settings clinicians may seek to increase diagnostic certainty after physical 
examination and history taking through additional diagnostic testing. These follow-up tests are 
often more invasive, expensive, inconvenient and carry a greater risk of harm. Tests that may 
be utilised during the diagnostic workup of a child with possible serious infection include blood 
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tests for white blood cell counts and inflammatory markers, urinalysis, lumbar puncture as well 
as imaging. (231) Inflammatory markers are proteins whose concentrations in the blood 
increases or decreases during inflammation and are seen to play an important role in 
identifying the presence, absence or severity of the inflammatory response in individuals 
suspected of having serious infection. One such inflammatory biomarker is C-reactive protein.   
4.3.2.1 The inflammatory biomarker C-reactive protein 
C-reactive protein (CRP) has been utilised as a test for differentiating between bacterial and 
viral infection because it has been shown that a very high CRP (>100mg/L) is more likely to 
occur in bacterial than viral infections, and a normal CRP is unlikely in the presence of 
significant bacterial infection. However, intermediate CRP concentrations may be found in 
both bacterial and viral conditions and low concentrations (>20mg/L) have been associated 
with increased risk of pneumonia. (232, 233) 
Although CRP testing is primarily carried out in a laboratory in a hospital setting, the 
availability of point of care tests which provide immediate results, and use finger stick droplets 
rather than large aliquots of blood, suggests that CRP testing may have a role in primary care 
settings. In the early stages of this thesis, CRP was widely used as a point of care test in 
primary care in some European countries, and its use was increasing, or being promoted in 
other developed countries. (234, 235) 
4.4 Proposed studies intended to assist clinicians’ diagnostic management of 
children with possible serious bacterial infection presenting to primary 
care  
4.4.1 The derivation and validation of a clinical prediction rule 
In the early stages of this thesis (to end 2007), several prediction rules based on clinical 
features from the patients’ history or physical examination had been developed for estimating 
the risk of serious bacterial infections overall (236, 237) and specific serious bacterial 
infections. (238-243) The prediction rules available at the time are described in Table ‎4.1. They 
were, however, of questionable appropriateness for clinical practice. Some had key 
methodological limitations (e.g. predictors were not identified and combined using 
multivariable statistical techniques), (237, 240, 243) or were limited to use in very young age 
groups (e.g. babies). (238, 242) Others had been derived in tertiary settings or in populations 
with a higher incidence of serious bacterial infection prior to the introduction of routine 
vaccination against Haemophilus influenzae type b and Streptococcus pneumoniae. (236, 237) 
Further to this, only one of these models had been externally validated (237) and in the 
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validation studies, the potential of the tool to rule out serious infection was variable when 
used in conjunction with laboratory tests. (244-246)  
Table ‎4.1. Clinical prediction rules comprised of predictors from history or physical examination for serious 
bacterial infection overall or specific serious bacterial infections in children (published to end 2007) 
Clinical 
prediction rule 
Predictors included in the rule Methodological and/or generalisability limitations 
All serious infections 
 
Bleeker et al., 
2001 (236) 
Duration of fever, history of poor micturition, 
history of vomiting, age >1 year, temperature, 
chest wall retractions, poor peripheral 
circulation 
Derived in children <36 months  
Derived in tertiary paediatric hospital with prevalence of 
serious bacterial infection 25% 
Yale 
observation 
scale McCarthy 
et al., 1982 
(237) 
Quality of cry, reaction to parents’, state 
variation, colour, state of hydration, response 
to social overtures 
Derived in children <24 months 
Derived in tertiary paediatric hospital with prevalence of 
serious illness 12% 
Derived prior to vaccination Haemophilus influenzae and 
pneumococcus 
Pneumonia 
 
Crain et al., 
1991 (238) 
Cough, tachypnoea, rales, retractions, rhonchi, 
rhinorrhoea, wheezing 
Derived in infants <2 months.  
Model not derived using  multivariable statistical analysis 
Meningitis 
 
Joffe et al., 
(239) 
Suspicious findings on neurological and or 
physical examination, physician visit in 
previous 48 hours, convulsions on arrival at 
emergency department, a focal seizure 
Outcome not verified in all children.  
Model not derived using  multivariable statistical analysis 
Offringa et al., 
1992 (240) 
Petechiae, nuchal rigidity, coma Model not derived using multivariable statistical analysis 
Pantell et al., 
2004 (242) 
Abnormal appearance, age, temperature Derived in infants < 3 months 
Oostenbrink et 
al., 2001 (241) 
Duration of main complaint, vomiting, 
meningeal irritation, cyanosis, petechiae, 
disturbed consciousness 
Derived in emergency department in children with 
meningeal signs  and  prevalence of serious infection 44% 
Bacteraemia 
Schwartz & 
Wientzen, 1982 
(243) 
Appearance, appetite, cry, resistance to 
examination 
Derived in children <36 months 
Derived prior to vaccination Haemophilus influenzae and 
pneumococcus 
Model not derived using multivariable statistical analysis 
 
The prediction rules available at the time were thus judged to be unsuitable for the 
identification of serious bacterial infection in children presenting to primary care settings. It is 
acknowledged that methods have since been developed for updating existing rules to 
overcome differences between the derivation population and the population of interest (62, 
247). However, methodological guidance on prediction rule updating was not available at the 
time this program of research was being conducted.   
Given the limitations of the existing prediction rules and absence at the time of 
methodological guidance for adjusting prediction models to other settings, I proposed deriving 
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a prediction rule comprised of predictors from the patients’ history and physical examination, 
using data sourced from primary care and low prevalence emergency department settings. The 
dataset to be used for this purpose was a prospective cohort study of 700 children aged 3 
months to 16 years attending the Paediatric Assessment Unit at the University Hospital 
Coventry and Warwickshire NHS Trust in the United Kingdom with suspected acute infection.  
Just over half the children in this cohort (51%) were referred from primary care, 28.3% were 
self-referrals and the remainder (16.6%) emergency ambulance transfers. I then planned to 
validate this rule in multiple datasets being compiled by an international collaboration of 
researchers in the area. (222) In addition, simplified versions of the rule were to be derived 
and the accuracy and reclassification ability of the simplified prediction rules compared to the 
original prediction rule. 
4.4.2 Determination of the diagnostic value of C-reactive protein (CRP) 
Despite the widespread use of C-reactive protein (CRP) in some countries and its increasing 
uptake in others at the time (throughout 2006 and 2007), the diagnostic value of CRP for 
identifying serious infections in children was uncertain and had not been systematically 
studied. In order to inform of the ability of CRP to accurately identify serious bacterial infection 
in children at first presentation, and its added value beyond existing clinical information, two 
studies were proposed. The first was a systematic review of the accuracy and independent 
value of CRP for serious bacterial and bacterial infection in non-hospitalised children. The 
second study was a modelling study to determine the added value of CRP over and above 
patient history and clinical examination. In this study, the area under the receiver operating 
characteristic curve (AUROC) of the derived rule, comprised of predictors from the patients’ 
history and physical examination (the base model), was to be compared to a model containing 
both the CRP test value and the derived rule (the extended model).   
4.5 The research completed, incomplete and research plan modification 
Of the four studies originally proposed to address the goal of this part of the thesis, two were 
not completed. An analysis of the dataset sourced to develop the prediction model was 
attempted but it was judged that a valid and clinically sensible prediction model comprised of 
variables from the medical history and physical examination could not be derived.    
Consequently, quantification of the added value of the inflammatory marker CRP beyond 
variables obtained from the medical history and physical examination could also not be 
determined.   
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Derivation of the prediction rule was judged to be unwise due to the frequency of missing 
predictor data and the limitations of available methods for handling missing data. Less than 
half of the cases in the dataset (47%) had complete data on all the predictors preselected for 
inclusion in statistical modelling, with predictor data missing for between 2% and 44% of cases. 
Serious bacterial infection was more common among cases with complete predictor data (17% 
vs 14% among cases with missing data) and a larger percent of cases with complete predictor 
data were considered to be urgent or very urgent on the Manchester Triage Scale (74% vs 
70%). Several approaches to managing the missing data were considered including 1) removal 
of participants with missing predictor values, 2) removing predictors with missing data, 3) 
single imputation with the arithmetic mean or the predicted score from a regression equation 
and 4) multiple imputation. Removal of participants with missing predictor data was not 
considered an appropriate approach as it had been shown to lead to inaccurate estimates of 
the predictor outcome associations and the predictive performance of the final model. (248, 
249) Removing predictors with missing data was considered, but judged to have an 
unacceptable trade-off in terms of the face value of the rule. The large amount of missing data 
for some predictors (e.g. respiratory rate) in the research setting suggested that predictor 
measurement may be difficult and it is likely that data for such variables will also be frequently 
missing in clinical practice. Removing these predictors from further analysis may be sensible in 
that it may lead to the derivation of a rule more likely to be applied in totality, with data from 
all the predictors used to derive the result. However, removal of such predictors would likely 
affect the face validity of the rule and threaten clinicians’ acceptance and implementation of it. 
Single imputation, while considered to be preferable to the deletion methods described, had 
been shown to produce biased parameter estimates and or to attenuate standard errors. (249) 
The final approach, multiple imputation, was considered to be the optimal method. Based on 
simulation studies and theoretical reasoning at the time, multiple imputation was assumed to 
yield unbiased results and appropriate standard errors. (250)  
Today, multiple imputation is accepted and advocated as the preferred approach for managing 
missing data in studies deriving multivariable models and is embedded in commonly used 
statistical packages. (1) At the time this study was undertaken however, the methods of 
multiple imputation were in development. (251) Definitive guidelines on the allowable 
proportion of missing data to which multiple imputation techniques could be validly applied 
were not available, and there were limited studies investigating the effects of varying amounts 
of missing values, the mechanisms of missingness, or approaches to handling missing data, on 
model performance to guide the analysis. Due to the large amount of missing data, limitations 
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of conventional methods for replacing missing values, and concern regarding the clinical 
sensibility and validity of a prediction rule derived using these methods, derivation of the 
proposed prediction rule was not completed.  
The remaining two studies were completed; one as proposed, and the second with some 
modification to the protocol. The first of these was a systematic review to determine the 
accuracy and independent value of C-reactive protein for the recognition of serious bacterial 
infection relative to the prevailing reference standard. This study is presented in the following 
chapter. The second completed study determined the effect of simplification of a prediction 
rule on performance (Chapter 6). When the planned prediction rule for identifying serious 
bacterial infection in children in a primary care setting could not be derived, an alternative 
dataset was sourced to allow the study to be conducted. Though not in the clinical area of 
interest, the issues raised are pertinent to diagnostic prediction rules developed for any clinical 
setting.  
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4.6  The current status of diagnostic prediction rules as a strategy for 
assisting clinicians’ diagnostic management of children with possible 
serious bacterial infection presenting to primary care 
The diagnostic management of children with possible serious bacterial infection has continued 
to be an area of intense interest among researchers and policy makers. (252, 253)  In recent 
years several clinical prediction rules for identifying serious infection in children presenting to 
the emergency department and primary care have been derived and evaluated (220, 254, 255) 
and some of the clinical prediction rules derived prior to the end of 2007 and described in 
Table 4.1, have undergone further development. (236, 237) The characteristics of, and stage of 
development of these clinical prediction rules which are comprised of clinical predictors or 
clinical and laboratory predictors such as C-reactive protein are presented in Table 4.2.  
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Table ‎4.2 Clinical prediction rules comprised of predictors from the history or physical examination (with or 
without laboratory predictors) for serious bacterial infection overall or specific serious bacterial infections in 
children derived and or evaluated since 2007 
Clinical prediction 
rule/Setting in 
which rule derived 
Predictors 
included 
in the rule 
Stage of 
development* 
Findings 
All serious infections 
Bleeker et al., 2001 
(236)/ED 
Clinical Narrow validation 
(Bleeker et al., 2007 
(256)) 
 
 
 
Impact study of 
randomised controlled 
design (Roukema et 
al., 2008 (198)) 
Discriminative ability of the prediction rule was poor in the 
validation dataset (AUROC derivation 0.75 95%CI 0.68 to 0.83 
versus AUROC validation 0.60 95%CI 0.49 to 0.70). After 
updating the rule the AUROC was 0.69 95%CI 0.63 to 0.75 
 
 
Increased length of stay in the emergency department† and 
number of laboratory tests ordered with implementation of 
the clinical prediction rule  
 
Bleeker et al., 2001 
(236)/ED 
Clinical + 
laboratory 
Narrow validation 
(Bleeker et al., 2007 
(256)) 
Discriminative ability of the prediction rule was similar in the 
validation dataset (AUROC derivation 0.83 95%CI 0.77 to 0.89 
versus AUROC validation 0.78 95%CI 0.69 to 0.86)  
Yale observation scale 
McCarthy et al., 1982 
(237)/ED 
Clinical Broad validation 
(NICE, 2007 (253)) 
Sensitivity was low in low prevalence settings at different cut-
offs (46.2% and 23.1%), intermediate prevalence settings at 
different cut-offs (40.5% and 22.3%) and high prevalence 
settings at different cut-offs (30.3% and 19.5%) 
Four-step decision 
tree (255)/PC 
Clinical Internal validation 
Broad validation 
(NICE, 2007 (253)) 
 
 
Narrow validation 
(Verbakel et al., 2015 
(257)) 
Sensitivity 96.8 (95%CI 83.3 to 99.9) 
Sensitivity 90% in one low prevalence setting, ranged from 
75.5% to 87.8% in two intermediate prevalence settings and 
from 23.0% to 89.1% in two high prevalence settings   
 
Sensitivity 100% (95%CI 71.5% to 100%) in the general 
practice setting, 82.7% (95%CI 72.2% to 92.4%) in pediatric 
outpatient setting and 69.5% (95%CI 62.6% to 75.9%) in the 
emergency department setting  
Nijman et al., 2013‡ 
(254)/ED 
Clinical + 
laboratory 
Narrow validation 
(Nijman et al., 2013 
(254))  
Impact study of 
randomised controlled 
design (de Vos- 
Kerkhof et al., 2015 
(204)) 
C statistic§ 0.69 (95%CI 0.53 to 0.86) in validation dataset 
versus 0.86 (95%CI 0.79 to 0.92) in the derivation dataset 
 
No difference in ‘correct’ diagnoses (false positives and false 
negatives) between study groups†. No difference in median 
length of stay. In the intervention group fewer full blood 
counts were performed and more urine dipsticks were 
correctly done according to current guidelines. 
Pneumonia 
Nijman et al., 2013 
(254)/ED 
Clinical + 
laboratory 
Narrow validation 
(Nijman et al., 2013 
(254)) 
 
Impact study of 
randomised controlled 
design (de Vos -
Kerkhof et al., 2015 
(204)) 
C statistic 0.81 (95%CI 0.69 to 0.93) in validation dataset 
versus 0.80 (95%CI 0.72 to 0.89) 
 
 
No difference in ‘correct’ diagnoses (false positives and false 
negatives) between study groups†. No difference in median 
length of stay. In the intervention group fewer full blood 
counts were performed and more urine dipsticks were done 
according to current guidelines. 
Table 4.2 Continued 
Pneumonia 
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Craig et al., 2010 
(220)/ED 
Clinical Narrow validation 
(Craig et al., 2010 
(220)) 
AUROC 0.84 (95%CI 0.82 to 0.87) in the validation dataset 
versus 0.84 (95%CI 0.83 to 0.86) in derivation dataset 
Pneumonia rule 
(255)/PC 
Clinical Internal validation 
(Van den Bruel et al., 
2007 (255)) 
 
 
Broad validation (Nice, 
2007 (253)) 
Sensitivity was 93.8% (95%CI 69.8 to 99.8) for the predictor 
variables ‘dyspnoea’ and ‘something is wrong’. Sensitivity was 
93.8% (95%CI 69.8 to 99.8) for the predictor variables 
‘dyspnoea’ and ‘different illness’ 
 
Sensitivity ranged from 92.4%  to 94.1% in two low 
prevalence settings and from 26.9% to 81.5% in three 
intermediate prevalence settings  
Oostenbrink., 2013 
(258)/ED 
Clinical + 
laboratory 
Broad validation 
(Oostenbrink et al., 
(258)) 
C statistic 0.86 and 0.86 in two validation datasets 
Bacteraemia 
Craig et al., 2010 
(220)/ED 
Clinical Narrow validation 
(Craig et al., 2010 
(220)) 
AUROC  0.74 (95%CI 0.66 to 0.82) in the validation dataset vs 
AUROC 0.88 (95%CI NA) in the derivation dataset 
Meningitis 
Meningitis rule 
(240)/ED 
Clinical Broad validation 
(NICE, 2010 (253)) 
Sensitivity ranged from 33.3% to 100% in two low prevalence 
settings, and was 95.5% in one high prevalence setting  
    
ED – emergency department; AUROC – area under the receiver operator characteristic curve; PC – primary care; NA – not available                                  
* Narrow validation is application of the rule in a similar clinical setting and population to derivation data.  Broad validation is 
application of the rule in multiple settings and varying prevalence of disease; † primary outcome; ‡ pneumonia not included; § c 
statistic equivalent to the AUROC 
Review of Table 4.2 indicates that efforts to develop a clinical prediction rule with 
demonstrated benefit when applied in practice have, as yet, been both incomplete and 
unsuccessful. This is particularly the case for primary care settings.  Despite the need for 
formal impact analysis to assess whether care provided when clinicians have access to a 
clinical prediction rule either leads to better outcomes for the patient, or provides other 
benefits relative to the current diagnostic pathway without adversely affecting patients, only 
two clinical prediction rules (one comprised only of clinical variables, and the other of clinical 
variables and the laboratory test C-reactive protein) have had the effects of application in 
practice assessed, and these were in emergency department settings. (198, 204) In these two 
studies, exposure to the clinical prediction rule did not lead to improvements in process of 
care outcomes.  In the first of these studies, care provided with a diagnostic prediction rule 
had no effect on ‘correct’ diagnoses (primary outcome) or length of stay in the emergency 
department, (204) and in the second, care provided with a diagnostic prediction rule did not 
shorten length of stay in the emergency department and increased the number of laboratory 
tests ordered. (198) Neither study reported patient outcomes.  
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In addition, to date there have been few studies deriving or validating clinical prediction rules 
for identifying serious infection in children in the primary care setting (Table 4.2), and though 
the one rule derived in this setting, the four-stage decision tree, has demonstrated value for 
ruling out serious infection, residual uncertainty remains. (255) The four-step decision tree 
developed in a general practice population in Belgium had high sensitivity (90%) when 
validated in one low prevalence setting, and 100% sensitivity in a general practice setting 
similar to the setting in which it was derived. (257) However, false positives are common 
(specificities of 44% and 77% in validation studies) and consequently additional clinical 
assessment or testing may be needed to reduce unnecessary referrals. Clinical prediction rules 
specifically for pneumonia have also shown value for ruling out pneumonia in some validation 
studies in low prevalence settings, (sensitivities of 92.5% and 94.1%), but again, the 
percentage of false positives was high (specificities <45%).  
At this point in time, further work is needed before diagnostic clinical prediction rules  based 
on clinical features for identifying serious infection in children presenting to primary care be 
implemented in practice.  Extensive prospective validation in the primary care setting and 
updating of existing rules should be undertaken in preference to the derivation of new rules, 
with the performance of the prediction rule compared to the existing diagnostic strategy. 
Finally, if clinical prediction rules with good performance in validation studies are identified, 
studies of the impact of application of the prediction rule, ideally reporting relevant patient 
outcomes, are an essential final step for determining whether the clinical prediction rule does 
more good than harm.   
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Chapter 5 The diagnostic accuracy and 
independent value of C-reactive 
protein for detecting bacterial 
infection in nonhospitalised infants 
and children with fever 
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5.1 Preface to Chapter 5 
C-reactive protein is an inflammatory biomarker that is now widely utilised as a laboratory and 
point of care test for assisting in the diagnostic management of children with possible serious 
bacterial infection.  At the time this program of research commenced, however, the accuracy of 
C-reactive protein for detecting bacterial infection in children presenting to primary care had 
not been established. This chapter presents the results of a systematic review conducted to 
determine the accuracy and independent value of the-reactive protein for detecting bacterial 
infection in non-hospitalised infants and children. 
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5.2  Abstract 
Objective:  To determine the accuracy of C-reactive protein for diagnosing serious bacterial 
and bacterial infections in infants and children presenting with fever.   
Study design: Systematic review of diagnostic accuracy studies. We included studies 
comparing the diagnostic accuracy of C-reactive protein with microbiologic confirmation of (a) 
serious bacterial and (b) bacterial infection. 
Results: For differentiating between serious bacterial infection and benign or nonbacterial 
infection (6 studies), the pooled estimate of sensitivity was 0.77 (95% CI 0.68 to 0.83); 
specificity 0.79 (95% CI 0.74 to 0.83); positive likelihood ratio, 3.64 (95% CI 2.99 to 4.43); and 
negative likelihood ratio, 0.29 (95% CI 0.22 to 0.40). In multivariate analysis, C-reactive protein 
is an independent predictor of serious bacterial infection. 3 studies investigating the accuracy 
of C-reactive for diagnosing bacterial infection could not be pooled, but all showed a lower 
sensitivity compared with studies using serious bacterial infection as the reference diagnosis.   
Conclusions: C-reactive protein provides moderate and independent information for both 
ruling in and ruling out serious bacterial infection in children with fever at first presentation.  
Poor sensitivity means that C-reactive protein cannot be used to exclude all bacterial infection. 
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5.3 Introduction 
Although fever is a common reason for children to be brought to medical attention, it remains 
a diagnostic and management challenge. Most children with fever will have a self-limiting 
illness that resolves in a few days without active intervention. Some children, however, benefit 
from antibiotic treatment, and some substantially so. Few clinical features distinguish those 
who benefit from those who do not, and doctors’ clinical judgment frequently is not able to 
distinguish children with bacterial infection from non-bacterial infection. (259) Because both 
doctors and patients are aware of the potential benefits of antibiotics for some patients and 
the potential risk of not treating a life-threatening infection in a small minority, there is an 
incentive to prescribe antibiotics, despite the costs, adverse effects, and increasing antibiotic 
resistance that result from this practice. (260-262) 
C-reactive protein (CRP) rises in response to infectious and inflammatory diseases and shows 
greater elevations in serious bacterial than in other bacterial infections. It may distinguish 
those children who have a bacterial infection that could benefit from antibiotics from those 
who do not. (234, 263, 264) Our aim in this review was to evaluate the diagnostic accuracy of 
CRP in infants and children with an initial complaint of fever (with or without signs of 
respiratory tract infection).  
5.4 Methods 
Because clinical assessment and prior diagnostic testing may change the spectrum of patients 
being assessed and therefore the diagnostic accuracy of a test, (265) we limited this review to 
studies conducted in children who came to medical attention initially with a complaint of 
fever.  Studies that included children who had been admitted to hospital (other than in an 
emergency department observation ward) were excluded from the review. 
We included studies that compared a blood or serum CRP measurement with a reference 
standard of a microbiologic diagnosis of (a) serious bacterial infection (versus benign bacterial 
or nonbacterial infection) or (b) bacterial infection (versus nonbacterial infection). We 
excluded studies in which more than 10% of participants were neonates, and the reference 
standard was for the diagnosis of a single specific disease (e.g. meningitis, gastroenteritis, or 
arthritis) or studies conducted in subgroups of patients with specific medical conditions, such 
as cancer or renal failure. No language restriction was applied. Ethics approval was not 
required to conduct this study. 
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5.4.1 Identification of studies 
We searched the databases Medline and EMBASE from inception to December 2007 using the 
following terms: C-reactive protein (MeSH) OR C-reactive protein (text word) OR CRP (text 
word) AND bacterial infections (MeSH) OR virus disease (MeSH) OR bacteria* (text word) OR 
virus (text word) OR viral (text word) AND (child (MeSH) OR child* (text word) OR infant 
(MeSH) OR infant* (text word). We checked the reference lists of all included papers and 
review articles and forward searched any identified papers. 2 reviewers screened the titles and 
abstracts from the electronic searches against the inclusion and exclusion criteria.  
Disagreements were resolved by discussion with a third reviewer.   
5.4.2 Quality assessment 
Quality of the included studies was assessed independently by 2 reviewers using QUADAS, 
(266) a validated tool for assessing quality of diagnostic studies. We used the 11-item version 
as recommended by the Cochrane Diagnostic Test Accuracy Working Group, which contains 
items relating to patient spectrum, reference standard, disease progression bias, verification 
bias, review bias, incorporation bias, test execution, study withdrawals, and indeterminate 
results. 2 of the 11 items were deemed not relevant due to the objectivity of the CRP test and 
were omitted. 1 item that asks whether patients received the same reference standard 
regardless of the index test result was split into 2 because it was possible that a different 
reference standard was applied but performance of the reference test was not related to the 
outcome of the index test. Percentage agreement and the ĸ statistic were calculated to assess 
the interobserver variation of the initial assessment of both reviewers.   
5.4.3 Data extraction 
Data were extracted by 2 reviewers independently on predesigned and piloted forms. Where 
necessary, we contracted authors for data or clarifying information. 
5.4.4 Data analysis 
Data from each study were extracted in 2 x 2 tables. We combined the categories of invasive 
bacterial and localised bacterial infection in the category of bacterial infection for the purpose 
of the 2 x 2 tables; similarly, we categorised mixed bacterial and viral infections (1 study) and 
proven or possible bacterial infections (1 study) as bacterial. In a sensitivity analysis, these 
categorisations had a negligible effect on the results. Heterogeneity in study results was 
examined graphically using plots of sensitivity versus 1 minus specificity. Clinical heterogeneity 
was examined using descriptions of study characteristics. Where there was sufficient 
homogeneity of results, we used a random-effects bivariate model to obtain summary 
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estimates of sensitivity and specificity and corresponding 95% confidence intervals. This model 
estimates and incorporates the correlation that may exist because of the trade-off between 
sensitivity and specificity due to changes in the threshold in the index test for defining disease 
used between studies. It is equivalent to a hierarchical summary receiver operating 
characteristic curve analysis in most situations. (267) The model also estimates the diagnostic 
odds ratio, a measure of overall test accuracy equivalent to the ratio of true to false test 
results. (268) Statistical codes were kindly provided by Roger Harbord of Bristol University. 
(267) Stata 9 was used for all analysis. 
5.5 Results 
5.5.1 Study characteristics 
The search retrieved 1770 potentially relevant titles and abstracts. Of these, 10 studies 
assessing a total of 2046 participants met the inclusion criteria for the review. All of the studies 
were conducted in emergency departments. 36 studies examining the diagnostic accuracy of 
CRP in children admitted to hospital were excluded. Characteristics of the studies investigating 
CRP for the identification of serious bacterial infection and for the differentiation of bacterial 
and nonbacterial/viral infection are summarised in Table ‎5.1. 
One study (236) used chart review to identify children with fever and no localising signs as part 
of a larger prospective study; all other studies were prospective. Fever was not defined in 4 
studies. (269-272) 4 studies (244, 245, 273, 274) included a small proportion of participants 
(less than 10%) younger than 1 month of age, and in 1 study (271) the minimum age was not 
reported and could not be obtained from the author.   
5.5.2 Quality assessment 
Result of the assessment of quality using the QUADAS checklist for the 6 studies with 2 x 2 data 
are shown in Table 5.2. In almost all studies, withdrawals and handling of uninterpretable 
results were poorly reported. None of the studies provided sufficient detail to judge whether 
those interpreting he results of the reference standard tests were blind to the CRP results. The 
ĸ statistic for interobserver variation in the initial quality assessment, before discussion with 
the third reviewer, was 0.53. 
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Table ‎5.1. Details of studies investigating the accuracy of C-reactive protein (CRP) to differentiate serious 
bacterial infection from benign bacterial/nonbacterial infection and bacterial from nonbacterial/viral infection 
Study, year 
published 
Population Index test 
Setting: 
Location 
N Inclusion criteria Mean age 
(range) 
Sample: Assay type 
Studies investigating CRP for the differentiation of serious bacterial infection from benign bacteria/nonbacterial 
infection and providing data for construction of a 2x2 table 
Pulliam et al., 
2001 (272) 
ED: USA 77 Fever (undefined) without 
apparent source after history and 
examination.  Excluded children 
with AOM, pharyngitis, clinical 
pneumonia, acute RTI, acute 
gastroenteritis 
9.7 months (1 
to 35 months) 
Serum: Turbidometric 
immunoassay 
Lacour et al., 
2001 (244) 
ED: Switzerland 124 Temperature >38°C without 
localising signs of infection in 
history or on physical 
examination 
10.9 and 11.2 
months (7 days 
to 36 months) 
Whole blood: rapid 
immunometric 
method* 
Isaacman and 
Burke, 2002 
(270) 
ED: USA 256 Fever (undefined) without 
apparent source 
NR (3 to 36 
months) 
Serum: heterogeneous 
immunoassay format 
Galetto-Lacour 
et al., 2003 
(245) 
ED: Switzerland 99 Temperature >38°C without 
localising signs of infection in 
history or on physical 
examination 
NR (7 days to 
36 months) 
Whole blood: rapid 
immunometric 
method* 
Berger et al., 
1996 (274) 
ED: 
Netherlands 
127 Rectal temperature ≥38°C NR (14 days to 
1 year) 
NR: NR 
Andreola et al., 
2007 (273) 
ED: Italy 408 Fever (rectal temperature >38°C) of 
uncertain source 
Median 10 
months (2 to 16 
months) 
Whole blood: 
nephelometric assay 
Studies using multivariable modelling to determine the predictive value of CRP for the detection of serious 
bacterial infection 
Bleeker et al., 
2001 (236) 
ED: 
Netherlands 
231 Fever ≥38°C without apparent 
source 
13 months (1 to 
36 months) 
Serum: NR 
Pulliam et al., 
2001† (272) 
As above     
Isaacman and 
Burke, 2002† 
(270) 
As above     
Berger et al., 
1996† (274) 
As above     
Andreola et al., 
2007† (273) 
As above     
Studies investigating CRP for the differentiation of bacterial infection from nonbacterial/viral infection 
McCarthy et 
al., 1978 (271) 
ED: USA 400 Febrile (undefined). May or may 
not have localising signs 
43.8 months 
(NR) 
Serum: NR 
Tejani et al., 
1995 (275) 
Participants in 
RCT: USA 
185 Included children with signs and 
symptoms of acute otitis media 
(symptoms, tympanic membrane 
signs, MEF on tympanocentesis) 
27 months (3 
months to 7 
years) 
Serum: Rate 
nephelometry 
Cobben et al., 
1990 (269) 
ED: 
Netherlands 
139 Symptoms of infection (including 
fever, vomiting, cough, dyspnoea, 
stridor, abdominal cramping, 
excluding AOM) 
  
ED – emergency department; AOM – acute otitis media; RTI – respiratory tract infection; NR – not reported; BC – blood culture; 
UC – urine culture; FBE – full blood examination; UA – dipstick analysis; STCU – stool culture; ENTC – ear, nose or throat swab 
culture; CXR – chest x-ray; ESR – erythrocyte sedimentation rate; RCT – randomised controlled trial; MEF – middle ear fluid 
+ test conducted in all children; - test not conducted or not reported; ± test conducted in some children 
*15 minutes from test to result; †Study provided data for construction of a 2x2 table and performed multivariable modelling  
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Table 5.1. Continued 
Study, year 
published 
Reference tests; methods used to detect the cause of infection Outcome definition 
FBE ESR UA 
or AC 
CXR CSF BC STCU ENTC F-up Other 
tests 
Viral 
testing 
 
Studies investigating CRP for the differentiation of serious bacterial infection from benign 
bacteria/nonbacterial infection and providing data for construction of a 2x2 table 
Pulliam et 
al., 2001 
(272) 
+ + + ± ± + - - - - - 
Proven serious bacterial infection 
(positive blood or urine culture or 
local infiltrate on CXR) 
Lacour et al., 
2001 (244) + - + ± ± ± - - + - - 
Serious bacterial infection (positive 
urine, blood or CSF culture, or local 
infiltrate on CXR) 
Isaacman 
and Burke, 
2002 (270) 
+ - ± ± - + - - - - - 
Occult bacterial infection (positive 
blood or urine culture or local 
infiltrate on CXR) 
Galetto-
Lacour et al., 
2003 (245) + - ± - ± ± - - + - - 
Serious bacterial infection (positive 
blood, urine, CSF culture, local 
infiltrate on CXR, positive CT and 
surgical exploration for deep 
abscess) 
Berger et al., 
1996 (274) 
+ + + - - + + + + ± - 
Serious bacterial infection (positive 
blood, urine, CSF, stool or specimen 
culture, or pulmonary infiltrate on 
CXR) 
Andreola et 
al., 2007 
(273) 
+ + + ± ± ± ± ± ± ± - 
Serious bacterial infection (positive 
blood, urine, CSF culture, infiltrate 
on CXR, sepsis according to criteria 
of signs and symptoms of 
inflammation plus infection, 
tachycardia, decreased capillary 
refill or mottling and 1 indication of 
altered organ function) 
Studies using multivariable modelling to determine the predictive value of CRP for the detection of serious bacterial 
infection 
Bleeker et 
al., 2001 
(236) 
- - ± - ± ± ± - + ± - 
Serious bacterial infection (positive 
culture or consensus diagnosis and 
negative follow-up) 
Pulliam et 
al., 2001† 
(272) 
As above 
 
Isaacman 
and Burke, 
2002† (270)  
As above 
 
Berger et al., 
1996† (274) 
As above 
 
Andreola et 
al., 2007† 
(273) 
As above 
 
Studies investigating CRP for the differentiation of bacterial infection from nonbacterial/viral infection 
McCarthy et 
al., 1978 
(271) 
± ± ± + ± ± ± - - ± ± 
Positive blood or other culture 
Tejani et al., 
1995 (275) + - - - - - - + + - + 
Positive culture in MEF or nasal 
wash specimens (including mixed 
bacterial or viral infections) 
Cobben et 
al., 1990 
(269) NR 
Positive culture, repeat clinical 
evaluation, infiltrate on CXR, 
recovery with antibiotics (including 
proven or possible bacterial 
infection) 
ED – emergency department; AOM – acute otitis media; RTI – respiratory tract infection; NR – not reported; BC – blood culture; 
UC – urine culture; FBE – full blood examination; UA – dipstick analysis; STCU – stool culture; ENTC – ear, nose or throat swab 
culture; CXR – chest x-ray; ESR – erythrocyte sedimentation rate; RCT – randomised controlled trial; MEF – middle ear fluid 
+ test conducted in all children; - test not conducted or not reported; ± test conducted in some children 
*15 minutes from test to result; †Study provided data for construction of a 2x2 table and performed multivariable modelling   
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5.5.3 CRP for the detection of serious bacterial infection 
7 of the 10 studies included in the review (1090 children) investigated the accuracy of CRP to 
differentiate serious bacterial infection from self-limiting bacterial or nonbacterial infection. 
(236, 244, 245, 270, 272-274) 1 of these 7 studies did not provide data for constructing a 2x2 
table. (236) Five studies conducted multivariate modelling to determine the independent 
predictive value of CRP. (236, 270, 272-274) The definition of serious bacterial infection varied 
somewhat but all included evidence of a bacterial infection on blood culture, chest radiograph, 
lumbar puncture, or urine culture. (Table ‎5.1) The prevalence of serious bacterial infection 
ranged from 11% to 29%. Visual inspection of the data demonstrated sufficient homogeneity 
to allow summary estimates of sensitivity and specificity. Summary estimates from the 
bivariate model were sensitivity, 0.77 (95% CI 0.68 to 0.83); specificity 0.79 (95% CI 0.74 to 
0.83); and diagnostic odds ratio 12.29 (95% CI 8.51 to 17.75) (Figure ‎5.1). The pooled positive 
likelihood ratio was 3.64 (95% CI 2.99 to 4.43), representing a small change in the probability 
of serious bacterial infection with a positive CRP test (Table 5.3). The pooled negative 
likelihood ratio was 0.29 (95% CI 0.22 to 0.40), suggesting a moderate change in the 
probability of a serious bacterial infection with a negative CRP.   
In the 5 studies performing multivariate analysis (236, 270, 272-274), CRP was an independent 
predictor of serious bacterial infection, that is, CRP adds information to other clinical features 
in determining the presence or absence of serious bacterial infection. 
5.5.4 CRP for the detection of bacterial and viral infection 
3 studies (722 children) assessed the accuracy of CRP to differentiate bacterial from viral 
infection (Table 5.3). (269, 271, 275) The prevalence of bacterial infection was 28%, 35% and 
82%, the latter occurring in a study that included a category of mixed and bacterial infections.  
Given the significant heterogeneity of these studies, we did not estimate pooled summaries of 
sensitivity and specificity. However, each of these studies showed more limited sensitivity than 
did the studies assessing CRP for the diagnosis of serious bacterial infection.   
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Figure ‎5.1. Results of studies estimating the sensitivity and specificity of C-reactive protein for the detection of 
serious bacterial infection and bacterial infection.  
 
Figure interpretation: Grey circles indicate serious bacterial infection; white circles indicate bacterial 
infection; the black circle indicates summary point for serious bacterial infection (summary estimate 
from the random-effects bivariate analysis). Each circle represents the sensitivity and specificity of the 
individual studies included in the review.  The size of the circle is proportionate to study size. 
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5.6 Discussion 
We conducted a systematic review of studies assessing the diagnostic accuracy of CRP for the 
diagnosis of bacterial infections in children initially evaluated because of fever. The results 
indicate that CRP is of moderate value for ruling out serious bacterial infection in a child with a 
fever but is of limited value for ruling out all bacterial infections. The diagnostic accuracy of the 
test for all bacterial infections is limited by the significant overlap in CRP values for children 
with viral and bacterial infections, especially in the early stages of a bacterial infection, (234, 
276-278) and the significant interindividual variation in test values. (279) 
All of the studies included in this review were conducted in emergency departments. This may 
limit the applicability of the results of the review for other setting in which children present 
with fever, such as general practice and outpatient pediatric clinics. The prevalence of bacterial 
infections seen in the studies included in this review was likely to be higher than would be 
seen in general practice. (280) As an indication of how the change in the pre-test probability 
might influence the clinical utility of the test, if we assume the prevalence of serious bacterial 
infection among children presenting with fever to an emergency department is 7%, (281) the 
probability of serious bacterial infection given a positive CRP test is estimated to be 22% and 
given a negative test is 2%. Assuming a pre-test probability of serious bacterial infection of 1% 
in general practice, (219) the probability of serious bacterial infection given a positive CRP test 
is estimated to be 4% and given a negative test is 0.3%.  
An earlier review in a more limited set of studies concluded that there was no evidence to 
support the use of CRP in children with fever or to make decisions regarding the initiation or 
suspension of antibiotics. (282) Our review, however, indicates that CRP contributes moderate 
independent information. Our study has included more recent studies and excluded 4 studies 
included in the prior review that were conducted in children admitted to hospital. A systematic 
review of the diagnostic accuracy of CRP for bacterial infection in adults concluded that it was 
not sufficiently sensitive or specific. (283) 
Procalcitonin is a biomarker that has been developed more recently and may also be useful in 
this patient group. In this review, 3 studies (244, 245, 273) compared measurement of 
procalcitonin and CRP, with 2 showing that procalcitonin had higher sensitivity and negative 
predictive value than CRP (93% vs 89% and 93% vs 79%). In the third study, CRP had a higher 
sensitivity and negative predictive value at the optimum cut-off values (69% vs 84%).   
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The results of this review indicate that CRP provides moderate but independent information in 
ruling in and ruling out serious bacterial infection in febrile children at first presentation. The 
test needs to be considered in the context of the other clinical findings and should not be 
relied on to excluded bacterial infection.   
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5.7 The current status of C-reactive protein for assisting in the diagnostic 
management of non-hospitalised children with fever and possible serious 
infection 
Since publication of this review in 2008, considerable research has been undertaken with the 
aim of clarifying the diagnostic accuracy of C-reactive protein and determining its value in 
clinical practice.  In a more broadly focused but comparable systematic review funded by the 
Health Technology Assessment Program (HTA) in the United Kingdom, researchers determined 
the value of all possible blood tests, including C-reactive protein, for ruling in and ruling out 
serious infection in children in ambulatory settings. (253) The review included 5 studies of C-
reactive protein published to mid-2009 and discussed the systematic review presented in this 
chapter. Three of the five studies included in the HTA review were included in the review 
presented in this chapter, and two studies included in the HTA review were excluded from the 
review presented in this chapter as they did not meet the reviews inclusion criteria. Despite 
this difference in included studies, the conclusions of both reviews with regard to the 
diagnostic accuracy of C-reactive protein were similar.  The HTA review reported a pooled 
positive LR of 3.64 (95%CI 2.99 to 4.43) compared to a positive LR of 3.15 (95%CI 2.67 to 3.71) 
in the review presented in this chapter and a negative LR of 0.29 (95%CI 0.22 to 0.40) and 0.33 
(95%CI 0.22 to 0.49) respectively.  The HTA review also considered studies directly comparing 
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laboratory tests, and examined test cut-off values, finding that both C-reactive protein and 
procalcitonin offer similar diagnostic performance and are superior to white blood cell count.  
However, neither C-reactive protein nor procalcitonin had sufficient value to confirm or 
exclude a serious infection and different cut-off values were  necessary depending on the 
purpose of the test (rule in or rule out) for the particular setting. (253)      
More recently, research on C-reactive protein has been undertaken to determine the value of 
the test beyond its diagnostic accuracy.  In a recent prospective observational study of febrile 
children presenting to the emergency department, introduction of bedside C-reactive protein 
testing substantially lowered length of stay in the emergency department. (284) Though not 
reporting on studies in children specifically, a recent Cochrane systematic review including six 
randomised controlled trials found that point of care C-reactive protein test used as an adjunct 
to primary care clinicians’ clinical examination reduced antibiotic prescribing amongst 
individuals with acute respiratory infections. However, C-reactive protein did not affect patient 
reported outcomes compared to standard care. (285) Understanding of the value of C-reactive 
protein in the workup of children with fever will likely be advanced when the results of a 
currently in process two part clinical trial become available.  The ERNIE2 studies are aimed at 
evaluating 1) the added value of point of care C-reactive protein in children with acute illness 
and considered on the basis of a clinical prediction rule to have a potentially serious illness 
(part A) (286), and 2) the effect of a multifaceted intervention comprising a point of care C-
reactive protein test and /or safety netting advice in children consulting a primary care 
clinician, and who, on the basis of a clinical prediction rule are determined to not have a 
potentially serious illness (part B). (287) The primary outcome in this cluster randomised 
factorial controlled trial, and the outcome for which this trial is powered to detect a difference, 
is clinicians’ immediate antibiotic prescribing rate with clinical recovery a secondary endpoint.  
The randomised component of the ERNIE 2 study , when complete will likely provide the best 
available advice to inform use of C-reactive protein in children in primary care practice , 
though limitations of patient management as an intermediate step in the pathway to affecting 
patient outcomes must be acknowledged. (288) 
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Chapter 6 The effect of simplification of a 
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6.1 Preface to Chapter 6 
The adoption of diagnostic prediction rules into practice is influenced by multiple contextual 
factors including potential users’ perceptions about attributes of the tool itself. A clinical 
prediction rule may not be used if it is considered too much effort to apply or is perceived as 
being too complex or complicated in terms of both the number of predictors included, and the 
calculations required to derive an output. In the final study of this thesis, a diagnostic 
prediction rule is simplified using various methods. The comparative performance of the 
original and simplified prediction rules is evaluated using traditional performance measures 
and utility measures which offer insight into the clinical consequences arising from application 
of the alternate rules.    
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6.2 Abstract 
Objective:  Scoring systems are developed to assist clinicians in making a diagnosis. However, 
their uptake is often limited because they are cumbersome to use, requiring information on 
many predictors or complicated calculations. We examined whether, and how, simplifications 
affected the performance of a validated score for identifying adults with chest pain in an 
emergency department who have low risk of major adverse cardiac events.  
Study design and setting:  We simplified the Emergency Department Assessment of Chest Pain 
score (EDACS) by three methods: 1) giving equal weight to each predictor included in the 
score, 2) reducing the number of predictors and 3) using both methods – giving equal weight 
to a reduced number of predictors. The diagnostic accuracy of the simplified scores was 
compared with the original score in the derivation (n=1974) and validation (n=909) datasets.   
Results:  There was no difference in the overall accuracy of the simplified versions of the score 
compared with the original EDACS as measured by the area under the ROC curve (0.74 to 0.75 
for simplified versions versus 0.75 for the original score in the validation cohort). With score 
cut-offs set to maintain the sensitivity of the combination of score and tests (ECG and c-
troponin) at a level acceptable to clinicians (99%), simplification reduced the proportion of 
patients classified as low risk from 50% with the original score to between 22 and 42%. 
Conclusion:  Simplification of a clinical score resulted in similar overall accuracy, but reduced 
the proportion classified as low risk and therefore eligible for early discharge compared to the 
original score. Whether the trade-off is acceptable, will depend on the context in which the 
score is to be used. Developers of clinical scores should consider simplification as a method to 
increase uptake, but further studies are needed to determine the best methods of deriving and 
evaluating simplified scores.  
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6.3 Introduction 
Clinical prediction rules are tools designed to improve clinical decision making. (2) They are 
often presented as simplified scoring systems. In such systems, the predictors (items from the 
patient’s history or examination) have a point value which is summed to give an overall integer 
score for a particular individual. The scoring system may provide users with an estimate of the 
predicted risk of the outcome of interest for each of the integer scores (289, 290) and or may 
stratify an individual into a risk group (e.g. low, medium or high risk). A course of action may 
be implied or recommended based on this stratification (e.g. suitable or not suitable for early 
discharge). (291) 
Despite increasing interest in the potential of scoring systems to augment the judgment of 
clinicians, the majority are rarely used. (105) One barrier to their use may be that the score is 
difficult to implement in practice. For example, the score may be cumbersome to use, 
requiring the collection of many pieces of information or information not normally collected 
during the consultation. (292) Further, it may be computationally complex with predictors of 
different point value, (293) of positive or negative value, or of non-integer point value. (294) 
Such characteristics also make the score difficult to remember and increase the potential for 
summing mistakes. Though presenting scoring systems as web based calculators or embedding 
them in electronic patient records may minimise these barriers, clinicians may be dissuaded 
from applying tools they believe are too complicated, not transparent or too much effort to 
apply.     
Intuitively, scoring systems that contain only a small number of predictors and require only 
simple calculations to derive a result are more likely to be used and to be used correctly in 
practice. (295) It may be possible to simplify scoring systems to facilitate use in practice 
without loss of predictive power. For instance, a simplified version of the well-known Wells 
rule for acute pulmonary embolism has been shown in prospective validation studies to have 
similar diagnostic performance to the original rule. (296) 
A scoring system to identify chest pain patients with a low risk of major adverse cardiac event 
(MACE) who could be discharged early from the emergency department (ED) has recently been 
developed and validated. (297) When used in conjunction with ECG and cardiac troponin tests 
as part of an accelerated diagnostic pathway, the combination of score and tests safely 
identifies just over half (51%) of the chest pain patients as  low short term risk of MACE and 
suitable for discharge to early outpatient follow-up. This is a substantial improvement over 
existing accelerated diagnostic pathways which, at best, identify only 15% of chest pain 
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patients as safe for early discharge. (298) The scoring system, known as the Emergency 
Department Assessment of Chest-pain score (EDACS) includes 7 predictors. Each predictor has 
a different point value (Table ‎6.1) and two predictors have a negative value, that is, their value 
is subtracted from the score total. The variation in point values may make derivation of an 
individual’s score somewhat onerous and subject to miscalculation.   
We sought to simplify EDACS by 1) assigning equal weights to predictors included in the score, 
2) reducing the number of predictors and 3) using both methods. We evaluated whether 
simplified versions of the score retained the original score’s diagnostic accuracy and clinical 
usefulness in allowing early discharge of patients with chest pain from the emergency 
department whilst maintaining an acceptable level of sensitivity.    
6.4 Methods 
6.4.1 Derivation and validation of the original EDAC score 
The EDAC score was derived in a population of 1974 consecutive patients aged 18 years and 
older who had had at least 5 minutes of symptoms consistent with acute coronary syndromes 
attending emergency departments in Brisbane, Australia and Christchurch, New Zealand 
between June 2007 and February 2010. Data were collected on prospective candidate 
variables and participants were followed for 30 days to determine the presence of MACE, 
defined as ST-elevation or non-ST-elevation myocardial infarction, emergency 
revascularisation procedure required, death from cardiovascular causes, ventricular 
arrhythmia, cardiac arrest, cardiogenic shock or a high atrioventricular block. Backward 
stepwise logistic regression was performed to identify a model which was converted into a 
scoring system by multiplying and rounding the model coefficients. The score originally 
included 6 predictors (male sex, age, diaphoresis, pain radiating to arm or shoulder, pain 
occurred or worsened with inspiration and pain reproduced by palpation). Based on clinician 
feedback on the acceptability of the score, the score was modified to include an additional 
predictor – presence of traditional cardiac risk factors or history of coronary artery disease 
(Table ‎6.1). Incorporation of this predictor meant that younger patients (≤50 years of age) 
would be assigned points if a history of coronary artery disease or 3 or more traditional risk 
factors (family history of premature CAD, dyslipidaemia, diabetes, hypertension or current 
smoker) were present.   
In clinical practice, the score is used in conjunction with ECG and cardiac troponin tests 
performed at 0 and 2 hours (after presentation to the ED) as part of an accelerated diagnostic 
pathway (EDACS ADP). Based on a survey of clinicians who indicated that a 1 in 100 error rate 
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in discharging patients from the ED who have a MACE within 30 days due to unrecognised ACS 
was acceptable, (299) a cut-off of 16 was the optimal score to maintain sensitivity of the 
EDACS accelerated diagnostic pathway near 99% while maximising specificity. The EDACs ADP 
recommends discharge with follow-up investigation when the EDACS is <16, there is no new 
ischemia on ECG and 0 and 2 hour troponin are both negative. Otherwise, patients are 
considered to be moderate to high risk and if no diagnosis is made, observed and a delayed 
troponin test conducted. The EDACS ADP was prospectively validated in a separate cohort of 
608 patients attending the same emergency departments between October 2010 and 
December 2011. (297)  
6.4.2 Development of simplified versions of the EDAC score 
We developed simplified versions of the original EDACS (Table ‎6.1) using the derivation dataset 
described above and tested them in an extended validation dataset (n=909). The methods for 
simplifying the scores were: 
1. Unweighted score:  assigns either +1 or -1 point to the predictors with 1 point for each 
decade of life from 40 years.  
2.  Reduced scores: we limited the reduced scores to a maximum of 4 predictors based 
on research that suggested 3 or 4 pieces of information are all that can be held in 
working memory at one time. (300) To develop the reduced scores, beta coefficients 
from the logistic regression model were standardised and the 3 strongest predictors 
identified being age, gender and pain radiating to the arm. To maintain face validity, 
the predictor ‘presence of traditional risk factors or history of coronary artery disease’ 
was incorporated into the reduced scores.   
(a) ‘Reduced and weighted’ score: the logistic model including the 3 strongest 
predictors was rerun and the beta coefficients were multiplied, rounded and doubled 
(to avoid half scores) to give different point values to each predictor.   
(b) ‘Reduced and unweighted’ score: the predictors were assigned a value of +1,   
with age assigned 1 point for each decade of life from 40 years.  
Scores for all patients in the derivation and validation data sets were calculated according to 
the original EDACS, ‘Unweighted score’, ‘Reduced and weighted score’ and ‘Reduced and 
unweighted score’.   
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Table ‎6.1. Original EDACS and simplified scores 
 Original EDACS Simplified scores 
Predictors included in the score Unweighted 
score 
Reduced Scores  
Weighted Unweighted 
Age  Age Points Age Points Age Points Age Points 
18-45 
46-50 
51-55 
56-60 
61-65 
66-70 
71-75 
76-80 
81-85 
86+ 
+2 
+4 
+6 
+8 
+10 
+12 
+14 
+16 
+18 
+20 
40-49, 
50-59, 
60-69 
70-79 
80-89, 
90-99 
+1 
+2 
+3 
+4 
+5 
+6 
18-45 
46-50 
51-55 
56-60 
61-65 
66-70 
71-75 
76-80 
81-85 
86+ 
+2 
+4 
+6 
+8 
+10 
+12 
+14 
+16 
+18 
+20 
40-49, 
50-59, 
60-69 
70-79 
80-89, 
90-99 
+1 
+2 
+3 
+4 
+5 
+6 
Male sex +6 +1 +9 +1 
Age 18-50 and either; 
known coronary artery disease 
(previous acute myocardial 
infarction, coronary artery bypass 
graft or percutaneous 
intervention); 
 or ≥ 3 Risk factors (smoking, 
hypertension, diabetes mellitus, 
hypercholesterolemia, family 
history coronary heart disease) 
+4 
 
+1 +4 
 
+1 
Diaphoresis +3 +1   
Pain radiates to arm or shoulder +5 +1 +8 +1 
Pain occurred or worsened by 
inspiration  
-4 -1   
Pain reproduced by palpation -6 -1   
Total Score range -8 to 34 -2 to 9 2-37 0 to 8 
 
6.4.3 Evaluation of original and simplified versions of the EDAC score 
We calculated the area under the Receiver Operating Characteristic (AUROC) curve for each 
version of the score in the derivation and validation datasets. We used the bivariate binomial 
method with adjustments for multiple comparisons to estimate the respective ROC curves and 
tested the differences between the areas for significance using STATA13. Calibration of the 
original and reduced models was evaluated in the validation dataset by dividing participants 
into risk deciles using the predicted probability for having MACE.  In each of the deciles, the 
number of expected MACE cases (predicted) for both models was compared to the actual 
number of MACE cases (observed).   
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For each of the simplified versions of the score, we determined score cut-offs that maintained 
the sensitivity of the combination of score and tests at approximately 99% or greater. Using 
these cut-offs, we calculated the sensitivity, specificity and proportion of patients classified as 
low risk by each score when used in combination with tests (ECG and c-troponin). We 
considered a score clinically useful if it classifies >40% of patients with chest pain as low risk 
(which is higher than in previously reported studies). 
We evaluated the ability of the alternative scores to classify patients to more appropriate risk 
categories. We calculated the event net reclassification improvement (NRIevents) as the net 
proportion of patients with events reassigned to a higher risk category by the simplified score 
in combination with tests, and the non-event net reclassification improvement (NRInonevents) 
as the net proportion of patients without events reassigned to a lower risk category. (301) We 
also calculated the net reclassification improvement (NRI) which reflects improved 
reclassification and is the sum of NRIevents plus NRInonevents. To account for differences in 
the relative importance of true positive and false positive classifications we calculate a 
weighted NRI. (302) For patients with suspected cardiac chest pain, a threshold of 2% (derived 
using the method of Pauker and Kassirer (53)),has been reported as the point of probability at 
which the risks from false positive testing are balanced with the risk of harm from untreated 
disease. (79) Based on this threshold, we determined the relative weight of true positives to 
true negatives to be 0.98 to 0.02 or 49:1 and used this weighting in the calculation of the 
weighted NRI. We used a bootstrap estimate of the variance of the statistic to calculate 95% 
confidence intervals for the NRI for events and non-events and the weighted NRI. (303) 
6.5 Results 
Age and sex distributions in the derivation and validation cohorts were comparable, as was the 
occurrence of MACE (Table ‎6.2). The presence of known coronary artery disease or 3 or more 
risk factors was slightly more common in the validation cohort as was the presence of the 
predictor ‘pain on palpation’. Cardiac troponin tests were positive in 20% of the derivation 
cohort and 16% of the validation cohort.   
In both the derivation and validation datasets, the AUROCs of the simplified scoring systems 
were similar to each other and to the original score (0.75 for the original score, 0.74 for the 
unweighted score, 0.75 for the reduced weighted score and 0.74 for the reduced unweighted 
score in the validation dataset; p≥0.05 for the difference between the original and simplified 
scores and for the difference between simplified scores) (Table ‎6.3).  The predictions of both 
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the original and reduced models track the actual observed cases of MACE well in the validation 
dataset (Appendix C). 
Table ‎6.2. Characteristics of the derivation and validation cohorts 
Characteristic Derivation cohort (n=1974)*  Validation cohort 
(n=909) 
Mean age (range) 60.5  (19-98) 60.1  (21-95) 
Male 1184 (60.0) 538 (59.2) 
Known coronary artery disease or >=3 risk 
factors 
864 (43.8) 435 (47.9) 
Age 18-50 and either known coronary artery 
disease or >=3 risk factors 
142 (7.2) 53 (5.8) 
Diaphoresis 998 (50.6) 450 (49.5 ) 
Pain radiates to arm 674 (34.1) 332 (36.5) 
Pain on inspiration 427 (21.6) 216 (23.8) 
Pain on palpation 166 (8.4) 114 (12.5) 
Troponin positive if >0.04 ng/mL in QLD cases 
and >0.03 ng/mL in NZ cases at 0 or 2 hours) 
393 (19.9) 145 (16.0) 
ECG positive at 0 or 2 hours 135 (6.8) 76 (8.4) 
MACE 305 (15.5) 133 (14.6) 
QLD Queensland; NZ New Zealand; ECG electrocardiogram  
*values are numbers (percentages) unless otherwise stated  
 
At score cut-offs which maintained the sensitivity of the combination of the EDAC score, ECG 
and troponin tests at approximately 99%, simplification of the score decreased specificity in 
the derivation and validation cohorts (Table ‎6.3). In the validation cohort, the specificity of the 
original EDACS in combination with ECG and c-troponin tests was 58.1%. This was reduced to 
47.4% for the unweighted score (cut-off <4,>=4), 48.6% for the reduced weighted score (cut-
off <17,>=17) and 26% for the reduced unweighted score (cut-off <3, ≥3).    
In the validation cohort, the original EDACS in combination with ECG and c-troponin classified 
50% of patients as low risk (Table ‎6.3). This was reduced to 41% for the unweighted score (cut-
off <4,>=4), 42% for the reduced weighted score (cut-off <17,>=17) and 22% for the reduced 
unweighted score. The 22% low risk classification by the reduced unweighted score is below 
the 40% minimum we pre-specified for clinical usefulness of a score. MACE occurred in 2 
patients classified as low risk by the original and unweighted scores (cut-off <4,>=4), in 1 
patient classified as low risk by the reduced weighted score (cut-off <17,>=17) and in no 
patients classified as low risk by the reduced unweighted score (cut-off <3, >=3) (Table ‎6.4 and 
Figure 6.1). Among those classified as higher risk by the original score, 29% of patients had 
MACE.  This was reduced to 24%, 25% and 19% in the unweighted, reduced weighted and 
reduced unweighted scores respectively (Figure 6.1).  
Use of the simplified scores resulted in more patients being incorrectly reclassified than 
correctly reclassified. Use of the unweighted score did not result in the reclassification of any 
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individuals with MACE to the higher risk category (NRIevent 0%) but a net 10.7% of individuals 
without MACE were incorrectly reclassified to the higher risk category. For the reduced 
weighted score, 1 patient with MACE was reclassified to the higher risk category (NRIevent 
0.75%) but a net 9.55% of individuals without MACE were incorrectly reclassified to the higher 
risk category. With the reduced unweighted score 2 individuals with MACE were correctly 
reclassified to the higher risk category (NRIevent 1.5%), however a net 31.8% of individuals 
without MACE were also incorrectly reclassified to the higher risk category. Even when taking 
into consideration the relative importance of failing to detect a MACE in a patient classified as 
low risk and classifying a patient who does not have MACE as high risk (failure to detect MACE 
was considered 49 times more important), the simplified scores do not improve classification 
(wNRI -2.8 and -16.2 for the reduced weighted and reduced unweighted scores) (Table ‎6.5 and 
Appendix C). 
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Table ‎6.3. Area under the receiver operator characteristic curve (AUROC) for the original and simplified versions 
of the score and sensitivities and specificities when the score is used in conjunction with ECG and c-troponin tests 
*p value is for the difference between the original and simplified versions of the score; †percent classified as low risk = 
FN+TN/total N 
Table ‎6.4. Proportion of patients assigned to low and high risk categories by the scores when used in combination 
with ECG and c-troponin tests by event in the validation dataset (n=909) 
Risk 
category 
Original score Simplified scores 
Unweighted score  
(cut-off ≥4) 
Reduced weighted score  
(cut-off ≥ 17) 
Reduced unweighted 
score 
(cut-off ≥3) 
Non event Event Non 
event 
Event Non 
event 
Event Non 
event 
Event 
Low risk 
 
451  
(58%) 
2  
(1.5%) 
368  
(47%) 
2  
(1.5%) 
377  
(49%) 
1  
(0.75%) 
 
204 
(26.3%) 
0 
(0%) 
Higher risk 
 
325  
(42%) 
131  
(98.5%) 
408  
(53%) 
131  
(98.5%) 
399 
 (51%) 
132  
(99.25%) 
 
572 
(73.7%) 
133 
(100%) 
Total 776 
(100%) 
133 
(100%) 
776 
(100%) 
133  
(100%) 
776 
(100%) 
133 
(100%) 
776 
(100%) 
133 
(100%) 
 
 Original score Simplified scores 
 Unweighted score Reduced weighted score Reduced unweighted score 
Cut-off ≥16 Cut-off ≥3 Cut-off ≥4 Cut-off ≥16 Cut-off ≥17 Cut-off ≥3 Cut-off ≥4 
Derivation dataset (n=1974) 
Sensitivity  
(95% CI) 
 
99.0  
(97.2-99.7) 
100  
(98.8-100) 
99.0  
(97.2-99.8) 
99.3  
(97.7-99.9) 
 
98.7  
(96.7-99.6) 
100  
(98.8-100) 
 
99.7  
(98.2-100) 
Specificity 
(95% CI) 
 
49.9  
(47.5-52.3) 
22.4 
(20.4-24.4) 
 
40.5  
(38.1-42.9) 
38.0  
(35.7-40.4) 
 
42.4  
(40.0-44.8) 
24.0  
(22.0-26.2) 
 
46.4  
(44.0-48.8) 
AUROC  
(95% CI) 
and  
p value* 
0.74  
(0.71-0.76) 
0.73 (0.70-0.76)  
p=0.20 
0.72 (0.69-0.74)  
p=0.02 
0.71 (0.68-0.74) 
 p=0.02 
Validation dataset (N=909) 
Sensitivity 
(95% CI) 
 
98.5  
(94.7-99.8) 
99.3  
(95.9-
99.9) 
 
98.5  
(94.7-99.8) 
99.3  
(95.9-99.9) 
 
99.3  
(95.9-99.9) 
100  
(97.2-100) 
 
97.7  
(93.5-99.5) 
Specificity 
(95% CI) 
 
58.1  
(54.6-61.6) 
25.4  
(22.4-
28.6) 
 
47.4  
(43.9-51.0) 
42.5  
(39.0-46.1) 
 
48.6  
(45.0-52.2) 
26.3  
(23.2-29.5) 
 
50.1  
(46.6-53.7) 
AUROC 
(95% CI) 
and p 
value* 
0.75  
(0.70-0.79) 
0.74 (0.69-0.78)  
p=0.28 
0.75 (0.71-0.79)  
p=0.98 
0.74 (0.70-0.78)  
p=0.96 
Percent 
classified 
as low risk  
(95% CI)† 
49.8  
(0.47-0.53) 
21.8  
(0.19-
0.25) 
40.7  
(0.38-0.44) 
36.4  
(0.33-0.40) 
 
41.6  
(0.38-0.45) 
22.4  
(0.20-0.25) 
43.1  
(0.40-0.46) 
Clinical prediction rules for assisting diagnosis 
 
144 
 
Table ‎6.5. Changes in classification with simplified scores when used in conjunction with ECG and c-troponin tests 
 Unweighted  Score 
(cut-off ≥4) 
Reduced weighted 
Score 
(cut-off ≥17) 
Reduced unweighted 
score 
(cut-off ≥3) 
Event NRI net %   
(95% CI) 
0 0.75  
(0 to 3.9) 
 
1.5  
(-0.6 to 3.6) 
Non-event NRI net %   
(95% CI) 
-10.7  
(-13.1 to -8.51) 
 
-9.5  
(-12.4 to -7.1) 
-31.8  
(-37.2 to -28.4) 
NRI* -10.7 -8.8 
 
-30.3  
weighted NRI  
(95% CI) 
Event to non event merit 
49:1† 
NA‡ -2.8  
(-13.8 to 8.2) 
-16.2  
(-27.9 to -6.3) 
NRI net reclassification improvement 
 * a negative value indicates worse classification; † correctly reclassifying patients with an event is considered 49 times more 
important than reclassifying patients without events; ‡a weighted NRI was not calculated as there were no event reclassifications 
with this score 
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6.6  Discussion  
This study has found that simplifying EDACS to facilitate use in practice comes at the cost of 
decreased specificity. Though there was no difference between the original and simplified 
scores in overall accuracy in the validation dataset, at cut-offs set to maintain sensitivity at 
around 99%, all three simplified scores when used in combination with ECG and c-troponin 
tests, were less specific than the original score with the proportion of patients who could be 
discharged early reduced from 50% to 43% at best. For two of the simplified scores (the 
reduced weighted and reduced unweighted score), the proportion classified as low risk was 
above the pre-specified clinically relevant minimum, and higher than the proportion of 
patients classified as low risk by existing scores. (291, 304) 
Whether the trade-off between simplicity and performance is acceptable, requires 
consideration of the consequences of both and the context within which the score is to be 
used. Application of the recommendations from the simplified score instead of the original 
EDACS would mean that more patients would undergo further investigation and observation.  
Prolonged observation and investigation of patients with chest pain contributes to emergency 
department overcrowding which is associated with high costs and adverse outcomes including 
increased mortality. (305) However, this should be balanced against the possible benefits of 
increased application of the accelerated diagnostic pathway which may occur with the 
simplified scores as they are easier to apply (information on fewer predictors is required) or 
calculate. (306) In the context of the assessment and disposition of chest pain patients, 
increased use of the EDACS accelerated diagnostic pathway could have major benefits. 
Recently, a randomised controlled trial found that a similar accelerated diagnostic pathway, in 
which use and application of the results of the pathway were at the discretion of the attending 
clinician, almost doubled the proportion of patients with chest pain who were successfully 
discharged within 6 hours of presentation at the emergency department. (201) Thus, even a 
small increase in the number of clinicians using the accelerated diagnostic pathway and then 
applying its recommendations could have significant benefits in terms of reduced consumption 
of health resources, costs and patient inconvenience.   
Simplification of the scoring system may also lead to more accurate implementation. Currently 
EDACS is provided to clinicians as a paper based score where clinicians manually compute the 
result. Given the need to add and or subtract the different point value of several predictors, 
some calculation error is inevitable. Simplifications that minimise the computational effort 
required to derive the result may result in fewer calculation errors and more accurate 
implementation of EDACS in clinical practice.  
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Although it could reasonably be expected that incorporating a less burdensome score would 
facilitate use, it could potentially have the opposite effect by reducing the face validity of the 
score. Scores with a reduced number of predictors may not contain predictor variables 
clinicians believe are important, reducing clinicians trust in it. Although we incorporated the 
predictor variable ‘traditional risk factors or history of coronary artery disease’ which was not 
statistically significant in the multivariable model but was considered by clinicians when absent 
from the score to decrease its credibility, we did exclude three other predictors from the 
reduced score (diaphoresis, pain occurred or worsened with inspiration and pain reproduced 
by palpation) that are commonly used in clinical practice, but which were not statistically 
significant predictors in the multivariable analysis. Attitudes that scoring systems over simplify 
the clinical assessment process, disrespect clinical complexity and the belief that more 
‘information’ (predictor variables) will improve prediction, may be a barrier to use of scoring 
systems in general and simplified scoring systems in particular. To determine the acceptability 
of the simplified versions of the score to clinicians, and their willingness or unwillingness to 
trade off accuracy for simplicity requires further study.   
We investigated 3 methods of simplifying the EDAC score: 1) assigning equal (unit) weights to 
each predictor included in the score, 2) reducing the number of predictors and 3) using both 
methods. At score cut-offs that maintain sensitivity at approximately 99%, equally weighting 
the predictors or reducing the number of predictors but maintaining different predictor 
weights reduced specificity to a similar degree. When both methods were applied (reducing 
the number of predictors and equally weighting these predictors) at a score cut-off that 
maintained adequate sensitivity, score specificity was reduced to a level below the 40% 
minimum specificity we considered clinically useful. 
Equal (unit) weighting is a common method of simplifying scoring systems and has been shown 
in a variety of contexts inside and outside healthcare to produce models yielding predictions 
that correlate highly with models using so called optimal weights (predictors ‘weighted’ to 
optimize the relationship between the prediction and outcome). (307) It has also been 
suggested that equally weighted models are more transferable to other settings because their 
weights are not specific to the population in which they were derived. (36) This method of 
simplification has been applied to the well-known Wells score for pulmonary embolism. In 
contrast to the findings of this study, simplification of the Wells PE score did not reduce the 
proportion of patients with PE who had been safely classified as low risk compared to the 
original score. (308) For the EDAC score, giving equal value to each of the predictors reduced 
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the range of possible scores substantially from a range of -8 to +34 for the original score to a 
range of -2 to 9 for the unweighted score. This lack of graduation between potential score cut 
points may explain in part the reduction in specificity of the simplified scores and is a possible 
limitation of this method of simplification.    
Reducing the number of predictor variables in the score is another method of simplifying 
scores to facilitate their use in practice. Such scores require less information and effort to 
derive a result. Typically in prediction models, a few variables with strong effects account for 
most of the predictive power, with the remaining weaker variables contributing relatively little. 
(309) While some loss of predictive value is inevitable when the relatively ‘weaker’ predictors 
are removed, such scores may still perform well in validation data because the potential for 
over fitting is reduced.  In this study, the simplified scores with a reduced number of variables 
performed reasonably well in the validation data, but only when weighting of the predictors 
was maintained.    
The area under the receiver-operating characteristic curve is a familiar and commonly used 
measure to compare prediction models. However, it has notable limitations, including 
insensitivity to changes in model performance. (310) Further, it focuses solely on accuracy 
without incorporating information on consequences. While we found no difference according 
to the AUROC between the original and simplified scores, from a clinical perspective, this 
analysis provides little useful information to inform model selection. In practice, the main aim 
of the EDACs score in patients with chest pain is to distinguish individuals in whom MACE can 
safely be excluded (estimated probability of MACE <2%) from those who should undergo 
further observation and testing. As such, we focus on the more clinically useful paired 
summary statistics (sensitivity and specificity) which express the magnitude of false negative 
and false positive test errors, and proportion classified as low risk with original and simplified 
models. Further, we assess the ability of the original and simplified models to more 
appropriately reclassify individuals into risk categories taking into account the relative value of 
false negative and false positive reclassifications.   
As yet, the simplified EDAC scores have only been temporally validated. A further limitation of 
our study is that the results reported are derived from the application of the scoring system to 
the data without the influence of the clinician. In practice, the EDACS score will be used in 
conjunction with clinical judgment.  We do not know what effect this might have on the 
accuracy of the original or simplified scoring systems presented here.  Ideally, further 
validation of the simplified scores would be conducted in different settings and by researchers 
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not involved in their development. (5) In addition, we suggest that future validations should 
also contrast the accuracy of the simplified scores with the current diagnostic pathway. This 
may be clinical judgment alone or a standard departmental protocol. If the scores are found to 
be more accurate than clinical judgment, further evaluation could be considered.  Such studies 
would determine the extent to which the scores are actually used and whether this use leads 
to improved outcomes for patients. The performance of the original EDACs score when used as 
an adjunct to clinical judgment (as part of an accelerated diagnostic pathway) is currently 
being evaluated in this manner (Australian New Zealand Clinical Trials Registry Number 
12613000745741). An interim step may be a modelling study to determine the incremental 
value of the scores over clinical judgment alone, similar to that conducted by Broekhuizen et 
al. (12)   
The complexity of a clinical prediction rule can be a barrier to uptake and simplification may 
assist. As this case illustrates, there may be a loss in the performance characteristics of the 
score, but in some contexts, a small loss may be acceptable if uptake is increased. Our study 
describes several means by which scores can be simplified and illustrates one approach to 
their evaluation. Many alternative and complementary methods of evaluation exist. A general 
methodology for performing and assessing the effects of simplification of prediction rules 
presented as scoring systems would be a useful supplement to the existing detailed 
methodological guidance on prediction tools development and evaluation.  
6.7 Conclusion 
Developers and evaluators of scoring systems should explore the effects of simplification on 
predictive performance. Where there is a trade-off between complexity and accuracy of the 
scoring system, the implications of each can be considered. The decision on which score to use 
(the original or simplified) will be context dependent; in some circumstances it may be 
acceptable to have some error if the score is more likely to be used and to be applied 
consistently and correctly.    
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Chapter 7 Discussion and Conclusions 
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7.1 Preface to Chapter 7 
This final chapter presents a summary of the thesis findings, explores their limitations and 
strengths within the context of the wider literature, outlines implications and makes 
suggestions for future research.  
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7.2 Summary of findings 
The first systematic review of this thesis aimed to determine the comparative performance of 
diagnostic prediction rules (when applied to study data independently of clinical judgment) 
and clinical judgment against a common reference standard. The review sought to address the 
limitations of existing studies comparing clinical prediction rules and clinical judgment by 
specifically reviewing diagnostic prediction rules intended for use in clinical practice and by 
reporting comparative performance using metrics against which the clinical value of the 
alternate methods can be judged.  
This systematic review (reported in Chapter 2) found no clear evidence for the superiority of 
either clinical judgment or diagnostic prediction rules. In none of the comparisons did 
diagnostic prediction rules both classify a larger proportion of patients as not having disease 
(thereby avoiding further testing or treatment) and miss fewer cases of disease. In one 
comparison, clinical judgement both classified a larger proportion of patients as not having 
disease and missed fewer cases of disease. In all other comparisons there was a trade-off 
between the proportions classified as not having disease and the proportion of missed 
diagnoses. For example, diagnostic prediction rules for the diagnosis of deep vein thrombosis 
were generally more efficient and classified a larger proportion of all participants as not having 
disease (therefore avoiding further testing) than clinical judgment, but this was often at the 
expense of missed diagnosis of deep vein thrombosis as determined by the reference 
standard. The differences between the two methods of judgment most likely represent a 
different threshold for positivity, with the clinical value of either method dependent upon the 
relative benefits and harms of missed diagnosis versus avoidance of further testing or 
treatment. 
The second systematic review of this thesis aimed to determine the effect of diagnostic 
prediction rules on patient and process outcomes. It was the first study to systematically 
review randomised trials comparing the effect of care provided with and without a diagnostic 
prediction rule across a range of clinical conditions. The review also examined the frequency of 
reporting of intervention characteristics and implementation methods necessary to interpret 
study findings and enable replication of study findings in practice.  
This systematic review (presented in Chapter 3) of 25 randomised trials found that few studies 
reported patient outcomes as the primary study outcome, but that diagnostic prediction rules 
have a positive effect on process outcomes for some clinical conditions. Exposure to diagnostic 
prediction rules for Group A Streptococcal throat infection reduced symptoms in the one study 
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reporting this outcome and reduced antibiotic prescribing in a meta-analysis of five trials. 
Diagnostic strategies for cardiac chest pain incorporating a diagnostic prediction rule improved 
early discharge rates (one study) and decreased hospitalisations (one study). The effects of the 
Ottawa Ankle Rules on process outcomes were positive when used as an add-on test in 
conjunction with clinical judgment (one study) but not when it was used as a triage test prior 
to clinical examination (one study). Diagnostic rules for acute appendicitis reduced time to 
therapeutic operation (one study) and showed a non-statistically significant reduction in non-
therapeutic operations in a meta-analysis of five studies. However, diagnostic prediction rules 
for children with fever did not improve the process outcomes measured. Details of the study 
interventions, particularly the control group interventions and the methods of implementing 
the diagnostic prediction rule, were infrequently reported.  
The third study of this thesis (presented in Chapter 4) aimed to derive and externally validate a 
diagnostic prediction rule for differentiating children presenting to the primary care setting 
with serious bacterial infection from those with self-limiting infection using an existing dataset. 
The derived prediction rule was also to be used as the basis for further studies to determine 
the added value of the inflammatory biomarker C-reactive protein, and the effect of prediction 
rule simplification on performance. However, as described in Chapter 4, efforts to derive the 
prediction rule were not successful. Due to the volume and likely nature of the missing data in 
the sourced dataset and concerns regarding the methods of dealing with missing data that 
were available at the time, I determined that derivation of a clinically sensible and valid tool 
could not be achieved. Consequently, the study of the added value of C-reactive protein over 
features from the history and clinical examination could also not be performed, and the study 
of the effect of simplification required modifications to the research plan. 
The fourth study, and third systematic review of this thesis (reported in Chapter 5), aimed to 
determine the diagnostic accuracy and independent value of the biomarker C-reactive protein 
in the primary care setting. At the time, C-reactive protein was widely used as a laboratory and 
point of care test in some countries and was being heavily promoted in others, yet its accuracy 
and independent value had not been established in the non-hospitalised paediatric population.  
This systematic review found that C-reactive protein provided moderate and independent 
information for both ruling in and ruling out serious bacterial infection in infants and children 
presenting with fever. All included studies were based in emergency department settings. 
From six of seven studies included in the review, the pooled positive likelihood ratio of 3.64 
(95%CI 2.99 to 4.43) represented a small increase in the probability of serious bacterial 
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infection with a positive C-reactive protein test, and the negative likelihood ratio of 0.29 
(95%CI 0.22 to 0.40) a moderate decrease in the probability of a serious bacterial infection 
with a negative CRP test. From five multivariable modelling studies, C-reactive protein was an 
independent predictor of serious bacterial infection, that is, when included in a model with 
other covariates, it had a statistically significant association with the outcome of serious 
bacterial infection. While this review suggests that measuring C-reactive protein is a helpful 
step in the diagnostic workup of non-hospitalised children, the modest likelihood ratios 
confirm the importance of assessing the result of the test in the light of clinical findings.    
The final study presented in this thesis (Chapter 6) aimed to determine the effect of different 
methods of simplifying a diagnostic prediction rule presented as a scoring system on 
performance. The complexity of clinical prediction rules has been identified as a barrier to the 
implementation of prediction rules in practice, but the effects of different methods of 
simplification on diagnostic accuracy and risk classification had not been explored. As 
discussed earlier in this chapter (page 140) and thesis (Chapter 4), this study was to be 
conducted using the CPR developed for identifying children with serious infection. When this 
was not possible, and an attempt to source other suitable data in the clinical area of interest 
was unsuccessful, data from a derivation and validation study of a prediction rule for the 
identification of chest pain patients with a low risk of major adverse cardiac event were 
utilised.  
In this study, methods of simplifying the prediction rule maintained overall accuracy as 
measured by the area under the AUROC but reduced the proportion of patients classified as 
low risk and led to worse reclassification. Three methods of scoring system simplification were 
tested: (1) giving equal weight to each predictor included in the score; (2) reducing the number 
of predictors; and (3) giving equal weight to a reduced number of predictors. The accuracy of 
the simplified and original scores, as measured by the area under the ROC was similar. 
However, when the original and simplified scores were used as part of a diagnostic pathway 
with ECG and cardiac troponin tests, and thresholds set at a pre-specified minimum sensitivity 
of >99, all simplification methods reduced the proportion of patients classified as low risk of 
major adverse cardiac events and therefore eligible for early discharge compared to the 
original score. The proportion of patients classified as low risk by diagnostic pathways that 
included the scores simplified using method 1 (equal weighting) or 2 (reduced number of 
predictors) was above the 40% threshold we had pre-specified as being the minimum required 
to be clinically useful. However when the score was simplified by method 3 (equal weighting 
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and reduced number of predictors) and used in the diagnostic pathway, the proportion 
classified as low risk was below this threshold (22%). Use of the simplified scores also resulted 
in more individuals being incorrectly reclassified into risk groups than correctly reclassified. 
This was the case even after taking into consideration the relative importance of failing to 
detect a major adverse cardiac event in a patient classified as low risk, and classifying a patient 
who did not have an event as high risk (missing a diagnosis of a major cardiac event was 
considered more important than the possible harm from over testing or treatment in someone 
without an event).  
7.3 Limitations and strengths of the studies and thesis in the context of the 
wider literature 
There are a number of important strengths of the thesis research projects. The systematic 
reviews of the comparative performance of diagnostic prediction rules and clinical judgment 
and the effect of care provided with and without a diagnostic prediction rule are the first in 
this topic area. They address a gap in the existing literature regarding the potential for 
diagnostic prediction rules to assist clinicians’ judgments, and to affect process and patient 
outcomes. Together these reviews give an overview of the current status of diagnostic 
prediction rules in the context of their stated potential as powerful tools to improve clinical 
decision making. Further, the reviews support calls for prediction research to shift from the 
development of more prediction rules, to rigorous evaluation of existing ones. (105, 311) By 
critiquing the design, conduct and reporting of the studies included in these reviews, areas for 
improvement in this field of research were also identified. 
Key strengths of the systematic review of the accuracy and independent value of C-reactive 
protein lie in its novelty and timeliness. At the time this review was conducted and published 
(2007-2008), C-reactive protein was widely used as a laboratory test in tertiary settings and 
routinely as a point of care test in some countries, and was being promoted or considered for 
use by primary care clinicians in other countries to assist in differentiating between children 
with a bacterial infection that may benefit from the use of antibiotics, and those with a non-
bacterial or self-limiting infection. However, its accuracy had not been evaluated using a 
systematic review methodology. Diagnostic tests that are introduced into practice without 
rigorous evaluation of their accuracy, a pivotal component in the evaluation of diagnostic 
tests, can lead to unwanted clinical consequences and increased healthcare costs arising from 
unnecessary testing. Using what was then emerging guidance for the conduct of systematic 
reviews of diagnostic test accuracy, but what is now recognised as the key guidance for this 
type of review, and employing a novel statistical method for estimating average sensitivity and 
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specificity, (312) this review informed the use and further evaluation of this particular 
biomarker in the primary care setting.  
While the study of the effects of prediction rule simplification on performance provides 
information on the effects of simplification of a prediction rule for a specific clinical indication, 
the strength of this study lies in its contribution to the existing literature related to the 
development, evaluation and implementation of diagnostic prediction rules. It extends the 
limited existing research on prediction rule simplification by examining different methods of 
simplification, by demonstrating one approach to the development and evaluation of 
simplified scores and by examination of the context-dependent clinical implications of 
simplification. A particular strength of this study was the use of reclassification and utility 
based metrics to assess the performance of the alternate models in addition to traditional 
performance measures and, in this way, provide more information on the clinical usefulness of 
the simplified rule.     
There are important limitations to each of these research projects, as identified explicitly in the 
preceding chapters. The findings of the systematic reviews of diagnostic prediction rules are 
primarily limited by the number and nature of the included studies. The conclusions of these 
reviews are based on few studies that were often judged to be at unclear or high risk of bias 
which may lead to the systematic over or underestimation of the test accuracy or treatment 
effect. (313-316) Further, the design features of many of the studies included in both the 
reviews has implications for interpretation of the study results. In the review of the 
comparative performance of diagnostic prediction rules and clinical judgment, for instance, 
study participants’ knowledge of the study design was likely to have influenced the probability 
estimates, diagnoses, intended or actual actions of clinicians upon which comparative 
performance is judged. For both reviews, screening of titles and abstracts was only performed 
by one reviewer, with only a small proportion checked by a second reviewer. Thus, it is 
possible that studies relevant to both reviews may have been overlooked despite 
implementation of other methods to minimise this possibility. The conclusions of the impact 
review are likely to be context specific and limited by inadequate sample size in many of the 
included studies. Furthermore, as judgments regarding the reporting of the study 
interventions and implementation methods in the impact review were based only on the 
presence of any description, rather than the adequacy of the description, the review is likely to 
have overestimated the reporting quality of the included studies. While the review of the 
comparative performance of diagnostic prediction rules and clinical judgment also aimed to 
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determine the added value of diagnostic prediction rules beyond that obtained from the 
clinicians’ implicit judgment, by including studies comparing multivariable prediction models of 
clinical judgment with and without a prediction rule, no eligible studies with this objective 
were identified.   
For the systematic review of the diagnostic accuracy and independent value of C-reactive 
protein, an important limitation arose from the absence of studies conducted in the primary 
care setting. All included studies were performed in the emergency department where the 
prevalence of serious bacterial infection is usually higher. In the lower prevalence primary care 
setting, C-reactive protein may be less useful for changing the pre and post-test probability of 
serious infection, as sensitivity and specificity have been shown to vary by prevalence, with 
lower test accuracy often seen in populations where the prevalence of the target condition is 
low. (78) 
The principle limitation of the study assessing the effects of diagnostic prediction rule 
simplification on performance was that the simplified scores have been only temporally 
validated. The more the validation cohort differs from the derivation cohort, the stronger the 
test of generalisability of the prediction rule. (62) While the populations in which the simplified 
rules were derived and validated were separated by time, the cohorts remained similar, 
sharing the same inclusion and exclusion criteria and the same predictor and outcome 
definitions and measurement methods. A further limitation arose from the derivation and 
validation of the simplified rules being performed by the same author. While evaluating one’s 
own prediction rule is a useful first step, it is less desirable than an independent evaluation 
conducted by researchers not involved in their derivation. (105, 317) Lastly, the act of 
simplification is predicated on the assumption that simplified scores are more likely to be 
adopted and used completely and correctly in practice. While some research suggests that 
complexity and useability are barriers to the use of some clinical prediction rules (95, 96) and 
other clinical innovations such as clinical practice guidelines (318) and clinical decision support 
systems, (319) as far as I have been able to determine there is no research evaluating the 
relationship between prediction rule complexity and actual use. 
The limitations of this thesis in addressing the aims of the thesis as a whole derive primarily 
from my decision not to continue with the derivation of a diagnostic prediction rule for the 
identification of serious bacterial infection in children. As a consequence, the second goal of 
the thesis (to assist primary care clinicians’ management of children with possible serious 
infection) could only be partially achieved, and modification of some aspects of the proposed 
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research plan was necessary. My decision not to proceed with the derivation was a pragmatic 
one, reached after preliminary analysis of the sourced dataset revealed that, whilst a 
prediction rule could have been derived, for reasons previously described (Chapter 4), I judged 
a valid and clinically sensible rule could not. The derivation of prediction rules for the sake of 
publication, that are suboptimal in terms of their validity and clinical sensibility, have been 
justifiably criticised. (102) The existence of such prediction rules in the literature conceivably 
undermines clinicians’ confidence in prediction rules as a whole and, further, may adversely 
affect implementation of potentially useful clinical prediction rules. Ultimately, they are 
unlikely to be accepted or implemented by the very clinicians that they are intended to assist. 
7.4 Implications and recommendations arising from this thesis 
The review of the literature related to the development and evaluation of diagnostic 
prediction rules over the duration of this thesis suggests that the literature, while dramatically 
increasing in volume, is failing to produce a commensurate amount of useful knowledge about 
the clinical value of these tools. The key implications arising from the findings of this thesis, 
general recommendations for research practice and one recommendation specific to 
childhood infections are discussed in detail below. 
General recommendations for diagnostic prediction rule research practice: 
 further investigation of the comparative performance of diagnostic prediction rules 
and contemporary diagnostic strategies in both the early and later stages of diagnostic 
prediction rule evaluation 
 improved design, conduct and reporting of comparative studies of diagnostic 
prediction rules  
 investigation of methods of developing and evaluating simplified prediction rules and 
investigation of whether, and how, the complexity and the face validity of a clinical 
prediction rule affects uptake 
 
Recommendation specific to the investigation of children with possible serious bacterial 
infection: 
 
 further investigation of the value of the biomarker C-reactive protein for identifying 
children with serious bacterial infection in the primary care setting 
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7.4.1 Further investigations of the comparative performance of diagnostic prediction rules 
and contemporary diagnostic strategies in both the early and later stages of 
diagnostic prediction rule evaluation 
Despite calls for research directly evaluating, in the same patients or study population, 
alternate diagnostic tests that might be used at the same place in the diagnostic pathway (124, 
320), the reviews of diagnostic prediction rules presented in this thesis indicate that such 
analyses are infrequently conducted in the field of prediction rule research. Evaluations of the 
added value of diagnostic prediction rules are also rare. Elucidating the comparative diagnostic 
performance of diagnostic prediction rules and clinical judgment and/or the added value of 
diagnostic prediction rules over clinical judgment is an important step in the early phase 
evaluation of diagnostic prediction rules, both for informing of the role of the prediction rule 
and guiding further evaluation, and for facilitating the acceptance and amenability of clinicians 
to further evaluation efforts. In the absence of direct comparative research, judgments must 
be made on the basis of indirect comparisons that are prone to confounding effects due to 
differences in patient groups and study methods. (321) However, evaluation of comparative 
performance adds complexity to the design and conduct of validation studies and practical 
guidance may be necessary to ensure ‘fair’ comparison (for example, the prediction rule and 
clinical judgment are compared at a similar time point in the diagnostic pathway). In the later 
stages of evaluation, comparative studies of care, provided with and without a prediction rule, 
are imperative for assessing the effect of prediction rules on health outcomes. While the 
existing clinical prediction rule development framework places comparative studies at the 
centre of later stage evaluations of clinical prediction rules, with randomised comparisons 
being the optimal design, the review presented in this thesis and other reviews of prediction 
rules in specific clinical areas (100, 106, 123), indicate that  few studies of this type are being 
conducted. This is likely to be a reflection of the challenging nature of this kind of evaluation, 
but may also suggest a lack of appreciation or understanding among developers and or 
potential users, of the steps required between the development of a prediction rule and its use 
in practice. Despite their limitations, modelling studies may be a useful alternative, or an 
interim step, to the conduct of randomised impact studies. (93, 322) 
7.4.2 Improved design, conduct and reporting of comparative studies of diagnostic 
prediction rules  
The systematic reviews of diagnostic prediction rules presented in this thesis identified 
numerous challenges to the design and conduct of comparative studies when they are 
undertaken. Many of the threats to the validity of these studies may be minimised or 
ameliorated by researchers following existing guidelines for the conduct and reporting of 
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diagnostic accuracy studies (STARD) and randomised trials (CONSORT), including extensions of 
these guidelines for studies of nonpharmalogic treatments and cluster trials. (178, 209) Though 
the existence of these guidelines or their endorsement by journals has led to improvement in 
reporting quality (323, 324), this improvement is modest and further enforcement of 
adherence to reporting guidelines among researchers, editors and peer reviewers may be 
necessary to improve the quality of reporting of comparative studies of prediction rules to a 
satisfactory level. Additional design considerations for studies comparing prediction rules to 
clinical judgment or usual care may be needed to minimise the risk of study-induced 
behavioural change.   
The review of the comparative performance of diagnostic prediction rules and clinical 
judgment has identified a number of methodological limitations and nuances within the 
included studies that impact on the observable comparative performance of the two 
approaches that should be further considered in future work in this area. Studies should 
include a more detailed discussion of the implications of the context of the comparison and 
factors that affect the location of test and treatment thresholds. For example, a CPR with a 
high sensitivity threshold may be being compared to clinical judgment in a context where 
ruling out the disease may not be the only consideration. Factors such as the seriousness of 
the target condition, the treatment options available, cost availability and side effects of 
diagnostic tests should also be discussed as factors that affect the test-treatment thresholds 
and consequently the interpretation of comparisons between CPRs and clinical judgment. (52)       
As it is not known which study characteristics are associated with diagnostic performance of 
prediction rules, further exploration of the heterogeneity in studies of comparative diagnostic 
performance should be undertaken to generate hypotheses for further testing. This may 
include analysis of subgroups according to prevalence, clinicians’ experience, thresholds for 
ruling in and ruling out, and clinical conditions. Within clinical conditions, the effect of different 
prediction rules could be explored. The size of the studies and their ability to detect a clinically 
important difference between diagnostic prediction rules and clinical judgment to assist users 
of the review in interpreting the individual study and review findings should be assessed.  In 
this review the outcome measures of ‘safety’ (false negative rate) and ‘effectiveness’ 
(proportion of study participants classified as not having disease) have been used.  These are 
less conventional measures than the standard specificity and sensitivity, but were used 
because of their greater applicability in the clinical context.  Further work is needed on 
methods of reporting the study finding and means for facilitating users understanding of the 
primary review outcomes.   Pooling of studies according to the difference (in the proportion of 
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missed cases of disease among those classified as not having disease) between the two 
alternatives, or using metrics summarising the difference (such as the median) are possible 
alternatives or additions. 
The review of the impact of diagnostic prediction rules has revealed a clear need for trials in 
this area firstly to clearly define how diagnostic prediction rules might be expected to affect 
patient and clinical process outcomes, and then to demonstrate these effects via the 
measurement and reporting of: 1) patient centred outcomes that ensure the effects of 
diagnostic prediction rules on all study participants are assessed; and 2) clinical process 
outcomes that allow the resulting health effects to be interpreted and translated into practice. 
Identifying the many mechanisms by which a diagnostic prediction rule may alter patient 
health, and the complex interactions between them, is likely to be a difficult task. It is, 
however, necessary to facilitate a full evaluation of the diagnostic strategy. A practical tool 
may assist in formulating a clear scientific rationale for the intended effects of diagnostic 
prediction rules by comparison with the existing diagnostic pathway. (50) The use of such a 
framework may highlight the need for studies to measure more patient and process outcomes 
than they currently do, which is likely to be both costly and challenging.   
The review of the impact of diagnostic prediction rules also found that reporting of 
intervention characteristics is poor, and needs to be improved if results are to be used to 
enhance diagnostic practice. Comparator strategies described as ‘standard care’ or 
‘conventional investigation’ were particularly poorly reported. Though such strategies may be 
difficult to translate into a prescriptive format, they are equally under evaluation in studies of 
the effect of diagnostic prediction rules, and not reporting them poses an irrevocable 
impediment to the interpretability of results. Furthermore, elements of implementation were 
rarely reported in these studies, making it difficult to determine the mediating effects of 
implementation factors on the study outcomes. Reporting such information is likely to be 
difficult under the space constraints of trial publication, but supplementary reports or 
graphical presentations may be an effective way to communicate these important details. 
(325)  
There are many questions remaining about the effect of diagnostic CPRs.  Firstly, it is unclear 
which factors differentiate between diagnostic prediction rules that improve patient or 
process outcomes and those that do not. Characteristics of the prediction rules themselves, for 
example, whether they are directive or assistive, or the way they are delivered could be 
further explored, though the feasibility of such analysis will be influenced by the number of 
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available studies. Secondly, just as medical interventions (pharmaceutical interventions or 
surgical procedures) when used as intended may cause harm, it is possible that the proper 
implementation of effective prediction rules may also contribute to undesirable outcomes 
(such as decreased clinician satisfaction, clinical reasoning ability or patient satisfaction with 
their clinician). Such potential harms should be further explored.  
7.4.3 Investigation of methods of developing and evaluating simplified prediction rules 
and investigation of whether, and how, the complexity and the face validity of a 
clinical prediction rule affects rule uptake  
The complexity of clinical prediction rules may be a modifiable barrier to their adoption, and 
developers and evaluators of prediction rules should derive, test and consider the clinical 
implications of simplified versions. As the simplification study presented in this thesis suggests, 
simplification may affect performance, but examination of the trade-off between usability and 
performance may have different implications in different situations. Given the fundamental 
role that clinicians play in the implementation of prediction rules, developing a prediction rule 
should not simply be a matter of identifying and publishing the most finely tuned model, but 
should be a clinician-centred process that considers the practical aspects of applying the tool in 
clinical practice. While assessing the effect of simplification of a prediction rule on 
performance can be done within typical validation and derivation studies and does not add 
significantly to the complexity of the evaluation process, obtaining an understanding and 
appreciation of prediction rule characteristics that may influence acceptance may require a 
qualitative study of clinicians for whom the prediction rule is intended. (297, 299) 
The findings of this study suggest further research in two areas. Firstly, simplification of a 
prediction rule is predicated on the assumption that simplified rules, as opposed to more 
complex rules, are more likely to be adopted and used correctly and in entirety by clinicians. 
However, given that simplification may compromise the face validity of the rule which may act 
to prevent adoption, this assumption should be tested. Secondly, the study described one 
approach to the development and evaluation of simplified rules. Alternative methods of 
simplification and of testing performance exist, and further research is necessary to identify 
the most appropriate methodology. 
7.4.4 Further investigation of the value of the biomarker C-reactive protein for identifying 
children with serious bacterial infection in the primary care setting 
The findings of the review of the accuracy of C-reactive protein suggested that further research 
into the value of C-reactive protein as an initial diagnostic test for the workup of childhood 
fever would be worthwhile. Following publication of the review (in 2008), considerable 
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research has been undertaken, with the aim of clarifying the diagnostic accuracy and 
elucidating the clinical value of C-reactive protein. In the first of these studies, a review funded 
by the Health Technology Assessment (HTA) program in the United Kingdom, the value of C-
reactive protein for ruling in and ruling out serious infection in children in ambulatory settings 
was examined. (222) Though the HTA review and the review presented in this thesis used 
slightly different methods and included some different studies, the conclusions with regard to 
the diagnostic accuracy of C-reactive protein were similar. More recently, research has focused 
on assessing the value of C-reactive protein beyond its diagnostic accuracy. In an in-process 
two-part clinical trial, the added value of a point of care C-reactive protein test, above and 
beyond readily available clinical information, will be determined in children considered to 
potentially have a serious bacterial infection on the basis of a clinical prediction rule. (286) 
Among the children without suspected serious infection (according to the prediction rule), 
point of care C-reactive protein testing and/or a brief intervention with safety net advice and 
usual care, will be evaluated for their effects on immediate antibiotic prescribing. (287)  
7.5 Conclusion 
The drive for a safer healthcare system has led to the development of strategies to improve 
the timeliness, accuracy and efficiency of diagnosis. Diagnostic prediction rules are one such 
strategy and, amongst developers of these tools at least, they are posited as having great 
potential to improve clinicians’ diagnostic reasoning and clinical decision making. Ultimately, 
their adoption is expected to improve patient outcomes and/or the efficiency of the diagnostic 
process while at least maintaining patient health.  
Although the clinical prediction rule literature base has expanded rapidly over recent decades, 
there has not been a commensurate increase in our understanding of their potential or actual 
ability to affect clinicians’ diagnoses, decisions or to alter patient health. Further, and with 
perhaps some justification, clinical prediction rules have generally not been warmly welcomed 
or adopted by the very clinicians they seek to assist. Research in the field of diagnostic 
prediction rules must shift from deriving new rules to considering the use and impact of these 
tools in clinical practice. In such studies, patient outcomes will be the ultimate judge of 
whether diagnostic prediction rules offer value to the clinical diagnostic process.    
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PRISMA checklist (page numbers correspond to page numbers in the thesis) 
Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or 
both.  
Page 37 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number.  
Page 39 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is 
already known.  
Paragraph 2 of 
Introduction 
section, Page 40 
Objectives  4 Provide an explicit statement of questions being addressed with 
reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
Paragraph 3 of 
Introduction 
section, Page 40 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
Paragraph 1 of 
Methods section, 
Page 40 
Eligibility 
criteria  
6 Specify study characteristics (e.g., PICOS, length of follow-up) 
and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving rationale.  
Paragraph 1 of 
Methods – Study 
Selection section, 
Page 41 
Information 
sources  
7 Describe all information sources (e.g., databases with dates of 
coverage, contact with study authors to identify additional 
studies) in the search and date last searched.  
Paragraph 1 of 
Methods – Data 
sources and 
searches section, 
Page 41 
Search  8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could be 
repeated.  
Appendix A 
 
Study 
selection  
9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
Paragraph 2 of 
Methods- Study 
Selection section, 
Page 41 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators.  
Paragraph 1 of 
Methods – Data 
extraction and risk 
of bias 
assessment 
section, Page 41 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
Paragraph 1 of 
Methods – Data 
extraction and risk 
of bias 
assessment 
section, Page 41 
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PRISMA checklist continued 
Section/topic  # Checklist item  
Reported on page 
#  
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of 
individual studies (including specification of whether this 
was done at the study or outcome level), and how this 
information is to be used in any data synthesis.  
Paragraph 1 of 
Methods –Data 
extraction and risk 
of bias assessment 
section, Page 41 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, 
difference in means).  
Methods – Data 
synthesis and 
analysis section, 
Page 42 
Synthesis of 
results  
14 Describe the methods of handling data and combining 
results of studies, if done, including measures of 
consistency (e.g., I
2
) for each meta-analysis.  
Methods – Data 
synthesis and 
analysis section, 
Page 43 
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
Paragraph 1 of 
Methods –Data 
extraction and risk 
of bias assessment 
section, Page 41 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
Paragraph 2 of 
Methods – Data 
synthesis and 
analysis section, 
Page 43 
RESULTS  
Study selection  17 Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
Results – Literature 
search section, 
Page 44. Figure 
2.1. 
Study 
characteristics  
18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
Results – Study 
characteristics 
section, Page 44 
Table 2.1.  
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if available, 
any outcome level assessment (see item 12).  
Results – Risk of 
bias assessment, 
Page 45. Figure 
2.2. Table 2.2 
Results of 
individual studies  
20 For all outcomes considered (benefits or harms), present, 
for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence 
intervals, ideally with a forest plot.  
Results – Study 
results section, 
Page 49-52. Table 
2.3 and 2.4, Figure 
2.3 and 2.4. 
Synthesis of 
results  
21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
Meta-analysis not 
conducted 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across 
studies (see Item 15).  
Results – Risk of 
bias assessment, 
Page 45. Figure 
2.2. Table 2.2 
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PRISMA checklist continued. 
Section/topic  # Checklist item  Reported on page #  
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity or 
subgroup analyses, meta-regression [see Item 16]).  
Not applicable 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy 
makers).  
Paragraph 1 of 
Discussion section, 
Page 60 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
Paragraph 5, 6 and 7 
of Discussion section, 
Page 62-63 
Conclusions  26 Provide a general interpretation of the results in the context of 
other evidence, and implications for future research.  
Paragraph 4, 
Discussion section, 
Page 63-64 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 
systematic review.  
Page 64 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. 
doi:10.1371/journal.pmed1000097  
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Electronic database search strategies 
MEDLINE  was searched 
using the Ovid    
interface on  24/4/13 for 
the period 1946 to  
March, Week 4, 2013 
1. ((clinician* or professional* or practitioner* or physician* or nurse*) adj3 (judgment* or 
judgement*or estimate* or diagno* or prediction* or assess* or decision* or intuition* or 
impression* or evaluation* or probabilit* or empirical* or subjectiv* or implicit* or unaided or 
unstructured or accuracy or performance)).ti,ab. 
2. (clinical adj3 (judgment* or judgement* or estimate* or diagnos* or assessment* or 
impression* or probabilit*)).ti,ab. 
3. ((empirical or subjective or implicit or unaided or unstructured) adj3 (judgment* or 
judgement*or estimate* or diagnos* or prediction* or assessment* or decision* or 
impression* or evaluation* or probabilit*)).ti,ab. 
4. 1 or 2 or 3 
5. *Decision Support Techniques/ 
6. (scor* or rule* or model* or guide* or algorithm* or protocol* or "formal estimate" or 
"formal estimates").ti. 
7. 5 or 6       
8. 4 and 7 
Embase was searched using 
embase.com on 27/2/12 
for the period 1974 to 
January, 2012 
1. score*:ti OR rule*:ti OR model*:ti OR guide*:ti OR algorithm:ti OR protocol*:ti 
2. (clinician* OR professional* OR practitioner* OR physician*) NEAR/3 (judgment OR 
judgement OR estimate OR diagnosis OR prediction OR assessment OR decision OR intuition OR 
impression OR evaluation OR probability OR empirical OR subjective OR implicit OR unaided OR 
unstructured) 
3.(empirical OR subjective OR implicit OR unaided) NEAR/3 (judgment OR judgement OR 
estimate OR diagnosis OR prediction OR assessment OR decision OR impression OR evaluation 
OR probability) 
4. 2 or 3 
5. 1 and 3 
Cumulative Index to 
Nursing and Allied Health 
Literature (CINAHL) using 
the EBSCOhost interface on 
27/2/12 for the period 
1982 to January, 2012 
1. TI (score* OR rule* OR model* OR guide* OR algorithm OR protocol OR "formal estimate") 
2. TI ( ((clinician* OR clinical OR professional* OR practitioner* OR physician* OR nurse*) N3 
(judgment OR estimate OR diagnosis OR prediction OR assessment OR decision OR intuition OR 
impression OR evaluation OR probability OR empirical OR subjective OR implicit OR unaided)) ) 
OR AB ( ((clinician* OR clinical OR professional* OR practitioner* OR physician* OR nurse*) N3 
(judgement  OR judgment OR estimate OR diagnosis OR prediction OR assessment OR decision 
OR intuition OR impression OR evaluation OR probability OR empirical OR subjective OR implicit 
OR unaided)) ) 
3. TI ( ((clinical) N3 (judgment OR estimate OR diagnosis OR assessment OR impression OR 
probability)) ) OR AB ( ((clinical) N3 (judgment OR estimate OR diagnosis OR assessment OR 
impression OR probability)) ) 
4. TI ( ((empirical OR subjective OR implicit OR unaided) N3 (judgment  OR judgement OR 
estimate OR diagnosis OR prediction OR assessment OR decision OR impression OR evaluation 
OR probability)) ) OR ( ((empirical OR subjective OR implicit OR unaided) N3 (judgment OR 
estimate OR diagnosis OR prediction OR assessment OR decision OR impression OR evaluation 
OR probability)) ) 
5. 2 or 3 or 4 
6. 1 and 5 
PubMed was searched on 
28/4/13 for systematic 
reviews of clinical 
prediction rules 
1. Medline[tiab] OR (systematic[tiab] AND review[tiab]) OR meta-analysis[ptyp]  
2. Score[ti] OR scores[ti] OR rule[ti] OR rules[ti] 
3. 1 AND 2 
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Appendix B Supplementary material from the 
systematic review of the effects of diagnostic 
clinical prediction rules 
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PRISMA checklist (page numbers correspond to page numbers in the thesis) 
Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or 
both.  
Page 65 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number.  
Page 67 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is 
already known.  
Paragraph 3 of 
Introduction 
section, Page 68 
Objectives  4 Provide an explicit statement of questions being addressed with 
reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
Paragraph 4 of 
Introduction 
section, Page 68 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
Paragraph 1 of 
Methods section, 
Page 69 
Eligibility 
criteria  
6 Specify study characteristics (e.g., PICOS, length of follow-up) 
and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving rationale.  
Paragraph 1 of 
Methods – Study 
Selection section, 
Page 69 
Information 
sources  
7 Describe all information sources (e.g., databases with dates of 
coverage, contact with study authors to identify additional 
studies) in the search and date last searched.  
Paragraph 1 of 
Methods – Data 
sources and 
searches section, 
Page 69 
Search  8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could be 
repeated.  
Appendix B 
 
Study 
selection  
9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
Paragraph 3 of 
Methods- Study 
Selection section, 
Page 69-70 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators.  
Paragraph 1  and  
of Methods – Data 
extraction, risk of 
bias and data 
synthesis section, 
Page 70 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
Paragraph 2 and 
3 of Methods – 
Data extraction, 
risk of bias and 
data synthesis 
section, Page 70 
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PRISMA checklist continued 
Section/topic  # Checklist item  
Reported on page 
#  
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of 
individual studies (including specification of whether this 
was done at the study or outcome level), and how this 
information is to be used in any data synthesis.  
Paragraph 1 of 
Methods –Risk of 
bias assessment 
section, Page 71 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, 
difference in means).  
Methods – Data 
synthesis section, 
Page 71 
Synthesis of 
results  
14 Describe the methods of handling data and combining 
results of studies, if done, including measures of 
consistency (e.g., I
2
) for each meta-analysis.  
Methods – Data 
synthesis section, 
Page 71-72 
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
Paragraph 1 of Risk 
of bias assessment 
section, Page 71 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
Paragraph 2 of Data 
synthesis section, 
Page 71-72 
RESULTS  
Study selection  17 Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
Results – Study 
selection section, 
Page 72. Figure 3.1 
Page 75. 
Study 
characteristics  
18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
Results – Trial 
characteristics 
section, Page .73-
74. Table 3.1.  
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if available, 
any outcome level assessment (see item 12).  
Results – Risk of 
bias. Page 80. 
Table 3.2. Page  
Results of 
individual studies  
20 For all outcomes considered (benefits or harms), present, 
for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence 
intervals, ideally with a forest plot.  
Results – Effects of 
diagnostic 
strategies 
incorporating 
diagnostic clinical 
prediction rules 
section, Page 82-93  
Table 3.3 to 3.8.  
Synthesis of 
results  
21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
Results – Effects of 
diagnostic 
strategies 
incorporating 
diagnostic clinical 
prediction rules 
section, Page 84 
and 88. Figures 3.2 
and 3.3. 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across 
studies (see Item 15).  
Results – Risk of 
bias. Page  80 
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Section/topic  # Checklist item  Reported on page #  
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity or 
subgroup analyses, meta-regression [see Item 16]).  
Results- Studies of 
acute appendicitis – 
Clinicians’‎decisions‎
section. Page 85. 
Results – Assessment 
of reporting of 
interventions section. 
Page 94.  Table 3.9 
Page 95-96.  
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy 
makers).  
Paragraph 1 of 
Discussion section, 
Page 97 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
Paragraph 2, 4, 7 and 
10 of Discussion 
section, Page 97-98, 
101. 
Conclusions  26 Provide a general interpretation of the results in the context of 
other evidence, and implications for future research.  
Paragraph 1 of 
Conclusions section, 
Page 102 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 
systematic review.  
Page 102 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. 
doi:10.1371/journal.pmed1000097  
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Electronic database search strategies 
Ovid MEDLINE(R) In-Process & Other Non-
Indexed Citations and Ovid MEDLINE(R) 
1946 to 30th May 2015.  Searched on 
16/06/2015.     
 
1. Randomized controlled trial.pt. 
2. Controlled clinical trial.pt. 
3. Randomized.ab. 
4. Placebo.ab. 
5. Clinical trials as topic.sh. 
6. Randomly.ab. 
7. Trial.ti. 
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 
9. exp animals/ not humans.sh. 
10. 8 not 9 
11. *Decision Support Systems, Clinical/ 
12. Rule*.ti. 
13. (rule* adj3 (decision OR clinical OR diagnos* OR predict*).ti,ab. 
14. Score*.ti. 
15. (score* adj3 (decision OR clinical OR diagnos* OR  predict* OR 
risk).ti,ab. 
16. ((aid or model) adj3 (clinical or decision or diagnos* or 
predict*).ti,ab. 
17. ((guide or algorithm or protocol) adj2 (diagnos* or decision or 
clinical or predict*)).ti,ab. 
18. 11 or 12 or 13 or 14 or 15 or16 or 17 
19. 18 and 10  
 
Cochrane Central Register of Controlled 
Trials (CENTRAL, Issue 5 of 12 May 2015) in 
the Cochrane Library.  Searched 24/6/2015 
(score* OR rule* OR ((protocol OR aid OR algorithm OR tool OR 
instrument) near/2 (diagnos* OR decision OR clinical OR predict*)) 
):ti 
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Table of studies excluded from the review with reasons for exclusion 
Reference Comment 
Not a study of randomised allocation to care with and without a prediction rule 
Ackerman SL, Gonzales R, Stahl MS, Metlay JP. One size does not fit all: evaluating an intervention 
to reduce antibiotic prescribing for acute bronchitis. BMC Health Serv Res. 2013;13:462. PubMed 
PMID: 24188573. Pubmed Central PMCID: 4228248.  
 
Not a randomised comparison 
Adams ID, Chan M, Clifford PC, Cooke WM, Dallos V, Dombal FT, et al. Computer aided diagnosis of 
acute abdominal pain: a multicentre study. British Medical Journal [Internet]. 1986; 293(6550):[800-
4 pp.].   
 
Before after study 
Ammirati F, Colivicchi F, Santini M. Diagnosing syncope in clinical practice. Implementation of a 
simplified diagnostic algorithm in a multicentre prospective trial - the OESIL 2 study (Osservatorio 
Epidemiologico della Sincope nel Lazio). European Heart Journal. 2000;21(11):935-40. PubMed 
PMID: 10806018.  
 
Not a controlled study 
Beltrán MA, Villar MR, Cruces KS. [Application of a diagnostic score for appendicitis by health-
related non-physician professionals]. Revista médica de Chile [Internet]. 2006; 134(1):[39-47 pp.] 
 
 
 
Not a randomised comparison 
Bajaj RR, Goodman SG, Yan RT, Bagnall AJ, Gyenes G, Welsh RC, et al. Treatment and outcomes of 
patients with suspected acute coronary syndromes in relation to initial diagnostic impressions 
(insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry 
of Acute Coronary Events [CANRACE]). American Journal of Cardiology. 2013;111(2):202-7. PubMed 
PMID: 23122889. 
Not a randomised comparison 
Bessen T, Clark R, Shakib S, Hughes G. A multifaceted strategy for implementation of the Ottawa 
ankle rules in two emergency departments. BMJ. 2009;339:b3056. PubMed PMID: 19675080. 
Pubmed Central PMCID: 2726279.  
 
Before after study 
Bressan S, editor Implementation of PECARN decision rule for children with minor head injury in the 
pediatric emergency department. Mediterranean Emergency Medicine Congress (VI); 2011.  
 
Before after study 
Boutis K, Grootendorst P, Willan A, Plint AC, Babyn P, Brison RJ, et al. Effect of the Low Risk Ankle 
Rule on the frequency of radiography in children with ankle injuries. CMAJ : Canadian Medical 
Association journal = journal de l'Association medicale canadienne. 2013 Oct 15;185(15):E731-8. 
PubMed PMID: 23939215. Pubmed Central PMCID: 3796622. 
Not a randomised comparison. An interrupted time 
series study with matched control 
Brand DA, Frazier WH, Kohlhepp WC, Shea KM, Hoefer AM, Ecker MD, et al. A protocol for 
selecting patients with injured extremities who need x-rays. N Engl J Med. 1982 Feb 
11;306(6):333-9. PubMed PMID: 7054709.  
 
Not a controlled study 
Broekhuizen BD, Sachs A, Janssen K, Geersing GJ, Moons K, Hoes A, et al. Does a decision aid help 
physicians to detect chronic obstructive pulmonary disease? The British journal of general 
practice : the journal of the Royal College of General Practitioners. 2011 Oct;61(591):e674-9. 
PubMed PMID: 22152850. Pubmed Central PMCID: 3177137.  
 
Not a randomised comparison. Study of the 
incremental value of the prediction rule 
Cameron C, Naylor CD. No impact from active dissemination of the Ottawa Ankle Rules: further 
evidence of the need for local implementation of practice guidelines. Cmaj [Internet]. 1999; 
160(8):[1165-8 pp.].  
  
 
Not a randomised comparison. Before after study of 
the effect of an active dissemination strategy. 
Investigators compared use of ankle radiography in 
hospitals receiving an educational intervention with 
some or no use of the OARs  with hospitals who 
declined the dissemination strategy (already using 
the OARs). 
Casey JR, Block S, Puthoor P, Hedrick J, Almudevar A, Pichichero ME. A simple scoring system to 
improve clinical assessment of acute otitis media. Clinical pediatrics [Internet]. 2011; 50(7):[623-9 
pp.].   
 
Not a controlled study 
Christian F, Christian GP. A simple scoring system to reduce the negative appendicectomy rate. 
Annals of the Royal College of Surgeons of England [Internet]. 1992; 74(4):[281-5 pp.].   
 
Not a randomised comparison 
Courtney DM, Kline JA. Prospective use of a clinical decision rule to identify pulmonary embolism as 
likely cause of outpatient cardiac arrest. Resuscitation [Internet]. 2005; 65(1):[57-64 pp.].   
 
Not a controlled study 
den Exter PL, Gomez V, Jimenez D, Trujillo-Santos J, Muriel A, Huisman MV, et al. A clinical 
prognostic model for the identification of low-risk patients with acute symptomatic pulmonary 
embolism and active cancer. Chest. 2013;143(1):138-45. PubMed PMID: 22814859.  
 
Not a controlled study 
Dobbs F. A scoring system for predicting group A streptococcal throat infection. British Journal of 
General Practice. 1996;46(409):461-4. PubMed PMID: 8949324. Pubmed Central PMCID: 
PMC1239715.  
 
Not a controlled study 
Dombal FT, Leaper DJ, Staniland JR, McCann AP, Horrocks JC. Computer-aided diagnosis of acute 
abdominal pain. British medical journal [Internet]. 1972; 2(5804):[9-13 pp.].   
 
Not a controlled study 
Drescher FS, Chandrika S, Weir ID, Weintraub JT, Berman L, Lee R, et al. Effectiveness and 
acceptability of a computerized decision support system using modified Wells criteria for evaluation 
of suspected pulmonary embolism. Ann Emerg Med. 2011 Jun;57(6):613-21. PubMed PMID: 
21050624.  
 
Not a randomised comparison 
Enochsson L, Gudbjartsson T, Hellberg A, Rudberg C, Wenner J, Ringqvist I, et al. The Fenyö-
Lindberg scoring system for appendicitis increases positive predictive value in fertile women--a 
prospective study in 455 patients randomized to either laparoscopic or open appendectomy. 
Surgical endoscopy [Internet]. 2004; 18(10):[1509-13 pp.].   
 
Not a controlled study 
Eccles M, Steen N, Grimshaw J, Thomas L, McNamee P, Soutter J, et al. Effect of audit and feedback,  No control group without Guideline.Guideline does 
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and reminder messages on primary-care radiology referrals: a randomised trial. Lancet. 2001 May 
5;357(9266):1406-9. PubMed PMID: 11356439. 
 
not appear to include a CPR. 
Gonzales R, Aagaard EM, Camargo CA, Jr., Ma OJ, Plautz M, Maselli JH, et al. C-reactive protein 
testing does not decrease antibiotic use for acute cough illness when compared to a clinical 
algorithm. Journal of Emergency Medicine. 2011;41(1):1-7. PubMed PMID: 19095403.  
 
No control group without CPR 
Green L, Mehr DR. What alters physicians' decisions to admit to the coronary care unit? J Fam Pract. 
1997 Sep;45(3):219-26. PubMed PMID: 9300001.  
 
Interrupted time series 
Goldman L, Cook EF, Brand DA, Lee TH, Rouan GW, Weisberg MC, et al. A computer protocol to 
predict myocardial infarction in emergency department patients with chest pain. N Engl J Med. 
1988 Mar 31;318(13):797-803. PubMed PMID: 3280998.  
 
Not a controlled study 
Holroyd BR, Wilson D, Rowe BH, Mayes DC, Noseworthy T. Uptake of validated clinical practice 
guidelines: experience with implementing the Ottawa Ankle Rules. The American journal of 
emergency medicine [Internet]. 2004; 22(3):[149-55 pp.].   
 
Not a randomised comparison 
Harizman N, Oliveira C, Chiang A, Tello C, Marmor M, Ritch R, et al. The ISNT rule and differentiation 
of normal from glaucomatous eyes. Archives of ophthalmology [Internet]. 2006; 124(11):[1579-83 
pp.].   
 
Not a controlled study 
Hsu P, Lam LT, Browne G. The pulmonary index score as a clinical assessment tool for acute 
childhood asthma. Annals of allergy, asthma & immunology : official publication of the American 
College of Allergy, Asthma, & Immunology [Internet]. 2010; 105(6):[425-9 pp.].   
 
Not a randomised comparison 
Iapichino G, Mistraletti G, Corbella D, Bassi G, Borotto E, Miranda DR, et al. Scoring system for the 
selection of high-risk patients in the intensive care unit. Critical care medicine [Internet]. 2006; 
34(4):[1039-43 pp.].   
 
Not a randomised comparison 
Jacobs AA. Clinical prediction of pneumonia. Annals of Internal Medicine. 1991;1114(4):428. 
 
 
Letter to editor 
Kerr D, Bradshaw L, Kelly AM. Implementation of the Canadian C-spine rule reduces cervical spine x-
ray rate for alert patients with potential neck injury. J Emerg Med. 2005 Feb;28(2):127-31. PubMed 
PMID: 15707805.  
 
Not a randomised comparison 
Kilroy DA, Ireland S, Reid P, Goodacre S, Morris F. Emergency department investigation of deep vein 
thrombosis. Emergency medicine journal : EMJ. 2003 Jan;20(1):29-32. PubMed PMID: 12533363. 
Pubmed Central PMCID: 1726005.  
 
Not a controlled study 
Kec RM, Richman PB, Szucs PA, Mandell M, Eskin B. Can emergency department triage nurses 
appropriately utilize the Ottawa Knee Rules to order radiographs?-An implementation trial. 
Academic Emergency Medicine. 2003;10(2):146-50. PubMed PMID: 12574012.  
 
Not a controlled study 
Khan I, Rehman AU. Application of alvarado scoring system in diagnosis of acute appendicitis. 
Journal of Ayub Medical College Abbottabad [Internet]. 2005; 17(3):[41-4 pp.].   
 
Not a controlled study 
Kotowycz MA, Cosman TL, Tartaglia C, Afzal R, Syal RP, Natarajan MK. Safety and feasibility of early 
hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized 
trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial). 
American Heart Journal. 2010;159(1):117.e1-6. PubMed PMID: 20102876.  
 
Not a randomised comparison (diagnostic CPR used 
for assessing inclusion in the study) 
Lopez PP, Cohn SM, Popkin CA, Jackowski J, Michalek JE, Appendicitis Diagnostic G. The use of a 
computed tomography scan to rule out appendicitis in women of childbearing age is as accurate as 
clinical examination: a prospective randomized trial. American Surgeon. 2007;73(12):1232-6. 
PubMed PMID: 18186378.  
 
Not a randomised comparison (diagnostic CPR used 
for assessing inclusion in the study) 
Leddy JJ, Kesari A, Smolinski RJ. Implementation of the Ottawa ankle rule in a university sports 
medicine centre. Medicine and science in sports and exercise. 2002 Jan;34(1):57-62. PubMed PMID: 
11782648.  
 
Not a controlled study 
Lee TH, Pearson SD, Johnson PA, Garcia TB, Weisberg MC, Guadagnoli E, et al. Failure of 
information as an intervention to modify clinical management. A time-series trial in patients with 
acute chest pain. Ann Intern Med. 1995 Mar 15;122(6):434-7. PubMed PMID: 7856992.  
 
 Not a randomised comparison 
Matloob SA, Roach J, Marcus HJ, O'Neill K, Nair R. Evaluation of the impact of the Canadian 
subarachnoid haemorrhage clinical decision rules on British practice. British journal of 
neurosurgery. 2013 Oct;27(5):603-6. PubMed PMID: 23730979.  
 
Not a controlled study 
McAdam WA, Brock BM, Armitage T, Davenport P, Chan M, de Dombal FT. Twelve years' experience 
of computer-aided diagnosis in a district general hospital. Ann R Coll Surg Engl. 1990 Mar;72(2):140-
6. PubMed PMID: 2185682. Pubmed Central PMCID: 2499113.  
 
Interrupted time series study 
McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the 
management of pharyngitis in children and adults. JAMA. 2004 Apr 7;291(13):1587-95. PubMed 
PMID: 15069046. 
Not a randomised comparison 
Mortola GP, Arnulfo G, Reboa G, Pitto G, Masini R, DiSomma C, et al. Clinical application of a 
computerized diagnostic aid in the initial evaluation of 250 outpatients with gastrointestinal 
complaints. Journal of Clinical Computing. 1987;16(3-4):93-103. PubMed PMID: 10302545.  
 
Not a randomised comparison 
Mainous AG, 3rd, Lambourne CA, Nietert PJ. Impact of a clinical decision support system on 
antibiotic prescribing for acute respiratory infections in primary care: quasi-experimental trial. 
Journal of the American Medical Informatics Association. 2013;20(2):317-24. PubMed PMID: 
22759620. Pubmed Central PMCID: PMC3638170   
 
Not a randomised comparison 
Man E, Simonka Z, Varga A, Rarosi F, Lazar G. Impact of the Alvarado score on the diagnosis of acute 
appendicitis: comparing clinical judgment, Alvarado score, and a new modified score in suspected 
appendicitis: a prospective, randomized clinical trial. Surg Endosc. 2014 Aug;28(8):2398-405. 
PubMed PMID: 24705731.  
 
Not a randomised comparison 
Naschitz JE, Rosner I, Rozenbaum M, Naschitz S, Musafia-Priselac R, Shaviv N, et al. The head-up  Not a controlled study 
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Types of primary and secondary outcomes reported in the included studies 
 
Study 
 
 
Patient 
outcomes 
Process outcomes 
Process of 
care 
Clinicians 
Decisions 
Accuracy Use and 
application 
Worrall et al 2007   X   
McIsaac & Goel 1998   X   
McIsaac et al 2002   X   
McGinn et al 2013   X  x 
Little et al 2013 X  x   
Douglas et al 2000  X x   
Farahnak et al 2007  X x   
Lintula et al 2010    X  
Lintula et al 2009    X  
Wellwood et al 1992 x  x X  
Roukema et al 2008  X    
Lacroix et al 2014  x X   
de Vos-Kerkhof et al 2015  x X   
Auleley et al 1997 x  X  x 
Fan et al 2006 x X x   
Than et al 2014 x  X   
Sanchis et al 2010  X    
Torres et al 2014 x  X   
Klassen et al 1993  x X   
Walter et al 2012  x X x  
Rodger et al 2006 X  x   
Horowitz et al 2007 X x    
Bogusevicius et al 2002  x  X  
Stiell et al 2010   X x x 
Stiell et al 2009   X  x 
X primary outcome x secondary outcome 
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Appendix C Supplementary material from 
the study of the simplification of a clinical 
prediction rule 
  
Clinical prediction rules for assisting diagnosis 
 
186 
 
The observed and expected major adverse cardiac events for the original and reduced model 
by decile of predicted risk in the validation dataset 
 
Calculation of reclassification indices 
Unweighted score (cut-off ≥4) 
Event NRI Pr(upIevent) – Pr(downIevent) = (number of events classified up – number of 
events classified down)/number of events 
 
(0 – 0)/133 = 0 
Non-event NRI Pr(downInonevent) – Pr(upInonevent) = (number of nonevents classified 
down – number of nonevents classified up)/number of nonevents 
 
(3-86)/776 = -.10696 = 10.7% 
Overall NRI [Pr(upIevent) – Pr(downIevent)] + [Pr(downInonevent) – Pr(upInonevent)] = 
event NRI + nonevent NRI 
 
0 + -.10696 = -.10696 = -10.7% 
Weighted NRI 
 
Based on decision threshold of 
2% the relative weight of true 
positives to true negatives is 
49:1. Therefore the 
corresponding weights for the 
event and non-event 
components of NRI become s1 = 
x +1 = 50 and s2 = (x + 1)/x = 
1.02041 
s1 x (P(eventIup) x P(up) – P(eventIdown) x P(down)) 
+ s2 x (P(noneventIdown) x P(down) – P(down) – P(noneventIup) x P(up)) 
(Pencina 2011) 
 
 
Not calculated as there are no event reclassifications with the unweighted 
score 
Reduced weighted score (cut-off ≥17) 
Event NRI Pr(upIevent) – Pr(downIevent) = (number of events classified up – number of 
events classified down)/number of events 
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(1-0)/133 = .00752 = 0.752% 
No-nevent NRI Pr(downInonevent) – Pr(upInonevent) = (number of nonevents classified 
down – number of nonevents classified up)/number of nonevents 
 
(24-98)/776 = -.0954 = -.954% 
Overall NRI [Pr(upIevent) – Pr(downIevent)] + [Pr(downInonevent) – Pr(upInonevent)] = 
event NRI + nonevent NRI 
 
0.752 + -9.54 = -8.788 
Weighted NRI 
 
Based on decision threshold of 
2% the relative weight of true 
positives to true negatives is 
49:1. Therefore the 
corresponding weights for the 
event and non-event 
components of NRI become s1 = 
x +1 = 50 and s2 = (x + 1)/x = 
1.02041 
s1 x (P(eventIup) x P(up) – P(eventIdown) x P(down)) 
+ s2 x (P(noneventIdown) x P(down) – P(down) – P(noneventIup) x P(up)) 
(Pencina 2011) 
 
 
50 x (132-131)/909 = .055005 
+ 1.02041 x (325-399)/909 = -.0830694 
 
wNRI = .055005 + -.0830694 = -.028064 = -2.81 
 
Reduced unweighted score (cut-off ≥3) 
Event NRI Pr(upIevent) – Pr(downIevent) = (number of events classified up – number of 
events classified down)/number of events 
 
(2-0)/133 =.015038 = 1.504% 
Non-event NRI Pr(downInonevent) – Pr(upInonevent) = (number of nonevents classified 
down – number of nonevents classified up)/number of nonevents 
 
(3-250)/776 =-.318299 = -31.8% 
Overall NRI [Pr(upIevent) – Pr(downIevent)] + [Pr(downInonevent) – Pr(upInonevent)] = 
event NRI + nonevent NRI 
 
1.504 + -31.8 = -30.29 
Weighted NRI 
 
Based on decision threshold of 
2% the relative weight of true 
positives to true negatives is 
49:1. Therefore the 
corresponding weights for the 
event and non-event 
components of NRI become s1 = 
x +1 = 50 and s2 = (x + 1)/x = 
1.02041 
s1 x (P(eventIup) x P(up) – P(eventIdown) x P(down)) 
+ s2 x (P(noneventIdown) x P(down) – P(down) – P(noneventIup) x P(up)) 
(Pencina 2011) 
 
50 x (133-131)/909 = .11001100 
+ 1.020408 x (325-572)/909 = -.271727172 
 
wNRI = .11001100 + -.271727172 = -.1617161709 = -16.172 
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